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ABSTRACT 
Infection is detrimental to wound healing and is the leading cause of mortality in 
wound patients. Currently, diagnosis of wound infection relies on clinical experience 
complimented by microbiological analysis and non-specific blood tests.  
Point of care diagnostics have the potential to revolutionise treatment of wound 
infection. Early identification of the causative organism of infection, would facilitate 
appropriate prescribing, reducing overuse of antimicrobials and the emergence of 
resistance, while improving patient outcomes. 
Analysis of bacterial culture headspace using Selected Ion Flow Tube Mass 
Spectrometry (SIFT-MS) was combined with multivariate analysis. Using this 
approach it is possible to discriminate between species of bacteria associated with 
wound infection in planktonic culture, including in simulated wound fluid.  
It is also possible to detect volatile profiles from discarded clinical wound dressing 
material, irrespective of dressing type. Within this research it is not possible to link 
the volatile profiles detected to specific bacterial species identified from routine 
wound swab microbiology. 
A collagen wound biofilm model has been developed that can be utilised for real-
time analysis of volatile metabolites during biofilm formation and growth. The 
biofilm model incorporates a collagen gel growth matrix and continuous flow of 
simulated wound fluid to provide wound-like conditions for biofilm culture. 
Discrimination between Staphylococcus aureus, Pseudomonas aeruginosa and 
Streptococcus pyogenes biofilms is possible using SIFT-MS in both full scan and 
selected ion modes when combined with multivariate statistical analysis. 
Comparison of headspace analysis of multi-species biofilms with that of single 
species biofilms reveals that the headspace is generally dominated by a volatile 
profile associated with one of the species within the biofilm community. 
This research successfully demonstrates the feasibility of using volatile analysis to 
discriminate between important pathogens associated with causing clinically 
relevant wound infection and lays a scientific foundation for the development of 
rapid point of care diagnostics.    
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Chapter 1: Introduction 
1.1 OVERVIEW 
Infection is detrimental to wound healing and is the leading cause of mortality in 
wound patients. Currently, diagnosis of wound infection relies on clinical experience 
complimented by microbiological analysis of the wound surface, which may not 
effectively inform treatment. Novel approaches to the diagnosis of wound infection 
are essential, not only to improve patient outcomes, but also to help combat the 
continuing emergence of antimicrobial resistance.  Discrimination between bacterial 
species through the analysis of volatile metabolites may inform the development of 
new rapid techniques for diagnosis of wound infection.    
The aim of this research was to investigate if bacterial species associated with causing 
wound infection produce species specific volatile profiles in vitro that can be used for 
discrimination between species.  The specific aims addressed to achieve this were; 
(1) To investigate if planktonic cultures of wound associated bacteria produce 
species specific volatile profiles in vitro, enabling significant discrimination. 
(2) To investigate if the concept of species discrimination based on volatile 
compound detection could be applied to analysis of discarded wound dressings, 
as part of routine wound care. 
(3) To develop and characterise a suitable biofilm model for culture and headspace 
analysis of wound associated bacterial biofilms, that provides wound-like culture 
conditions.  
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(4) To investigate the volatile profiles of biofilm cultures of wound associated 
bacteria in vitro that can be used for the discrimination between species. 
(5) To investigate the effect of multispecies biofilms on bacterial volatile profiles in 
vitro. 
  
This thesis consists of seven chapters. This chapter (Chapter 1) comprises a general 
introduction, which includes wound healing and infection, biofilm formation and 
models of biofilm infection, and an overview of bacterial production of volatile 
metabolites. Chapter 2 describes the experimental methods employed throughout 
this research and introduces the analytical instrumentation used for the detection of 
volatile metabolites. Chapter 3 details a proof of concept study, to determine if 
bacterial species associated with wound infection produce species specific volatile 
profiles when cultured in complex media and simulated wound fluid. Chapter 4 
investigates the detection of volatile compounds from discarded wound dressing 
material, to determine if dressing materials capture volatile compounds from the 
patients wound and if these volatiles can be related to the bacteria present. Chapter 
5 describes the development of a collagen wound biofilm model, to facilitate the 
analysis of bacterial volatile metabolites under controlled conditions, that are more 
representative of the real wound environment. Chapter 6 investigates the detection 
of species specific volatile profiles from biofilm cultures of wound associated bacteria 
for discrimination between species, and explores any effect of culturing multispecies 
biofilms on the headspace volatiles detected. Chapter 7 presents a general 
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discussion, the main conclusions of this research and recommendations for future 
work.  
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1.2 SKIN STRUCTURE  
The skin is comprised of distinct layers; the epidermis, where keratinocytes are the 
primary cell type, the dermis, primarily comprised of fibroblasts, and a subcutaneous 
fat layer (Figure 1.1). The epidermis is the outer layer, protecting the body from water 
loss and environmental threats, and is itself comprised of layers. These layers are 
characterised by the maturation of keratinocytes as they migrate towards the skin 
surface. The stratum basale is the deepest layer of the epidermis and comprises 
dividing basal cells (stem cells), some of which differentiate to form keratinocytes 
and begin migration (Baroni et al., 2012; Losquadro, 2017). Keratinocytes mature as 
Figure 1.1: Structure of the skin, showing epidermis, dermis and subcutaneous layers, 
vascular network, nerve cells and hair follicle arrangement through the layers. 
Reproduced (modified) with permission from Cancer Research UK/Wikimedia commons 
CC-BY-SA 4.0. 
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they progress through the subsequent epidermal layers; the stratum spinosum and 
the stratum granulosum, which are responsible for synthesis of structural proteins 
including keratin and lipids. When they reach the outermost layer, the stratum 
corneum, the keratinocytes undergo structural changes, lose their organelles and 
become compact, flat squamous cells known as corneocytes (Baroni et al., 2012). 
Tight junction attachments form between keratinocytes, these combined with 
keratin filaments and the cross-linked proteins and covalently bound lipids of the cell 
envelope, provide a tough resistant barrier (Losquadro, 2017). Nutrients are supplied 
to the epidermis by diffusion, as there is no direct blood supply crossing the 
basement membrane known as the dermal-epidermal junction (Losquadro, 2017; 
Baroni et al., 2012). This layer not only separates the two distinct sections of the skin 
barrier but also conveys overall structural integrity, limiting the passage of molecules 
between the two layers and regulating the transit of migrating cells (Losquadro, 
2017).  
The dermal-epidermal junction contains an array of structural proteins and anchoring 
filaments, including a lattice of type IV and VIII collagen fibres (Burgeson and 
Christiano, 1997; Losquadro, 2017). The dermis lies below the epidermis, between 
the dermal-epidermal junction and the subcutaneous fat layer, and is responsible for 
variations in local thickness of the skin.  
The dermis is primarily composed of collagen, and the major cellular component are 
fibroblasts which produce collagen, elastin and other dermal proteins (Losquadro, 
2017; Wang et al., 2015). The dermis also contains blood vessels, nerves and sweat 
and sebaceous glands. The upper layer of the dermis, the papillary dermis, contains 
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loosely packed fibroblasts, collagen and blood vessels. The deep layer, the reticular 
dermis, is thicker and contains fewer cells, but a courser denser network of collagen 
fibres (Losquadro, 2017; Nyström and Bruckner-Tuderman, 2019). The extracellular 
matrix of the dermis is primarily composed of two types of collagen fibres; type I 
which make up 80% of the dermis, and conveys tensile strength, and type III which 
makes up a further 15%, and gives the skin pliability (Meigel, Gay and Weber, 1977; 
Losquadro, 2017). Both collagen and elastin (another structural protein which gives 
the tissue its elasticity) are synthesised within fibroblast cells (Branchet et al., 1991; 
Losquadro, 2017; Meigel, Gay and Weber, 1977; Nyström and Bruckner-Tuderman, 
2019; Wang et al., 2015). The blood supply to the dermis consists of a network of 
vessels throughout the reticular dermis with vascular loops supplying the papillary 
dermis (Losquadro, 2017). Structures that traverse the layers of the skin include the 
pilosebaceous units; comprising of a hair follicle, sebaceous gland, arrector pili 
muscle and nerve ending which cross the dermis and epidermis. Sweat glands are 
located in the reticular dermis and subcutaneous tissue, with ducts that traverse the 
epidermis; of these, the eccrine glands empty on to the skin surface and the apocrine 
glands to the hair shaft (Mellott, Zamierowski and Andrews, 2016; Losquadro, 2017). 
In addition to providing a physical barrier against potential pathogens, the skin also 
exhibits a variety of biochemical and immunological functions; these include 
chemical barriers in the form of lipids, sweat and sebum, and secretion of 
antimicrobial peptides, complement proteins, cytokines and chemokines (Baroni et 
al, 2012; Di Meglio, Perera and Nestle, 2011). Keratinocytes employ surface 
receptors to detect and recognise the presence of microbes, including detection of 
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lipopolysaccharide (LPS), peptidoglycan and flagellin, which allows the keratinocytes 
to distinguish commensals from potentially harmful pathogens, facilitating activation 
of the skins immune response (Nestle et al., 2009). This results in recruitment and 
activation of immune cells, including neutrophils macrophages and natural killer cells 
(Di Meglio, Perera and Nestle, 2011). In addition, the presence of commensal flora 
provide competition for nutrients and physical space (Nestle et al., 2009).  
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1.3 WOUNDS 
In the UK, wound management is predominantly led by nurses and mainly includes 
patients treated in the community (66%), at secondary care facilities or those in long 
term care (Guest et al., 2015).  Annually, the management of wounds by the NHS is 
estimated to require 18.6 million practice nurse visits, 10.9 million community nurse 
visits, 7.7 million GP appointments and 3.4 million hospital outpatient appointments, 
at a total estimated cost of between £4.5 billion and £5.1 billion (Guest et al., 2015). 
A recent study identified 11% of wounds managed by the NHS as unhealed surgical 
wounds, of these 68% were infected or considered at risk of infection at the 
commencement of management within the community (Guest, Fuller and Vowden, 
2018). The study revealed that over a 12 month follow-up period, 18% of patients 
received antimicrobial dressings, 66% were prescribed systemic antimicrobials and 
28% of patients were prescribed topical antimicrobials for a duration of 6 months or 
more. On average, patients whose wounds were not afflicted by infection healed in 
1.9 months at an estimated cost of £2000 per wound, while the cost of managing 
unhealed surgical wounds with infection ranged from £5000 to £11200 per wound 
(Guest, Fuller and Vowden, 2018). 
 
1.3.1 Wound Types 
Wounds result from loss of integrity of the skin barrier due to injury, such as burns, 
or illnesses which result in the development of chronic skin ulcers (Singer and Clark, 
1999). Wounds that result from injury are initially classified as acute wounds 
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regardless of aetiology, and may be caused by accident or traumatic injury, burn 
injury or surgery (Whitney, 2005). Acute wounds that fail to progress through the 
expected stages of healing, and therefore do not heal in a timely manner, are 
classified as chronic wounds.  
Chronic wounds are defined as those which exhibit a delay in the normal wound 
healing trajectory (Metcalf, Bowler and Hurlow, 2014; Percival, 2017).  Over ninety 
percent of chronic wounds are accounted for by venous ulcers, diabetic ulcers and 
pressure sores (Mustoe, O’Shaughnessy and Kloeters, 2006). These chronic wounds 
are associated with the pathophysiology of the patients concomitant underlying 
medical conditions. Venous ulcers occur in the legs, as a result of poorly functioning 
valves. Diabetic ulcers develop from minor cuts and abrasions due to poor circulation 
and compromised immune function, and pressure ulcers occur in patients who are 
bedridden or those who have very limited mobility (Kathawala et al., 2019).  All 
chronic wounds are characterised by their failure to heal and chronic inflammation 
of the wound bed (Demidova-Rice, Hamblin and Herman, 2012). In addition to 
underlying pathophysiology, infection of the wound bed plays a significant role in the 
transition of an acute wound to a chronic wound state (Edwards and Harding, 2004). 
 
1.3.2 Wound Healing 
Wound healing is a continuous process classified in to four distinct yet overlapping 
phases; haemostasis, inflammation, proliferation and remodelling (Figure 1.2) 
(Mellott, Zamierowski and Andrews, 2016). During haemostasis a fibrin clot is formed 
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and aggregation of platelets occurs, this controls bleeding from the site of injury. 
Chemokines are released from activated platelets to attract cells involved in the 
inflammatory phase; namely neutrophils, macrophages and lymphocytes. These 
inflammatory cells then release pro-inflammatory cytokines and growth factors, 
ingest foreign material, increase vascular permeability and stimulate fibroblast 
activity (Gosain and DiPietro, 2004; Guo and DiPietro, 2010; Mellott, Zamierowski 
and Andrews, 2016).  
The proliferation phase is characterised by angiogenesis and granulation tissue 
formation, filling the wound site with new tissue. Fibroblast proliferation and 
collagen synthesis then result in re-epithelialisation by keratinocytes, which migrate 
to the surface from the basal layer (stratum basale) of the epidermis (Gosain and 
DiPietro, 2004; Guo and DiPietro, 2010; Mellott, Zamierowski and Andrews, 2016).  
The process of remodelling occurs gradually over time whereby synthesis, cross-
linking and proper alignment of collagen conveys strength to the new tissue. As this 
process progresses the proportion of mature type I collagen to type III collagen 
increases. However, scar tissue will retain a higher proportion of type III collagen long 
term compared to healthy skin, and will not regain the full strength of normal skin 
(Robins et al., 2003; Singh, Young and McNaught, 2017). Progression of wound 
healing is dependent on a variety of factors, such as wound size, depth and location 
on the body, the age of the patient and the presence of underlying disease (Morton 
and Phillips, 2016).  
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Acute wounds; those resulting from burns or traumatic injury, surgical wounds and 
minor injuries, usually progress through the normal phases of healing in a timely 
manner. However, failure to manage healing of these wounds properly can result in 
complications, infection and delayed healing. Chronic wounds fail to progress, and in 
general wounds failing to heal within 3 months are considered chronic (Morton and 
Phillips, 2016). The expected healing trajectory of a wound of any size can be 
estimated based on the expected rate in reduction of wound size over time (Whitney, 
2005).  
Chronic wounds are often associated with underlying medical conditions including 
diabetes mellitus and vascular disease, or infection. Several factors characterise 
chronic wounds, including poor oxygenation, high levels of inflammatory cytokines, 
proteases and reactive oxygen species, senescent fibroblasts, and high levels of 
bacterial colonisation (Nicks et al., 2010; Siddiqui and Bernstein, 2010; Morton and 
Phillips, 2016). 
 
1.3.3 Skin Microflora 
The surface of the skin, as well as its hair follicles, sweat and sebaceous glands, are 
covered with approximately 106 bacteria per square centimetre (Belkaid and Segre, 
2014). However, skin sampling technique influences the estimated bacterial load, 
whereby one study has shown that 1 x 104 organisms per square centimetre was 
detected by swabbing, 5 x 104 per square centimetre by scraping and 1 x 106 per 
square centimetre from the analysis of punch biopsy specimens taken from skin at 
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the inner elbow of healthy human volunteers, detected by qPCR sequencing of 16s 
rRNA (Grice et al., 2008).  Samples from this skin site were found to be dominated by 
Proteobacteria, particularly Pseudomonas species and Janthinobacterium species 
(Grice et al., 2008).  
Species diversity of the skin microflora occurs between individuals, as well as across 
the varied range of microenvironments represented by different body sites, and 
includes a high diversity of viral and fungal commensals (Oh et al., 2014). Studies 
comparing bacterial microflora detected across body sites have been conducted 
using sequencing of 16S rRNA collected from twenty skin sites representing diverse 
microenvironments, including sebaceous, dry and moist sites (Grice et al., 2009) and 
comparing those collected from skin and other body sites (Costello et al., 2009). Both 
studies concluded that the composition of the microbial community varies with the 
type of sampling site, and that variation between individuals is greater than the 
variation over time in each individual subject sampled. Propionibacteria species and 
Staphylococci were found to dominate sebaceous skin sites, while Corynebacteria 
species predominated at moist sites, although staphylococci were also present. Dry 
skin sites were found to harbour mixed communities without notable dominant 
species (Grice et al., 2009). These sequencing based studies identified 19 microbial 
phyla across 20 skin sites (Grice et al., 2009), and 22 microbial phyla from 27 skin and 
other body sites (Costello et al., 2009). However, both studies concluded that the 
vast majority of sequences identified were attributed to four phyla, Actinobacteria, 
Firmicutes, Proteobacteria and Bacteroidetes (Grice et al., 2009; Costello et al., 2009).  
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Historically, studies of the skin microflora have relied on culture based methods to 
identify resident organisms and it is now apparent that the diversity of the skin 
microflora was hugely underestimated (Fredricks, 2001).  Early studies of the skin 
microflora identified organisms such as species of Staphylococci, Micrococci, 
Corynebacterium and Propinibacterium, but concluded that gram negative rods were 
uncommon inhabitants of human skin (Roth and James, 1989; Evans et al., 1950), in 
direct contrast to the contemporary studies discussed above which identified 
Proteobacteria as the third most common phyla using sequencing based approaches.  
 
1.3.4 Wound Infection 
Bacterial infection delays wound healing and plays a significant role in the failure of 
a wound to move through the four phases of healing (haemostasis, inflammation, 
proliferation and remodelling) in a timely manner (Barajas-Nava et al., 2013; Bowler, 
Duerden and Armstrong, 2001; Edwards and Harding, 2004; Morton and Phillips, 
2016). However, the mere presence of bacteria within a wound site does not 
necessarily result in a clinically significant effect on the patient. The ‘wound infection 
continuum’ (Figure 1.3) describes the progression of infection in a wound by breaking 
down this continuous process in to a number of phases (Haesler and Ousey, 2018). 
The first phase, contamination, is characterised by the presence of low numbers of 
microbes within the wound bed that are not actively undergoing replication, and do 
not elicit a host response (Macgregor et al., 2008; Landis, 2008; International Wound 
Infection Institute, 2016). During the second phase, known as colonisation, microbes 
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begin to replicate within the wound bed and increase in number, although there is 
no tissue damage or host response seen, and this microbial proliferation has no 
clinical impact on the wound (Macgregor et al., 2008; Landis, 2008; International 
Wound Infection Institute, 2016).  
Local infection occurs when multiplying organisms begin to have a detrimental effect 
on wound healing, causing damage to tissue within the wound bed. Microbes move 
deeper in to the wound tissues and proliferate at a faster rate, resulting from failure 
of the host immune system to control bacterial proliferation and invasion (Macgregor 
et al., 2008; Landis, 2008; International Wound Infection Institute, 2016) The term 
local infection has previously been used interchangeably with ‘critical colonisation’, 
with some debate surrounding use of the latter to define clinical observation of 
infection in the absence of microbiological analysis. The most recent international 
consensus document advises against use of ‘critical colonisation’ to avoid ambiguity 
(International Wound Infection Institute, 2016). Without intervention, local infection 
may spread to adjacent tissue beyond the wound border (spreading infection), where 
infection may involve deep tissues, muscles and organs or body cavities. Eventually 
infection may progress to affect the body as a whole (systemic infection), with 
microbes spreading through the systemic circulatory and lymphatic system, resulting 
in sepsis, organ failure and death (Macgregor et al., 2008; International Wound 
Infection Institute, 2016). Wound contamination will likely be poly-microbial, with 
bacteria originating from the surrounding skin flora and other endogenous sources, 
primarily from the oral cavity, gastrointestinal and genitourinary tracts (Bowler, 
Duerden and Armstrong, 2001).  
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In chronic wounds, coagulase negative staphylococci and Staphylococcus aureus 
generally dominate at the early stage of infection, subsequently infection of the 
wound bed frequently involves endogenous gram negative rods including Escherichia 
coli, Klebsiella pneumonia and Enterobacter species, as well as Pseudomonas species 
and Acienetobacter species from environmental sources (Bowler, Duerden and 
Armstrong, 2001; Daeschlein, 2013). Changes in the wound microenvironment allow 
anaerobes to become established as the infection matures. Anaerobes may originate 
from the gastrointestinal tract and oral cavity, where a high proportion of such 
organisms make up the normal microflora, and may include Bacteroides, Prevotella, 
Porphyromonas and Peptostreptococcus species (Bowler, 2002; Bowler, Duerden and 
Armstrong, 2001; Daeschlein, 2013). 
The presence of bacterial infection and bacterial toxins (e.g. LPS) in the wound bed 
results in an excessive inflammation leading to tissue damage (Demidova-Rice, 
Hamblin and Herman, 2012; Crompton et al., 2016); inflammatory cells produce 
proteases which breakdown collagen and other extracellular matrix proteins and 
growth factors within the wound bed (Demidova-Rice, Hamblin and Herman, 2012). 
S. aureus, Pseudomonas aeruginosa and beta-haemolytic streptococci, as well as 
anaerobes, are primarily implicated in delayed healing in both acute and chronic 
wounds (Bowler, Duerden and Armstrong, 2001; Alrawi, Crowley and Pape, 2014; 
DiMuzio et al., 2014). The causative organisms of wound infection are now widely 
thought to exist as biofilms; aggregates of microorganisms encased in a self-
produced extracellular matrix (James et al., 2008; Kennedy, Brammah and Wills, 
2010; Bertesteanu et al., 2014). If the microbial burden of wounds is not adequately 
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managed, then there is a significant risk of the development of sepsis. This is serious 
complication in patients with chronic wounds and severe burns, and is the leading 
cause of mortality. Early management of clinically relevant wound infection is 
essential to minimise the risk of sepsis (Ma, Tian and Liang, 2016; Patil et al., 2017; 
White et al., 2015). 
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1.4 BIOFILMS 
It is now widely accepted that bacteria commonly exist in sessile communities known 
as biofilms, rather than as individual free swimming cells. Biofilms are complex 
communities of microorganisms attached to surfaces or formed from aggregates of 
cells, encased in self-produced extracellular polymeric substances (EPS) (Hall and 
Mah, 2017; Roy et al., 2018) comprised of polysaccharides, proteins, lipids and 
extracellular DNA (Vyas and Wong, 2016). Biofilms in environmental water systems 
were identified as early as 1936 when the tendency for marine organisms to adhere 
to solid surfaces was first observed (Zobell and Anderson, 1936). However, the 
potential importance of biofilm formation in a clinical setting didn’t become apparent 
for several decades. The first clinically relevant biofilms were identified when 
bacterial aggregates were recognised in the formation of dental plaques, within 
sputum from the lungs of cystic fibrosis patients and adhered to indwelling catheters 
(Costerton, Geesey and Cheng, 1978; Lam et al., 1980; Gibbons et al., 1966; Høiby, 
2009; Høiby and Axelsen, 2009; Marrie and Costerton, 1984). It is now understood 
that biofilm formation plays a role in the establishment and persistence of a vast 
array of infections and diseases (Costerton, Stewart and Greenberg, 1999; Dufour, 
Leung and Lévesque, 2010). Once established, biofilms are known to be highly 
resistant to antimicrobials and the host immune response, being responsible for 
various clinically relevant infections, including lung infection in cystic fibrosis, 
endocarditis, osteomyelitis, acute burn infection and chronic wound infections 
(Cooper, Bjarnsholt and Alhede, 2014; Høiby et al., 2015; Furukawa, Kuchma and 
O’Toole, 2006).  
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1.4.1 Biofilm Formation 
The formation and development of biofilm can be described as occurring in 5 stages 
(Figure 1.4); Initial attachment to the surface, whether inanimate or a tissue, 
followed by irreversible attachment where cells become more firmly adhered and 
EPS production begins. The first stage of maturation includes early development of 
biofilm architecture, followed by a further second phase of maturation where this 
architecture develops complexity, and finally the dispersal phase characterised by 
the release of cells from the biofilm (Stoodley et al., 2002). Quorum sensing (QS); 
population density dependent cell to cell signalling systems, mediate co-ordinated 
behaviour in bacteria when certain threshold cell densities are established, and are 
considered fundamental regulators of biofilm formation and virulence (Passos da 
Silva et al., 2017; Saxena et al., 2019). However, the importance of QS regulation of 
biofilm formation is influenced by the local environmental conditions, and hence the 
contribution of QS to biofilm infection varies depending on the site of infection 
(Passos da Silva et al., 2017). 
The intra cellular signalling molecule cyclic di-GMP (c-di-GMP) is thought to be 
responsible for co-ordinating the transition from planktonic to the biofilm mode of 
growth, with high levels of this signalling molecule associated with biofilm formation 
and low levels of c-di-GMP present in motile cells (Valentini and Filloux, 2016). The 
mechanism of surface attachment varies between bacterial species. Initial 
attachment of P. aeruginosa (a widely studied model organism) during biofilm 
formation is mediated by flagellar swimming motility and usually occurs at the cell 
poles (Sauer et al., 2002; Ha and O’Toole, 2015). Movement across a surface by these 
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reversibly attached cells is facilitated by type IV pili mediated ‘twitching motility or 
swarming motility powered by flagella (O’Toole and Kolter, 1998b; Ha and O’Toole, 
2015).  
Irreversible’ attachment is facilitated by suppression of these motility functions (Ha 
and O’Toole, 2015). In S. aureus there are several modes of surface attachment, 
either involving a polysaccharide antigen named polysaccharide intercellular 
antigen (PIA) or by PIA independent mechanisms involving alternative strain 
dependant attachment proteins (Archer et al., 2011). Production of EPS stabilises and 
reinforces attachment and facilitates the development of three-dimensional biofilm 
structures. The composition of the EPS varies depending on the species present 
within the biofilm and influences the formation of structural architecture (O’Toole 
and Wong, 2016; Borlee et al., 2010), with EPS production thought to be regulated 
by quorum sensing  (Frederick et al., 2011).  
Maturation occurs as cells within the biofilm divide and multiply, and as a result of 
EPS production; the overall structure of the biofilm architecture is dependent on the 
nature of the components of the EPS. This process can result in the formation of cone 
shaped or mushroom shaped microcolonies interspersed with water channels. 
Gradients of pH, oxygen and nutrients within the biofilm provides a diverse range of 
microenvironments, allowing fastidious organisms with a variety of specific 
environmental requirements to co-exist within multispecies biofilms (Costerton et 
al., 1995; Kuchma, Connolly and O’Toole, 2005; Frederick et al., 2011; Flemming and 
Wingender, 2010).  
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Maturation occurs as cells within the biofilm divide and multiply, and as a result of 
EPS production; the overall structure of the biofilm architecture is dependent on the 
nature of the components of the EPS. This process can result in the formation of cone 
shaped or mushroom shaped microcolonies interspersed with water channels. 
Gradients of pH, oxygen and nutrients within the biofilm provides a diverse range of 
microenvironments, allowing fastidious organisms with a variety of specific 
environmental requirements to co-exist within multispecies biofilms (Costerton et 
al., 1995; Kuchma, Connolly and O’Toole, 2005; Frederick et al., 2011; Flemming and 
Wingender, 2010).  
The final phase of the biofilm life-cycle, dispersal, involves detachment of cells from 
the biofilm and their release in to the environment; a process essential for 
dissemination to a new location and enabling disease transmission (Kaplan, 2010; 
Petrova and Sauer, 2016). There are several processes by which cells can leave a 
biofilm, which include both active and passive mechanisms of dispersal. Passive 
mechanisms include abrasion, erosion and sloughing which are driven by the actions 
of external forces on the biofilm. Active dispersal is mediated from within the biofilm, 
usually in response to changes in conditions in the local biofilm environment (Fleming 
and Rumbaugh, 2017), driven by many species dependent ques and signalling 
systems involved in the active dispersal of cells from within the biofilm. These 
ultimately lead to degradation of areas of the EPS to facilitate mobilisation of cells 
from within the biofilm which are then released as planktonic cells able to disperse 
to a new location (McDougald et al., 2012). 
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1.4.2 Biofilms in Wounds 
The formation of biofilms in the wound bed has been implicated in the transition 
from an acute to chronic wound state, due to resultant persistent inflammation, 
delayed granulation and epithelial migration, and impaired migration and 
proliferation of keratinocytes (Rajpaul, 2015). Microscopic evaluation of the 
presence of biofilm in both chronic and acute wounds resulted in identification of 
large aggregates, classified as biofilm by the authors, in 60% of chronic wounds and 
6% of acute wounds (James et al., 2008). In addition, the authors noted that small 
micro colonies were often present in the acute wounds examined in this clinical 
study. Furthermore, a systematic review and meta-analysis on studies conducted 
between 2008 and 2015 reported evidence for the presence of biofilms in 78.2% of 
human chronic wounds (Malone et al., 2017). The studies included diabetic foot 
ulcers, venous leg ulcers, pressure ulcers and non-healing surgical wounds. A recent 
study assessed the presence of biofilm in acute epidermal wounds, blisters that were 
formed on the buttocks of healthy human volunteers (Bay et al., 2018). This study 
demonstrated the formation of aggregates of coagulase negative staphylococci in 
78% of wounds. These were generally localised at the wound edges and were 
significantly more common within the wounded tissue than on the adjacent healthy 
skin (Bay et al., 2018).  
Animal studies have been performed to assess the effect of biofilm formation on 
wound healing under controlled conditions. For example, in a rabbit model of wound 
infection (Gurjala et al., 2011), S. aureus was found to form a mature biofilm within 
24 hours of inoculation and generate a sustained low grade host response localised 
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within the wound bed. The study also demonstrated that the presence of biofilm 
contributed to the impairment of wound healing processes. A mouse model of 
chronic wound infection has been used to compare the effect of biofilm formation in 
diabetic and healthy animals (Nguyen et al., 2013). Biofilm formation delayed healing 
in both groups but the effect was exaggerated in the diabetic animals, demonstrating 
the importance of this underlying pathophysiology for predisposing the development 
of chronic wounds. These studies clearly demonstrate the presence of biofilm in a 
variety of wound types, providing evidence for the involvement of biofilm formation 
in the development of wound infection.  
 
1.4.3 Biofilm Tolerance 
Reduced susceptibility to antimicrobials is intrinsic to the biofilm mode of growth, 
but is usually considered tolerance rather than true resistance, and can be lost when 
biofilm bacteria are released in to the environment and revert to a planktonic state 
(Bridier et al., 2011). Contributing mechanisms include, interaction with the 
extracellular matrix slowing penetration of antimicrobial agents, slow growth rate 
resulting in reduced susceptibility, heterogeneous metabolism due to distinct sub-
populations and the presence of persisters (Olsen, 2015). The concentration of 
antibiotics required to treat biofilms are thought to be 100 to 1000-fold higher than 
the planktonic minimum inhibitory concentration (MIC) (Hall and Mah, 2017; Del 
Pozo, 2018). As a result biofilm infections are likely to persist long-term despite 
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antibiotic treatment, and are prone to relapse after treatment is completed (Hall and 
Mah, 2017; Del Pozo, 2018).  
Mature biofilms are characterised by the production of EPS which can interact with 
and inhibit the diffusion of antimicrobial agents. Positively charged antimicrobials in 
particular, may become bound to negatively charged polymers present within the 
biofilm EPS, preventing transit into the biofilm structure and interaction with drug 
targets (Jolivet-Gougeon and Bonnaure-Mallet, 2014). Nutrient and oxygen 
concentration vary between the surface and centre of biofilm formations, resulting 
in variability in the growth rate of bacterial cells within the biofilm (Stewart, 2015; 
Høiby et al., 2010). This impacts susceptibility to antimicrobials which are only 
effective against actively growing cells, for example the β-lactams which inhibit 
bacterial cell wall synthesis (Stewart, 2015; Høiby et al., 2010). In addition, dormant 
persister cells are thought to exist as a small sub-population, able to repopulate a 
biofilm when cell numbers are depleted by an antimicrobial, possibly resulting in the 
resurgence of infection after treatment (Lewis, 2010; Fisher, Gollan and Helaine, 
2017). Furthermore, a high mutation rate among biofilm bacteria compared to their 
planktonic counterparts, as well as high cell density facilitating increased horizontal 
gene transfer, results in an elevated occurrence of multi-drug resistance mechanisms 
among bacterial cells within a biofilm (Jolivet-Gougeon and Bonnaure-Mallet, 2014). 
In addition, expression of β-lactamase enzymes, induced in response to exposure to 
β-lactam antibiotics can accumulate in the biofilm EPS (Giwercman et al., 1990; 
Bagge et al., 2004), affording protection not only to the enzyme producing cells 
themselves but also adjacent cells within the biofilm. 
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1.5  DIAGNOSIS OF WOUND INFECTION 
There is no universally adopted consensus for the diagnosis of wound infection 
(Hughes, 2016), which usually relies on the ability of clinicians to identify the clinical 
signs of infection. Diagnosis of wound infection is therefore somewhat subjective, 
relying on the specific experience of the clinician and their interpretation of clinical 
symptoms and non-specific test results (Haalboom et al, 2019). Indicators of infection 
include increased pain, an excessive or increased volume of exudate, localised heat 
and swelling, malodour and erythema (Hughes, 2016; Macgregor et al., 2008). 
However, in chronic wounds these classic clinical signs of infection are often minimal 
or absent (Siddiqui and Bernstein, 2010). Conversely, the systemic response to burn 
injury results in the release of high levels of inflammatory mediators (Greenhalgh et 
al., 2007; Jeschke and Herndon, 2014). As a result the standard indicators are difficult 
to apply to both these wound types.  
Visual observation is often important during preliminary wound assessment, 
whereby the appearance of the wound is categorised and documented. Photography 
and digital tracing may be employed to facilitate recording of wound appearance 
parameters and can subsequently be employed to monitor progression (Li et al, 
2020). There is no definitive testing available to identify wound infection, but 
microbiological wound cultures are often employed to supplement clinical diagnosis 
and inform treatment (Blokhuis-Arkes et al., 2015; Greenhalgh et al., 2007). 
However, it should be noted that bacterial load or type detected cannot provide a 
diagnosis in itself and microbiological analysis should only be used to complement 
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clinical diagnosis; to confirm the presence of pathogenic strains within the wound 
bed and establish antibiotic sensitivities (Sibbald et al, 2003; International Wound 
Infection Institute (IWII), 2016; Macgregor et al., 2008; Edwards and Harding, 2004; 
Landis, 2008).  
A bacterial load in excess of 105 cfu per gram of tissue within the wound bed, as 
measured by wound biopsy, has been correlated with an increased risk of the 
development of sepsis. However, although wound biopsy is considered the gold 
standard method for the identification of bacteria in the wound bed, this is rarely 
used in routine clinical practice because it is an invasive and painful procedure  
(Sjöberg et al., 2003; Uppal et al., 2007; Haalboom et al., 2019). The signs and 
symptoms that clinicians use as indicators of wound infection vary as the wound 
infection continuum progresses (see section 1.3.4) and are outlined in Table 1.1 
below.  
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1.5.1 Antimicrobial Resistance 
The relationship between antibiotic use and resistance was documented in the 
1940s, before penicillin was widely available for clinical use; when the first bacterial 
penicillinase enzymes were isolated from Escherichia coli (Greenwood, 2008). At this 
early stage in the development of β-lactam antibiotics, it was also demonstrated that 
resistance to penicillin could be induced in Staphylococci, by repeatedly sub-culturing 
Table 1.1: Signs and symptoms indicative of infection as the phases of the wound 
infection continuum progress (International Wound Infection Institute (IWII), 2016). 
Local Infection Spreading infection Systemic infection 
Subtle Classic     
Hypergranulation Erythema Lymphangitis Severe sepsis 
Bleeding, friable  
granulation 
Local warmth Crepitus Septic shock 
Swelling Wound breakdown/ 
dehiscence 
Organ failure 
Epithelial 
bridging  
and pocketing 
in granulation 
tissue 
 
Purulent 
discharge 
Death 
Delayed 
healing 
Malaise/Lethargy 
 
Wound 
breakdown 
and enlargement 
New or 
increasing  
pain 
Loss of appetite 
 
Inflammation,  
swelling of lymph  
glands 
 
Delayed healing Increasing  
malodour 
 
New or 
increasing  
pain 
   
Increasing  
malodour 
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in the presence of the antibiotic (Greenwood, 2008; Kong, Schneper and Mathee, 
2010).  
Bacteria employ a variety of mechanisms to convey resistance to antibiotics, 
including deactivation of the antibiotic, modification of the target site, antibiotic 
sequestering and efflux. In addition, bacteria exhibit high levels of genetic plasticity, 
allowing adaptation to new antibiotic treatments. This manifests as genetic mutation 
to avoid the mechanism of action of the antibiotic, or uptake of DNA by horizontal 
gene transfer resulting in acquisition of established resistance mechanisms (Munita 
and Arias, 2016; Peterson and Kaur, 2018). For example, there are three primary 
mechanisms of resistance to the β-lactam antibiotics: Firstly, deactivation of the 
antibiotic through hydrolysis by β-lacatmase enzymes; a mechanism of resistance 
found among both gram-positive and gram-negative organisms (Wilke, Lovering and 
Strynadka, 2005; Babic, Hujer and Bonomo, 2006; Peterson and Kaur, 2018). 
Secondly, alteration of the target site, through modification or acquisition of resistant 
penicillin binding proteins (PBPs), found in several important gram-positive 
pathogens, including species of Staphylococci and Streptococci (Wilke, Lovering and 
Strynadka, 2005; Peterson and Kaur, 2018). Finally, prevention of access of the 
antibiotic to the target site through alterations to membrane permeability, and 
upregulation of efflux pumps which actively remove antimicrobial compounds from 
the bacterial cell, as identified in Pseudomonas species and other gram-negatives 
(Wilke, Lovering and Strynadka, 2005; Babic, Hujer and Bonomo, 2006; Peterson and 
Kaur, 2018). 
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1.5.1.1 Strategies to Combat AMR 
It is now widely accepted that we are facing a public health crisis as antimicrobial 
resistance (AMR) continues to emerge globally, resulting in ever increasing numbers 
of multi-drug resistant organisms. It is estimated that without intervention, annual 
deaths attributed to antimicrobial resistance will reach 10 million by 2050 with a 
global economic cost of 100 trillion USD (O’Neill, 2014, 2016).  Both the World Health 
Organisation and the UK Government have committed to addressing this crisis 
through the development of ‘The global action plan on antimicrobial resistance’ and 
‘The review on antimicrobial resistance’ (World Health Organization, 2016; O’Neill, 
2016). The final report of ‘The Review on Antimicrobial Resistance’ (O’Neill, 2016) 
highlights 10 fundamental recommendations or ‘commandments’ for tackling the 
AMR crisis. These are summarised in Table 1.2 and firstly, includes suggested 
strategies to reduce the current demand by altering the ways antibiotics are 
consumed and prescribes (1-7). Secondly, the need to increase the number of 
available antimicrobials to treat infections that have developed resistance to those 
currently available (8-9) and finally, the need for global cooperation in these actions 
(10). However, a review of achievement of these recommendations two years after 
publication of the final report, suggests progress has so far has been slow and that 
more investment and government commitment are required to achieve these goals 
(Collier and O’Neill, 2018). 
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The research detailed within this thesis has relevance to strategy number 5 ‘Promote 
new, rapid diagnostics to cut unnecessary use of antibiotics’. Infection is the greatest 
cause of mortality in wound patients and is of particular concern in those with burn 
wounds (Lachiewicz et al., 2017; Mir, Khurram and Khan, 2017). As a result, and due 
to the difficulty associated with definitively diagnosing wound infection and reliably 
identifying the causative organism, antibiotic treatment is commonly prescribed 
empirically (Shortt and Thoma, 2008; Lachiewicz et al., 2017; Mir, Khurram and Khan, 
2017). Treatment strategies vary widely, with choice of antibiotic usually determined 
by the perceived risk of infection, and the most likely contaminating organism based 
on wound location and knowledge of local epidemiology (Shortt and Thoma, 2008; 
Mir, Khurram and Khan, 2017; Nicks et al., 2010). The common practice of empirical 
prescribing of antimicrobials is a major concern leading to huge over-use of 
antibiotics and further perpetuates the rise in antimicrobial resistance. The 
development of new rapid approaches to the diagnosis of wound infection would 
allow clinicians to confidently identify infection at an early stage and aid 
identification of the causative organisms. This would facilitate early use of 
appropriate antibiotics and eliminate the need for empiric therapy, thus eliminating 
use of antibiotics when they are not required, while promoting targeted therapy. 
 
1.5.2 Emerging Approaches to Wound Diagnostics 
Considering the difficulties associated with wound management it is unsurprising 
that there is increasing interest in the use of novel technologies for wound 
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monitoring and infection diagnosis. The use of three-dimensional imaging to monitor 
wound healing progress has been explored (Savage and Jeffery, 2013). The authors 
found that the technology could be successfully implemented for the measurement 
of wound size, volume and depth, and that it provided a useful record of the visual 
status of the wound. However, it was concluded that the high cost compared to 
traditional photography and the time consuming set up required made the 
technology unsuitable for routine clinical management without further technological 
advancements (Savage and Jeffery, 2013).   
Several studies have investigated the use of small sensors to monitor a variety of 
wound parameters. For example, a sensing system combining temperature, moisture 
and pressure sensors with a wireless telemetry system connected to a portable 
receiver has been trialled in healthy volunteers (Mehmood et al., 2015). This study 
successfully demonstrated the potential to continuously monitor these wound 
parameters in real-time, without disturbing the wound, and suggested that changes 
in both temperature and moisture level could provide early indication of infection.  
Sensing of uric acid as an indicator of wound severity has been explored by a number 
of studies, which have integrated uric acid sensors into wound dressings, so called 
‘smart dressings’ (Sharp and Davis, 2008; Phair et al., 2014; Kassal et al., 2015). The 
application of uric acid sensing is two-fold; uric acid concentration is expected to rise 
as wound healing progresses normally (Sharp and Davis, 2008), but a rapid and 
sustained decrease in uric acid concentration could indicate increased metabolism 
by invasive bacterial species (capable of uric acid metabolism, such as P. aeruginosa) 
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and hence provide an early indication of infection (Phair et al., 2014; Kassal et al., 
2015).  
Another sensing approach to chronic wound management is the use of pH detection 
for monitoring healing progression (Rahimi et al, 2016). Development of a flexible pH 
sensor array based on a polymer coated paper substrate allows pH mapping of the 
wound bed, in contrast to traditional probe devices which allow only single point pH 
measurement. This study successfully demonstrates the linear range of the sensor 
array between pH 4 and 10, and suggests the response rate, stability and 
biocompatibility of the device will make it suitable for integration in to a wound 
dressing for regular monitoring of chronic wounds (Rahimi et al., 2016).  A further 
study investigating the use of pH monitoring for wound management reports the 
development of a dual electrochemical sensor array, combining a pH sensor with a 
bacterial attachment sensor (Sheybani and Shukla, 2017). The aim of combining the 
two sensing elements was to increase selectivity over the use of pH sensors alone, to 
improve accuracy of the detection of bacterial infection in the wound bed. The 
authors used a polymer coating to stabilise the sensor array and promote bacterial 
attachment while preventing non-specific protein fouling. The study reports 
successful detection of bacterial growth within 30 minutes of inoculation at 102 cfu 
mL-1, a pH range of 1 to 13 and 14 day stability of the sensor array, which was tested 
in the presence of a simulated wound fluid (Sheybani and Shukla, 2017). 
Another ‘smart dressing’ technology has been developed that integrates lipid vesicles 
containing a fluorescent dye within a wound dressing to provide an early detection 
system for pathogenic bacterial biofilms (Thet et al., 2016). In this study the authors 
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successfully demonstrated the efficacy of the dressing using an ex vivo porcine skin 
model of wound infection, whereby contact with bacterial biofilms of P. aeruginosa, 
S. aureus and Enterococcus faecalis resulted in release of the self-quenching dye from 
its vesicles, activating the fluorescence.  
A recent study investigated the use of a multi-electrode sensor array for long term 
monitoring of wound healing (Kekonen et al., 2019). The sensor was integrated in to 
a primary wound dressing and used to monitor the electrical impedance of both 
intact and wounded skin.  The study reported a significant reduction in electrical 
impedance measured when the sensor was in contact with wounded skin compared 
to intact skin and suggested the sensor may be suitable for long term monitoring of 
wound healing processes. In addition, the study demonstrated concurrent 
stimulation of the wound with low intensity direct current, resulting in production of 
hydrogen peroxide at clinically relevant concentrations. Hydrogen peroxide is a 
known antimicrobial and production at the wound site may aid healing by preventing 
development of infection (Kekonen et al., 2019) 
An investigation in to the use of Field Asymmetric Ion Mobility Spectroscopy (FAIMS), 
a technique used to analysed gas phase ions based on their mobility in a carrier gas, 
demonstrated the potential application of this technology to the diagnosis of wound 
infection (Sun et al., 2019). The authors combined the FAIMS technology with 
machine learning analysis to demonstrate the ability to successfully recognise 
96.15% of samples from wounds infected with E. coli compared and uninfected 
controls. The study included samples from excised tissue, wound secretions and 
drain fluid that were culture positive for E. coli either alone or in combination with 
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other organisms. If further development of this study demonstrates that FAIMS 
technology can be utilised to recognise uninfected controls from a range of clinical 
relevant organisms this technology has the potential to provide useful diagnostic 
insight.    
Use of the imaging mass spectrometry (IMS) technique MALDI IMS has been explored 
for the assessment of treatment of pressure ulcers (Taverna et al, 2015). This 
technique permits direct analysis of intact tissue without preliminary protein 
purification and was utilised within this study to identify protein signatures from 
three distinct niches; wound bed, hypertrophic epidermis and adjacent dermis, 
within chronic, intermediate and healing pressure ulcers. The authors found 
characteristic localisation of proteins within the different wound niches and suggest 
this technique could be implemented to facilitate monitoring response to treatment 
in pressure ulcers (Taverna et al., 2015).     
Development of low cost sensors for direct non-invasive detection of wound 
infection could revolutionise diagnostics. A recent study (Salinas Alvarez et al, 2019) 
begins to explore the use of a combination of low cost gas sensors for the detection 
of volatile compounds emitted from P. aeruginosa and 6 other microorganisms found 
on the skin. In this study four gas sensors for the detection of ammonia and amines, 
carbon dioxide, alcohol and acetone were investigated. The authors found that there 
were clear differences in the sensor response between this microbial species 
analysed, indicating the potential of this approach for the development of non-
invasive diagnosis of infection.  
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Electronic nose technology aims to simulate the ability of the human olfactory 
system, through the use of multiple gas sensors, to detect characteristic signatures 
of odorous volatile compounds (Sun et al., 2017). One study describes the 
optimisation of an array of 34 electrochemical and metal oxide sensors for the 
detection of bacterial infection of wounds. The optimal combination of 20 of these 
sensors, determined within this study, achieved a recognition rate of 96.15% of 
samples of E. coli, S. aureus, P. aeruginosa and bacterial culture media, effectively 
demonstrating the feasibility of this technology for identifying wound infections (Sun 
et al., 2017).   
Further development of these and additional novel approaches to wound 
management, and in particular the diagnosis of wound infection, is essential to 
improve patient care while reducing over-use of antibiotics in light of the ongoing 
AMR crisis. 
 
1.5.3 Microbial Volatiles 
Bacteria produce volatile compounds; metabolites with a low molecular weight and 
high vapour pressure that readily evaporate, and are released in to the surrounding 
environment. Bacterial production of over 1000 volatile compounds has been 
described, with a single species capable of producing up to 80 different compounds 
(Audrain et al., 2015; Schulz and Dickschat, 2007). Primary fermentation of 
carbohydrates gives rise to short chain fatty acids (including lactate, acetate and 
propionate) and ethanol, while secondary fermentation produces butyrate, 
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propionate, propanol, butanol, and hexanol (Thorn and Greenman, 2012). 
Degradation of fatty acids through the β-oxidation pathway provides precursors for 
a range of classes of volatile compounds produced by bacteria (Schulz and Dickschat, 
2007; Audrain et al., 2015). Decarboxylation of these fatty acid derivatives then 
results in the production of alkanes, alkenes and methyl ketones (Schulz and 
Dickschat, 2007). Acetoin and 2,3-butanedione arise from fermentation of pyruvate 
(Audrain et al., 2015), and modification of branched amino acids results in production 
of branched alcohols and branched aldehydes (Schulz and Dickschat, 2007; Audrain 
et al., 2015). Organic sulphur compounds such as dimethyl sulphide and 
methanethiol are derived from the amino acid methionine, while hydrogen sulphide 
production results from the breakdown of cysteine, another sulphur containing 
amino acid (Audrain et al., 2015). Nitrogen containing compounds, such as ammonia 
and amines are produced by metabolism of amino acids (Halász et al., 1994; Audrain 
et al., 2015) and trimethylamine is generated by catabolism of choline by anaerobic 
bacteria and through reduction of trimethylamine oxide under both aerobic and 
anaerobic conditions (Craciun and Balskus, 2012; Audrain et al., 2015). Bacterial 
metabolism of the aromatic amino acids gives rise to phenolic and indolic 
compounds. For example, phenol, 4-ethylphenol and 4-methylphenol from tyrosine, 
phenylpropanoate and phenylacetate from phenylalanine, and Indole and skatole 
from tryptophan (Windey, De Preter and Verbeke, 2012). Metabolism of carbon 
energy sources differs between bacterial species due to the availability of different 
metabolic pathways and hence result in the production of species specific volatile 
profiles (Thorn and Greenman, 2012). These differences can be detected by 
Chapter 1 – Introduction 
 
40 
 
implementing a variety of analytical techniques. In recent years there has been 
increasing interest in monitoring microbial volatile metabolites as a non-invasive 
approach to the diagnosis of infection.  
Gas chromatography (GC) is considered the gold standard technology for the analysis 
of volatile compounds, and has been implemented in several studies investigating 
the potential of using detection of bacterial volatile metabolites in the diagnosis of 
infection. Analysis of breath samples to identify markers of lung infections have been 
the focus of a number of studies, including breath sampled from ventilated patients 
using thermal desorption tube GC-MS, coupled with microbiological analysis of 
lavage fluid samples to determine if volatile analysis could identify infection in these 
patients (Fowler et al., 2015). The authors of this study found that the volatile profiles 
of the breath of ventilated patients showed clear separation between infected and 
non-infected patients.   
Volatile compound profiling using solid phase microextraction (SPME) and two 
dimensional GC with time of flight mass spectrometry (GCxGC TOFMS) has been 
employed for in vitro discrimination of 6 bacterial species associated with infection 
of the lungs of cystic fibrosis patients (Nizio et al., 2016). Similarly, GCxGC TOFMS has 
been employed in the analysis of respiratory epithelial cells infected with P. 
aeruginosa, respiratory syncytial virus or both, in a human bronchial epithelial cell 
line to determine if infection could be identified using volatile analysis (Purcaro et al., 
2018). It was found that detection of volatile metabolites could be utilised to 
discriminate between cells that were and were not infected with P. aeruginosa. GC-
MS has been used within in vitro studies for the analysis of the headspace of pure 
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planktonic bacterial cultures, to characterise and compare VOCs released or 
consumed by S. aureus and P. aeruginosa cultures (Filipiak et al., 2012b) and to 
characterise and quantify VOCs in the headspace of E. coli and P .aeruginosa cultures 
using needle-trap GC-MS (Zscheppank et al., 2014). Both of these studies concluded 
that the volatile compounds produced varied between species under the specific 
culture conditions investigated.  
The potential application of volatile analysis to the diagnosis of wound infection using 
GC-MS has also been explored, through the analysis of the headspace of bacterial 
biofilms cultured in a model of wound infection utilising human skin explants (Ashrafi 
et al., 2018). This study successfully demonstrated the detection of volatile 
compound profiles from bacterial biofilms in these models.  GC-MS analysis of breath 
or bacterial culture headspace usually requires immobilisation and pre-
concentration of headspace volatiles onto sorbent material, which can be performed 
using desorption tubes, SPME fibres or using a needle trap system, as in the studies 
mentioned above. In addition to the pre-concentration step, the length of GC-MS run 
times makes this technique time consuming. So, although considered the gold 
standard technique, highly sensitive for the identification of volatile compounds, 
particularly in complex mixtures, GC-MS is not well suited to real-time analysis. 
Rapid mass spectrometry techniques that lack a chromatographic separation phase 
have been developed that facilitate real-time analysis of volatile compounds in 
gaseous samples. These included Proton Transfer Reaction Mass Spectrometry (PTR-
MS) and Selected Ion Flow Tube Mass Spectrometry (SIFT-MS), techniques which rely 
on selective soft ionisation with little fragmentation of compounds (Thalavitiya 
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Acharige, Koshy and Koo, 2018). Application of technologies to detect and quantify 
bacterial volatile compounds in real-time has the potential to inform development 
of non-invasive point of care diagnostics. SIFT-MS is used for real-time analysis of the 
gaseous headspace of bacterial culture within this research.  
SIFT-MS facilitates real-time detection and quantification of volatile compounds in 
humid air samples; reagent ions (H3O+, NO+, O2+) generated in a gas ion discharge 
source and selected by a quadrupole mass filter are injected in to a fast flowing 
helium carrier gas in the reaction flow tube. Figure 2.2 shows a schematic of the 
Profile 3 SIFT-MS instrument. The sample gas is introduced to the flow tube via a 
heated sample inlet (120°C), where chemical ionisation occurs resulting in the 
production of characteristic product ions. Downstream reagent and product ions are 
separated and counted by a further quadrupole mass spectrometer and electron 
multiplier detector system. Absolute concentrations of trace gases can be quantified 
based on the ratios of ion count rates and the previously determined reaction rate 
constants contained within the integrated SIFT-MS kinetics library (Smith and Španěl, 
2011, 2015; Španěl, Dryahina and Smith, 2006) when running the instrument to 
monitor for specific product ions.  
SIFT-MS has been applied to a number of studies investigating detection of microbial 
volatiles. SIFT-MS has been used to directly measure hydrogen cyanide (HCN) levels 
in the breath of cystic fibrosis patients chronically infected with P. aeruginosa and in 
uninfected controls (Gilchrist et al., 2013). This study determined that measurement 
of HCN may provide a non-invasive approach to the diagnosis of P. aeruginosa lung 
infection. 
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In addition, SIFT-MS has been utilised to determine the potential application for the 
identification of organisms responsible for causing urinary tract infections, through 
analysis of the headspace of sterile urine samples inoculated with 8 species of 
interest (Storer et al., 2011). This study was able to successfully demonstrate 
discrimination of 5 of the 8 species investigated, through analysis of a panel of 21 
volatile compounds. Coupled with multivariate statistical data analysis techniques, 
SIFT-MS has been employed for the differentiation of pathogenic bacterial species in 
planktonic culture in complex culture media (Thorn, Reynolds and Greenman, 2011; 
Dryahina et al., 2016).  
SIFT-MS has also been used to identify the presence of pathogenic bacteria in 
inoculated blood samples and this approach compared to an established blood 
culture system (Scotter et al., 2006). The study found that in general the time to 
positive result was faster when determined by SIFT-MS than by the BacT/ALERT 
automated system. These studies demonstrate the potential of SIFT-MS for the 
detection and quantification of microbial volatile metabolites originating from 
organisms growing in a range of sample types; human breath, biological matrices and 
complex culture media.  
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1.6 BIOFILM MODELS  
In vitro studies of biofilms usually employ one of two general approaches; a closed 
multi-well plate based model, or an open flow system with continuous perfusion of 
nutrients in to and waste products out of the system (Coenye and Nelis, 2010). Both 
these approaches involve the development of biofilm on a solid surface. The simplest 
and most commonly used biofilm model system utilises multi-well plates to analyse 
the ability of organisms to form biofilm on plastic surfaces; the bottom and sides of 
the culture plate wells, or on the surface of small coupons placed in the wells. The 
biofilm forming ability of different strains and species can be compared using crystal 
violet to stain adhered cells (Fletcher, 1977; Djordjevic, Wiedmann and 
McLandsborough, 2002; O’Toole and Kolter, 1998a).  
A development of this approach is the Calgary biofilm device, which involves use of 
a specialised lid which fits in to a standard 96-well plate; the lid contains pegs that 
protrude in to the well of the plate (Ceri et al., 1999). Formation of biofilm on these 
pegs negates the potential problem of sedimentation of non-adherent bacterial cells 
which may occur in the bottom of culture plate wells. After biofilm has been cultured 
on the device, pegs can be individually removed or the entire lid moved to a new 96-
well plate for further experiments such as antimicrobial susceptibility testing (Olson 
et al., 2002). Both these multi-well plate based methods for biofilm culture are batch 
culture type models, which will result in the nutrient supply becoming exhausted and 
build-up of waste products unless the nutrient media is manually replaced.  
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A variety of devices have been developed that facilitate the culture of biofilms under 
continuous flow conditions. For example, the modified Robins device consists of an 
acrylic block containing multiple ports which house disks, constructed from the 
material of interest, attached to sampling plugs. Nutrient media is continuously 
pumped through the device and the disks on which the biofilm is formed can be 
removed and replaced during experimentation, by removing the attached sampling 
plug, to allow for sampling of the biofilm (Nickel et al., 1985; Kharazmi, Giwercman 
and Høiby, 1999). Flow cell devices allow for biofilm formation in a small channel 
machined into a plastic block or constructed from microscope slides and coverslips 
(Berg and Block, 1984; Caldwell and Lawrence, 1988; Mittelman, Kohring and White, 
1992). The small and precise construction of these devices allow for controlled flow 
of media through the device and precise control of the internal pressure and shear 
forces, and also facilitates direct microscopy of the developing biofilm (Tolker-nielsen 
and Sternberg, 2014).  
Flow displacement reactors include the rotating disk reactor (Vinogradov et al., 
2004), annular biofilm reactor (Caylet et al., 2011) and CDC biofilm reactor 
(Fernández-Rivero et al., 2017) all of which involve the formation of biofilm on solid 
coupons housed on rods or disks submerged in nutrient media within a glass reaction 
vessel, facilitating simultaneous formation of a number of identical biofilms. Shear 
forces are generated either by rotation of the coupon holders or by a magnetic 
stirring baffle. A constant supply of nutrients is provided by an influx of fresh media 
into the reaction vessel which results in displacement of waste media out through 
the effluent port (Coenye and Nelis, 2010).  
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The drip flow biofilm reactor consists of multiple parallel reaction channels each 
designed to house a microscope slide coupon, the reaction vessel is orientated at a 
10° angle to allow nutrients dripping in at the top of the reaction chamber to drip on 
to and flow over the surface of the coupon. This allows biofilm formation close to the 
air-liquid interface under low shear conditions (Goeres et al., 2009).  
 
1.6.1 Wound biofilm models 
A variety of models have been described for the investigation of biofilms of bacterial 
species associated with wound infection. The Lubbock chronic wound biofilm (LCWB) 
model (Sun et al., 2008) uses media comprised of Bolton broth with 50% plasma and 
5% horse red blood cells to provide nutrients similar to those available within the 
wound bed. The model uses the ejected pipette tip, used for inoculation, as a solid 
surface for biofilm growth. The Lubbock chronic wound biofilm model was 
subsequently adapted to facilitate efficacy testing of topical antimicrobial treatments 
soaked in to gauze dressings (Kucera et al., 2014). Following initial formation of the 
biofilm on a solid surface in the LCWB model, the biofilm was transferred to an 
artificial wound bed comprised of two layers of media consisting of Bolton broth set 
with gelatine and agar. Although the Lubbock model aims to provide nutrients akin 
to those found within a real wound bed it relies on the formation of biofilm on a solid 
surface. However, wound infection in vivo will consist of biofilm growth on the 
surface of, or suspended within the semi-solid matrix of the tissue (James et al., 
2008).  
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Collagen based gel matrices have been used as a substratum for culturing biofilms in 
vitro, in an attempt to more closely simulate the semi-solid nature of a wound, 
allowing biofilms to develop within, as well as on, the surface of the growth matrix 
(Werthén et al, 2010). This model is the first to implement the use of collagen gel 
matrices to provide a growth medium for biofilm formation more reflective of the 
environment found in a real wound bed. Collagen gels produced to include a 
simulated wound fluid are cast in to wells of a micro titre plate or 8 well culture slides 
and polymerised. The collagen surface is then inoculated and biofilms allowed to 
form. The author’s demonstrated growth of P. aeruginosa and S. aureus biofilms in 
this model system.  
This model has been further developed to allow for efficacy testing of antimicrobial 
dressings (Hakonen et al., 2014). The use of collagen gel matrices has also been 
implemented to develop a model of infection of diabetic foot ulcers (Price et al., 
2016). Whereby collagen gels are cast into 6 well plates with tissue culture inserts, 
resulting in formation of a gel with a central void which is filled with simulated wound 
fluid, to generate a ‘closed high-exudate’ model, for testing topical antimicrobial 
treatment against S. aureus and P. aeruginosa.  
Finally, collagen gels have also been used in combination with keratinocytes and 
fibroblasts; harvested and cultured from surplus human skin from plastic surgery 
patients, for development of ‘human skin equivalents’ (Haisma et al., 2013). These 
‘human skin equivalents’ have been wounded and used to produce a biofilm model 
of thermal wound infection.   
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Human skin samples have also been utilised within a wound biofilm model system 
(Ashrafi et al., 2018). Ex vivo cutaneous human skin with incisional or excisional 
wounds were housed within wells of a 24-well plate and bathed in nutrient media 
(Mueller Hinton broth). This was used as a substrate for biofilm formation, to form a 
human skin wound infection model, mimicking both surgical and open wounds. 
Although these models provide a realistic matrix for culture of wound associated 
biofilms, replication of the models using human skin would require access to healthy 
human skin samples which is likely to be prohibitive to many researchers.   
The models described above are all closed systems, which do not include the addition 
of nutrients to the biofilm during formation and growth, to simulate the replacement 
of nutrients and moisture that occurs within the wound bed, as described previously. 
The Duckworth biofilm model was designed to provide a continuous flow of nutrients 
to the growing biofilm, supplied from beneath, to simulate the production of exudate 
within a wound.  This model utilised a 3D printed device, containing rows of wells 
which house agar plugs, each supporting a cellulose membrane on which the biofilms 
were cultured (Duckworth et al., 2018).  Although the authors used nutrient broth 
for the characterisation of this model, they also suggested that a simulated wound 
fluid could be used, to provide a nutrient supply that better represents the wound 
environment.   
The drip flow biofilm reactor has been utilised to develop wound biofilm models that 
incorporate a continuous flow of nutrient media. Biofilms have been grown on a 
polycarbonate membrane, inspired by the colony biofilm model (Anderl, Franklin and 
Stewart, 2000), placed on top of a moistened absorbent pad fixed to a microscope 
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slide housed in the channels of the drip flow reactor (Lipp et al., 2010; Agostinho et 
al., 2011). The purpose of the absorbent pad used in these studies was to provide 
nutrients to the growing biofilm from beneath. However, although the mode of 
delivery was designed to simulate that of a real wound, the choice of a complex 
culture media (tryptone soya broth) does not closely simulate the nutrients available.  
The drip flow reactor system has also been use to develop a multispecies model of 
chronic wound infection (Woods et al., 2012). Firstly, the authors cultured biofilms 
from homogenised chronic wound tissue samples, after 7 days biofilms were 
disrupted and plated on to various agars for anaerobic incubation in order to 
demonstrate the successful culture of anaerobic species within the multispecies 
biofilm. Secondly, they used the drip flow reactor set up with absorbent pad and 
cellulose membrane, as described in the studies mentioned above, to culture 3 
species biofilms containing S. aureus, P. aeruginosa and the obligate anaerobe 
Clostridium perfringens.  
These studies utilising the drip flow reactor, provide a constant flow of nutrients to 
simulate the production of exudate within the wound bed. However, they lack the 
provision of a semi-solid matrix and simulated wound fluid used to provide wound-
like conditions in the collagen based wound biofilm models described previously. 
Combining both of these approaches would allow development of a continuous flow 
biofilm model, with a collagen matrix perfused with a simulated wound fluid. This 
would utilise important elements from both types of model, and provide in vitro 
wound-like conditions without the logistical and ethical issues associated with the 
use of human tissue or animal models. 
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Chapter 2: Materials & Methods 
2.1 CULTURE MEDIA 
All components of bacterial culture media were obtained from Oxoid Ltd. 
(Basingstoke, UK), unless otherwise stated. Dehydrated culture media were 
reconstituted according to manufacturer’s instructions and sterilised by autoclaving 
at 121°C for 15 minutes. Tryptone Soya Agar; CM0131 (TSA) and Blood Agar (blood 
agar base No. 2; CM0271 with 5% defibrinated horse blood) were used as general 
purpose non-selective solid media throughout this study.  
The following selective media were used during the multispecies biofilm experiments 
described in chapter 6;  
 Mannitol Salt Agar; CM0085 (MSA) for selective isolation of Staphylococcus 
aureus.  
 Pseudomonas C.F.C. Selective Agar (CFC), comprised of Pseudomonas Agar 
base; CM0559 and C.F.C supplement; SR0103 with glycerol (Fisher, UK) (5mL 
per 500mL), for selective isolation of Pseudomonas aeruginosa. 
 Colistin-Oxolinic Acid Blood Agar (COBA), comprised of Blood Agar base No. 2 
with 5% defibrinated horse blood and streptococcus selective supplement; 
SR0126, for selective isolation of Streptococcus pyogenes. 
Initially, headspace analysis of wound associated bacteria cultured in liquid media, as 
described in chapter 3, were carried out using Tryptone Soya Broth; CM0129 (TSB). 
Antimicrobial susceptibility testing, as described in chapter 5 was carried out using 
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Mueller-Hinton Broth; CM0405 (MHB). Phosphate buffered saline; BR0014 (PBS), 
reconstituted according to manufacturer’s instructions and sterilised by autoclaving 
at 121°C for 15 minutes was used as a diluent throughout this research.  
 
2.1.1 Simulated Wound Fluid (SWF) 
The second phase of experiments described in Chapter 3, culturing planktonic 
bacteria under ‘wound-like’ conditions utilised a simulated wound fluid (SWF) 
consisting of equal volumes of foetal bovine serum (FBS; Gibco, UK) and a solution of 
0.1% bacteriological peptone (Oxoid, UK) and 0.85% NaCl (Fisher, UK) (Bowler et al., 
2004; Werthén et al., 2010; Said et al., 2014; Price et al., 2016). The peptone/NaCl 
solution was sterilised by autoclaving at 121°C for 15 minutes and allowed to cool 
prior to the addition of sterile FBS. Simulated wound fluid was also used for the 
culture of bacterial biofilms in the collagen wound biofilm model, as described in 
Chapters 5 and 6. 
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2.2 BACTERIAL STRAINS 
Bacterial isolates were obtained from the University of the West of England, Bristol 
(UWE) culture collection (CC). Strains used for this study (Table 2.1) include isolates 
originally obtained from the National Collection of Type Cultures, UK (NCTC), the 
American Type Culture Collection, USA (ATCC), the National Collection of Industrial, 
Food and Marine Bacteria, UK (NCIMB) and clinical isolates held within the UWE 
culture collection. 
Bacterial cultures were maintained on cryopreservation beads (Microbank, Pro Lab 
Diagnostics, Canada) at -80°C, resuscitated as required on TSA or blood agar (i.e S. 
pyogenes) and incubated aerobically at 37°C. Working cultures were maintained on 
sealed plates at 4°C for up to 4 weeks.  
Chapter 2 – Materials & Methods 
54 
 
 
Ta
b
le 2
.1
: B
acte
rial iso
lates u
sed
 w
ith
in
 th
is stu
d
y, in
d
icatin
g b
acte
rial sp
ecies an
d
 strain
 re
feren
ce n
u
m
b
er. 
Sp
ecies 
Strain
 referen
ce
 
Strain
 in
fo
rm
atio
n
 
Stap
h
ylo
co
ccu
s au
reu
s 
N
C
IM
B
 6
5
7
1
 
O
rigin
al strain
 re
feren
ce 'H
eatley O
xfo
rd
'  
Stap
h
ylo
co
ccu
s au
reu
s 
A
TC
C
 6
5
3
8
 
Iso
lated
 fro
m
 a h
u
m
an
 lesio
n
 
Stap
h
ylo
co
ccu
s au
reu
s 
C
C
 4
3
7
 (M
R
SA
-Llew
elyn
) 
C
lin
ical strain
 
Stap
h
ylo
co
ccu
s au
reu
s 
C
C
 1
7
4
  
C
lin
ical strain
 
Strep
to
co
ccu
s p
yo
gen
es 
N
C
TC
 1
0
8
7
1
 
Iso
lated
 fro
m
 h
u
m
an
 skin
 le
sio
n
s 
Strep
to
co
ccu
s p
yo
gen
es 
N
C
TC
 1
0
8
7
4
 
Iso
lated
 fro
m
 h
u
m
an
 case o
f p
yo
d
erm
a an
d
 n
ep
h
ritis 
Strep
to
co
ccu
s p
yo
gen
es 
N
C
TC
 1
0
8
8
1
 
Iso
lated
 fro
m
 h
u
m
an
 skin
 le
sio
n
s 
P
seu
d
o
m
o
n
as aeru
gin
o
sa
 
N
C
IM
B
 1
0
5
4
8
 
Iso
lated
 fro
m
 an
 In
fected
 w
o
u
n
d
 
P
seu
d
o
m
o
n
as aeru
gin
o
sa
 
A
TC
C
 1
5
4
4
2
 
Iso
lated
 fro
m
 an
im
al ro
o
m
 w
ater b
o
ttle, strain
 u
sed
 in
 B
S E
N
 stan
d
ard
 m
eth
o
d
s 
P
seu
d
o
m
o
n
as aeru
gin
o
sa
 
N
C
IM
B
 8
2
9
5
 
Typ
e strain
 
P
seu
d
o
m
o
n
as aeru
gin
o
sa
 
C
C
 1
9
7
  
C
lin
ical strain
 
Esch
erich
ia co
li 
N
C
TC
 1
0
4
1
8
 
Strain
 u
sed
 fo
r an
tib
io
tic assays an
d
 sen
sitivity testin
g 
Esch
erich
ia co
li 
A
TC
C
 1
0
5
3
6
 
Strain
 u
sed
 in
 B
S EN
 stan
d
ard
 m
eth
o
d
s 
Esch
erich
ia co
li 
N
C
TC
 1
2
9
0
0
 
R
eferen
ce strain
 fo
r te
stin
g cu
ltu
re m
ed
ia
 
Esch
erich
ia co
li 
C
C
 4
4
3
 (SM
H
6
0
9
9
) 
C
lin
ical strain
 
P
ro
teu
s m
irab
ilis 
N
C
IM
B
 7
0
1
8
8
0
 
Iso
lated
 fro
m
 h
u
m
an
 so
u
rce
 
P
ro
teu
s m
irab
ilis 
C
C
 3
2
4
 (N
P
1
) 
C
lin
ical strain
 
P
ro
teu
s m
irab
ilis 
C
C
 3
2
5
 (N
P
4
) 
C
lin
ical strain
 
P
ro
teu
s m
irab
ilis 
C
C
 3
2
6
 (N
P
6
) 
C
lin
ical strain
 
Stap
h
ylo
co
ccu
s ep
id
erm
id
is 
N
C
IM
B
 1
2
7
2
1
 
Typ
e strain
, iso
lated
 fro
m
 a n
o
se
 
Stap
h
ylo
co
ccu
s ep
id
erm
id
is 
N
C
TC
 1
1
5
3
6
 
Typ
e strain
, iso
lated
 fro
m
 th
ro
at 
 
 
 
Chapter 2 – Materials & Methods 
55 
 
2.3 PREPARATION OF BACTERIAL INOCULUM 
TSA or blood agar plates were inoculated by streak plating a single colony from 
bacterial working cultures and incubated overnight at 37°C. These were used to 
prepare suspensions of the test organism in 10 mL of liquid culture media, adjusted 
to an OD620nm of 0.2 (equalling a cell density of 1.4 – 2.1 x 108 cfu mL-1). 
To prepare a mixed inoculum containing S. aureus and S. pyogenes, inoculum 
suspensions of each organism were prepared in 10mL SWF adjusted to an OD620nm of 
0.4. Five mL each of these suspensions was then mixed together, resulting in an 
inoculum suspension containing both organisms at a concentration equivalent to an 
OD620nm of 0.2 of each organism. 
 
2.4 ENUMERATION OF BACTERIA 
Bacterial numbers were determined by enumeration using either the spread plate 
method or using the Whitley Automated Spiral Plater (WASP; Don Whitley Scientific 
Limited, UK) following serial dilution of the bacterial inoculum in PBS. 
 
2.4.1 Spread Plate Method 
One hundred microlitres of a diluted bacterial suspension was pipetted on to the 
surface of an agar plate and spread evenly across the surface with a sterile plastic L-
shaped spreader, appropriate dilutions were plated in duplicate. Plates were allowed 
to dry and inverted before incubation overnight at 37°C. Colonies were counted and 
Chapter 2 – Materials & Methods 
56 
 
the average (mean) calculated for the duplicate plates. The total number of colony 
forming units (cfu) were calculated as follows; 
𝑐𝑓𝑢 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑥 (
1
𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
) 𝑥 (
1
𝑣𝑜𝑙𝑢𝑚𝑒(𝑚𝐿)
) 
 
2.4.2 Spiral Plating 
The 50 µL Log function of the spiral plater was used to dispense 50 µL of bacterial 
suspension on to the surface of agar plates, appropriate dilutions were plated in 
duplicate. Plates were allowed to dry and inverted before incubation overnight at 
37°C. The total number of colony forming units was calculated using a counting grid 
and tables provided by the instrument manufacturer. 
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2.5 PLANKTONIC CULTURES FOR HEADSPACE ANALYSIS 
2.5.1 Liquid Culture - TSB 
One mL of the bacterial inoculum suspension (prepared in TSB as described in Section 
2.3) was used to inoculate 9 mL of sterile TSB aseptically dispensed into sterile 40 mL 
glass vials with a PTFE screw cap containing a silicone septum (Supelco, UK), resulting 
in a final starting OD620nm of 0.02. Vials were incubated aerobically at 37°C and 200 
rev min-1 (Stuart S150 Orbital Incubator; Bibby Scientific, UK) for 5 h or 24h. 
 
2.5.2 Liquid Cultures - Simulated Wound Fluid 
One mL of the bacterial inoculum suspension (prepared in peptone/NaCl diluent as 
described in section 2.1) was used to inoculate 40 mL glass vials (as specified above), 
containing 5 mL FBS (Sigma Aldrich) and 4 mL peptone/NaCl resulting in a SWF (see 
Section 2.3) at a final starting OD620nm of 0.02 in each test vial. Vials were incubated 
aerobically at 37°C and 200 rev min-1 (Stuart S150 Orbital Incubator; Bibby Scientific, 
UK) for 5 h or 24 h. 
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2.6 COLLAGEN WOUND BIOFILM MODEL 
2.6.1 Collagen Coating of Glass Slide Coupons 
The collagen gel matrix was prepared based on the method described by Werthén et 
al. (2010) by preparing a collagen solution (2.0 mg mL-1) in SWF (see Section 2.1.1). 
High concentration collagen (type I) from rat tail supplied in 0.02 M acetic acid 
(Corning Incorporated, Wiesbaden, Germany) was neutralised to pH 7 with 1 M 
sodium hydroxide according to manufacturer instructions and diluted to the desired 
concentration with SWF. For example, to prepare 10 mL of 2.0 mg mL-1 collagen 
solution in SWF from a collagen stock solution supplied by the manufacturer at a 
concentration of 9.59 mg mL-1; 48 µL of ice cold NaOH was added to 7.866 mL of ice 
cold SWF and mixed. On ice, 2.086 mL of ice cold collagen stock solution was then 
added and the solution mixed gently. Sterile glass microscope slides measuring 76 
mm x 26 mm were coated with 1.5 mL of neutralised collagen solution (2.0 mg mL-1), 
resulting in a depth of 760 µm. Collagen coated slides were incubated at 37°C for 1 
hour to allow polymerisation of the three-dimensional collagen matrix. 
 
2.6.2 Growth of Bacterial Biofilms within the Collagen Wound Biofilm Model 
The collagen wound biofilm model apparatus is shown in figure 2.1. One millilitre of 
inoculum suspension (section 2.3) in SWF was used to inoculate each collagen coated 
microscope slide (individually housed in sterile petri dishes) and incubated at 33°C 
for 2 hours to allow initial adherence of bacterial cells. An incubation temperature of 
33°C was chosen to simulate average wound bed temperature (Dini et al., 2015). 
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Following incubation, the inoculated slides were rinsed gently three times with 1 mL 
of sterile SWF to remove planktonic cells, and carefully transferred to individual 
channels within a commercially available drip flow reactor (Biosurface Technologies 
Corporation, Bozeman, MT, USA).  Sterile silicone tubing  (3mm ID) was used to 
connect a 500 mL Duran bottle containing the sterile SWF medium to the miniert 
valve lid inlets via a 23 Gauge 11/4“ sterile needle. Waste was collected in 250 mL 
Duran bottles connected to the waste outlet ports using lengths of sterile silicone 
tubing (8mm ID).  The reactor was incubated at 33°C for 48-72 hours at an angle of 
10° to allow SWF to flow through the individual chambers of the model system 
(Figure 2.1). The collagen wound biofilm model was continuously perfused with SWF 
at a flow rate of 2 mL hr-1 for the duration of incubation to simulate the flow of a 
moderately exuding wound (Thomas et al., 1996). 
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2.6.3 Enumeration of Bacterial Biofilms 
Bacterial biofilms were sampled at 0, 3 and 6 hours, then every 6 hours until 48 hours 
and finally at 72 hours. At each time point a coated slide was aseptically removed 
from the reactor and the entire collagen layer containing the bacterial biofilm 
scraped into a 50 mL falcon tube using a sterile L-shaped scraper, while rinsing with 
3 x 1 mL phosphate buffered saline (PBS). Two millilitres of 500 µg mL-1 collagenase 
solution (Life Technologies Limited, Paisley, UK) was added to the tube and mixed, 
incubated at 37°C for 20 minutes, and then subsequently vortex mixed and incubated 
for a further 20 minutes. The resulting suspension was disrupted by sonication in a 
water bath (Fisherbrand FB11078, Fisher Scientific Limited, Loughborough, UK) at 35 
kHz for 5 minutes. Collagenase solution was washed from the bacterial cells; whereby 
the suspension was centrifuged at 4000 x g (Beckman Coulter Allegra X-30R), the 
supernatant discarded and pellet re-suspended in 10 mL PBS, this process was 
repeated a total of two times. Bacterial density (cfu slide-1) was determined by 
serially diluting in PBS and spiral plating on to TSA as described in section 2.4.2 and 
colonies counted after 24 hours incubation at 37°C.  
The effect of collagenase solution on the viability of S. aureus, P. aeruginosa and S. 
pyogenes was tested. Whereby, a suspension of each of the organisms was prepared 
in SWF and treated with either collagenase solution or PBS. Following incubation the 
bacterial suspensions were spiral plated on to TSA for enumeration. The recovery of 
organisms from the collagenase treated and PBS control solutions were compared 
using t-tests. No statistically significant difference between the collagenase treated 
and PBS controls (p>0.05) was found for S. aureus, P. aeruginosa or S. pyogenes. 
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2.7 IMAGING OF BACTERIAL BIOFILMS AND COLLAGEN MATRIX 
During preparation of collagen gel matrices for imaging experiments, a #1 glass cover 
slip measuring 18mm x 18mm was included between the microscope slide and 
collagen gel layer. The inclusion of a coverslip facilitated the sampling of a suitable 
sized section of the biofilm for microscopy. This was removed by cutting the collagen 
around the cover slip with a bespoke square stainless steel cutter and lifting away 
the coverslip supporting the biofilm sample with the aid of a scalpel blade. 
 
2.7.1 Scanning Electron Microscopy (SEM) 
Biofilm samples and an un-inoculated collagen gel control were fixed in 4% 
glutaraldehyde (Sigma-Aldrich Company Limited, Gillingham, UK) in a 0.1 M 
phosphate buffer for 1 hour at room temperature. This was rinsed in PBS and 
dehydrated with increasing concentrations of ethanol and hexamethyldisilazane 
(Acros Organics, Geel, Belgium), air dried in a fume hood, mounted and gold sputter 
coated. A FEI Quanta 650 FEG scanning electron microscope operating at 10 kV was 
used to examine the samples. 
 
2.7.2 Confocal Scanning Laser Microscopy (CSLM) 
Biofilm samples were stained using the FilmTracer LIVE/DEAD Biofilm Viability Kit 
(Fisher Scientific UK Limited, Loughborough, UK) according to manufacturer’s 
instructions: 3 µL each of Component A (SYTO 9 green fluorescent nucleic acid stain 
3.34 mM in DMSO) and Component B (Propidium iodide 20 mM in DMSO) were 
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added to 1 mL of sterile filtered deionised water to prepare a working solution. Three 
hundred microliters of the prepared staining solution was gently added to the biofilm 
surface. Samples were incubated at room temperature for 30 minutes in the dark. 
Following incubation samples were rinsed gently with sterile filtered deionised water 
to remove excess stain and imaged using the x40 oil objective of the Leica DMi8 
Inverted microscope with confocal scanner (Leica Microsystems (UK) Limited, Milton 
Keynes, UK). Confocal Z-stack scans were exported to Fiji (Schindelin et al., 2012) for 
processing and producing figures. 
  
Chapter 2 – Materials & Methods 
64 
 
2.8 DETECTION OF BACTERIAL VOLATILE METABOLITES 
During this research volatile compounds were detected from the gaseous headspace 
of bacterial cultures in vitro, cultured both in liquid media and in a collagen wound 
biofilm model. Two selected ion flow tube mass spectrometers were used during this 
work; the Profile 3 (Instrument Science Limited, UK) and the Voice200 Ultra (Syft 
technologies, New Zealand). A brief description of the selected ion flow tube mass 
spectrometry (SIFT-MS) validation procedures and operational parameters for both 
instruments is included in this section. 
 
2.8.1 Profile 3 SIFT-MS Instrument 
The Profile 3 SIFT-MS instrument contains a reaction flow tube 5 cm in length and 
uses helium as a carrier gas (Smith and Španěl, 2011) and has a limit of detection of 
<10 ppb for quantification of volatile compounds (Instrument Science, 2006). Daily 
validation checks were carried out every day that the instrument was used during 
this research and are outlined in Table 2.2.  
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2.8.1.1 Headspace analysis of liquid bacterial cultures using the Profile 3 SIFT-MS. 
Following incubation for 5 or 24 hours, samples were analysed by SIFT-MS (Profile 3; 
Instrument Science Limited, UK) in Full Mass Scan (FS) mode using the H3O+ reagent 
ion.  Samples were introduced to the instrument by piercing the silicone septum of 
the sample vial with a sterile needle attached to the heated SIFT-MS direct sampling 
inlet, samples were vented with a second sterile needle attached to a 0.2 µM syringe 
filter (Ministat; Sartorious Stedim Biotech, Germany) to allow the free flow of 
headspace gases. Each sample was analysed three times using repeat scans of 100 
Table 2.2: Table of daily validation checks carried out to confirm performance of the Profile 
3 SIFT-MS instrument. 
Validation Step Procedure 
Instrument Source Tuning H3O+ Full Mass Scan 10 -100 m/z, 10 seconds, x3. 
Confirm reagent ion peak generation at 19 m/z 
and water cluster peaks at 37 m/z, 55m/z and 73 
m/z.  
 
Quadrupole Performance  H3O+ Full Mass Scan 10 -100 m/z, 10 seconds, x3. 
Confirm peak alignment at 19 m/z and 73 m/. 
 
Sample Flow Rate Multi Ion Mode, Scan for Water. 
Make 5 exhalation in to the sample inlet and 
confirm water vapour content equals 5.5% - 6.0%. 
 
Reagent Ion Intensity Multi Ion Mode, Scan for Water. 
Confirm total count rate ≥ 1 x 106 cps. 
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seconds, over a spectrum range of 10–200 m/z, to generate a total of nine scans per 
bacterial strain from three independent samples.  
 
2.8.1.2 Headspace analysis of dressing samples using the Profile 3 SIFT-MS. 
Following incubation, the gaseous headspace of the dressing samples were analysed 
by SIFT-MS (Profile 3, Instrument Science Limited, UK) in ‘Full Mass Scan’ mode using 
the H3O+ precursor ion; each sample was analysed using 3 repeat scans of 100 
seconds, over a spectrum range of 10-200 m/z. Headspace samples were introduced 
to the instrument by piercing the silicone septum of the sample bag with a sterile 
needle attached to the SIFT-MS direct sampling inlet. 
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2.8.2  Voice200 Ultra SIFT-MS instrument 
The Voice200 Ultra SIFT-MS instrument can use either a nitrogen or helium carrier 
gas, and was run using helium for the duration of this research. The instrument has 
a limit of detection of 50 ppt for quantification (Syft Technologies Ltd, 2012) and can 
perform full mass scans over a spectrum range of 10 – 250 m/z.  
The flow tube pressure was checked daily to ensure the inlet flow is within the correct 
range of 80 – 120 mTorr with the inlet cap removed, the flow tube pressure with the 
inlet cap in place should be less than 20 mTorr. The Voice200 ultra incorporates an 
automated daily instrument validation procedure, which was carried out on every 
day the instrument was used during this research. Before the validation procedure 
was initiated the calibration gas cylinder was turned on and the flow pressure 
matched to that of the flow tube pressure. The validation procedure consists of 9 
steps outlined in Table 2.3.  
The ‘Syft standard validation’ results in application of an internal correction factor 
for compound quantification, based on the analysis of the Syft standard calibration 
gas which contains toluene, isobutene, tetrafluorobenzene, hexafluorobenzene, 
ethylbenzene, ethylene, benzene and octafluorotoluene at 2ppm. This step may 
result in adjustment of the instrument calibration function (ICF) if necessary, which 
facilitates reliable quantification of compounds with known reaction rates that are 
stored in the Labsyft compound library and ensures day to day repeatability of the 
instruments performance. 
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Table 2.3: Steps in the Syft Voice200Ultra automated daily validation procedure 
Validation Step Description 
Reset quadrupoles 
 
Sets quadrupoles to the correct modes for validation. 
 
Carrier gas 
 
 
Ensures carrier gas is switched on and checks flow 
rate. 
 
Downstream pressure 
validation 
 
 
Measures downstream chamber pressure with and 
without carrier gas flow to detect leaks in 
downstream vacuum chamber. 
 
Upstream quad scanline 
validation 
 
Checks the reagent ion peak alignment. 
Downstream quad scanline 
validation 
 
Checks alignment of product ion masses using Syft 
standard. 
 
Detector verification 
 
 
Adjusts detector voltage to maintain maximum count 
rate of each reagent ion. 
 
Detector linearity 
validation 
 
 
Ensures the detector provides a linear response to a 
range of reagent /product ion ratios. 
 
Syft Standard Validation 
 
 
Compares measured and expected values for Syft 
standard mixture and adjusts ICF if required. 
 
Background 
 
Full Scan with inlets closed to detect instrument 
contamination. 
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Within this research the Voice200 ultra was used to analyse biofilm samples cultured 
in the collagen wound biofilm model, two analysis methods were created for this 
research using the following parameters: 
(1) Full scan (FS) mode, H3O+ 10 – 200 m/z, NO+ 10 – 200 m/z, O2+ 10 – 200 m/z, using 
3 repeat scans.  
(2) Selected Ion Mode (SIM), selected compounds, scanned masses and their 
branching ratios listed in Table 2.4, scan duration of 60 seconds.  
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Table 2.4: Voice200 Ultra SIFT-MS Selected Ion Mode scan parameters, including 
selected compounds, and scanned masses used for quantification and corresponding 
branching ratios. 
  H3O+ NO+ O2+ 
 
Mass 
Branching 
 ratio (%) 
Mass 
Branching 
 ratio (%) 
Mass 
Branching 
 ratio (%) 
Ethanol 47 100 45 100   
1-butanol 57 95 57 5 56 80 
Isobutyl alcohol 57 100 73 95 42 25 
2-methyl-2-
propanol 
57 100 57 100 59 100 
3-methyl-1-butanol 71 100 87 85 59 85 
Acetaldehyde 45 100 43 100   
2-methylpropanal   71 100 72 70 
2-methylbutanal 87 94 85 98 58 72 
3-methylbutanal 69 
87 
30 
70 
85 100 
  
Acetoin 89 100 118 100 88 20 
Acetone 59 100 88 100   
Butanone   102 100 72 35 
2,3-butanedione 87 100 86 75 86 35 
3-methylbutanoic 
acid 
103 95 85 
132 
30 
70 
  
Butane 
    
43 
58 
42 
65 
20 
10 
Dimethyl sulfide 63 100 62 100 62 60 
Dimethyl disulfide 95 100 94 100 61 
94 
10 
80 
Hydrogen cyanide 28 100     
Ammonia 18 100   17 100 
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2.8.2.1 Headspace analysis of bacterial biofilms using the Voice200 ultra in full scan 
mode. 
Following 48 hours of continuous culture in the collagen wound biofilm model, 
biofilm headspace gases were sampled by connecting the heated direct sample inlet 
of the SIFT-MS instrument (Voice200Ultra, Syft technologies, NZ) to the reactor 
channel via a length of PEEK tubing (Supelco, UK) of O.D. 1/16 in. × I.D. 0.030 in. The 
SIFT-MS instrument was operated in Full Scan Mode (FS) using method parameters 
described above in section 2.8.4; 3 independent biofilms of each strain were 
analysed. 
 
2.8.2.2 Headspace analysis of biofilms – Selected Ion mode 
The channels of the drip flow reactor were connected to the SIFT-MS instrument as 
described above. The SIFT-MS instrument was operated in selected ion mode (SIM) 
using the H3O+, NO+ and O2+ reagent ions to quantify the concentration of selected 
compounds in the bacterial biofilm headspace. The method parameters of the SIM 
scan are detailed above in section 2.8.4. Scanning each biofilm for 60 seconds, 
resulted in a total of 12 replicate measurements of each of the 19 compounds (shown 
in table 2.2), 3 independent biofilms of each strain were analysed.  
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2.8.3 Gas Chromatography – Mass Spectrometry 
2.8.3.1 HS-SPME-GC-MS analysis of bacterial biofilms 
To ensure correct operation of the GC-MS instrument, auto-tune calibration of the 
mass spectrometer was undertaken monthly and daily blanks samples were analysed 
to rule out contamination of the GC column. Volatile compounds were sampled from 
the headspace of drip flow reactor channels by solid phase microextraction (SPME) 
using a 75 µm Carboxen/Polydimethylsiloxane (CAR/PDMS) fibre assembly (Supelco, 
UK) for 30 minutes at 33°C. After sampling, the fibre was retracted and transported 
in a sealed container to the GC-MS instrument and immediately inserted into the 
heated inlet. The GC (6890N, Agilent Technologies) was programmed with the 
following method, adapted from the method described by Shestivska et al. (2012): 
splitless injection, inlet temperature held at 305°C, Helium carrier gas flow rate 1 mL 
min-1, oven temperature programme set to 35°C for 3 minutes, then 4°C per minute 
ramp up to 100°C followed by 8 °C per minute ramp up to 300°C with a 5 minute hold 
at the final temperature. A 25 m, 5%-Phenyl-methylpolysiloxane column (HP-5ms, 
Agilent technologies) was used. The mass selective detector (5973 MSD, Agilent 
Technologies) was used in ‘Full Scan Mode’ to detect ions over a spectrum range of 
15-400 m/z. Analysis software (Agilent MassHunter Workstation software) was used 
for compound identification using chromatogram deconvolution algorithms and 
comparison with the NIST2.0 library with a minimum match score of 80%. 
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2.9 ANTIMICROBIAL SUSCEPTIBILITY  
A ceftazidime stock solution was prepared by dissolving ≥100 mg of powder in 
saturated sodium bicarbonate solution in a 100 mL volumetric flask, the minimum 
volume required to dissolve the powder was used. The volume was then made up to 
100 mL with filter sterilised deionised water.  The final concentration of the stock 
solution was calculated as follows; 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑔 𝐿−1) = (
𝑤𝑒𝑖𝑔ℎ𝑡 (𝑚𝑔)
𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (𝐿)
) ∗ 𝑝𝑜𝑡𝑒𝑛𝑐𝑦 
 
2.9.1 Minimum Inhibitory Concentration (MIC)  
The antimicrobial susceptibility of P. aeruginosa NCIMB 10548 to ceftazidime was 
tested based on the broth microdilution method described by BS EN ISO 20776-
1:2006 (British Standards Institution, 2006). Ceftazidime was prepared in Mueller-
Hinton Broth (MHB) at concentrations ranging from 256 mg L-1 to 0.25 mg L-1. Fifty 
microliters of each antibiotic concentration and a control (0 mg L-1) were dispensed 
in triplicate into wells of a 96 well multi-well plate. Overnight plate cultures were 
used to prepare a suspension of P. aeruginosa NCIMB 10548 in 10 mL MHB; colonies 
were picked from the overnight plate cultures and emulsified in 10 mL PBS and 
adjusted to an OD625 of 0.08 – 0.13. The suspension was then diluted by adding 100 
µL to 9.9 mL of MHB, to produce an inoculum suspension of approximately 1 x 106 
cfu/mL. Fifty microliters of the inoculum suspension was added to each of the wells 
of the multi-well plate containing 50 µL of MHB or MHB with antibiotic. The resulting 
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final inoculum was approximately 5 x 105 cfu mL-1 and final antibiotic concentrations 
ranged from 128 mg L-1 to 0.125 mg L-1, plus antibiotic free controls. Additionally, 
three wells were prepared containing 100 µL of MHB only as un-inoculated negative 
controls. The multi-well plate was then incubated at 37°C for 18 hours. The inoculum 
suspension was serially diluted and 100 µL spread plated (see Section 2.4.1) on to 
TSA and incubated at 37°C overnight to confirm appropriate inoculum preparation. 
Following incubation each test well of the plate was visually inspected to identify 
turbidity, (indicating growth of the test organism) and compared to the control wells. 
The MIC was recorded as the lowest concentration of ceftazidime that completely 
inhibited visible growth of P. aeruginosa. Agar plates were counted after 18-24 hours 
to confirm inoculum density was within the required range. 
 
2.9.2 Antimicrobial Susceptibility of Biofilms 
Biofilm cultures were grown on collagen coated slides in the drip flow reactor system 
(see Section 2.6.2). Antibiotic treatment was started after either 6 hours, when 
cultures are at an early stage of biofilm development, or 30 hours of continuous 
culture, when biofilms are established and maturing. Residual SWF was drained via 
the tubing and the media reservoir refilled with fresh SWF containing antibiotic. 
Biofilms were sampled periodically as described in Section 2.6.3, to determine the 
effect of antibiotic treatment on biofilm density over time. 
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2.10 DATA ANALYSIS 
The use of selected ion flow tube mass spectrometry results in the generation of large 
complex data sets containing many variables; either mass spectral product ion 
intensities or volatile compound concentrations. Univariate methods and descriptive 
statistics can be utilised to identify and visualise between group differences for 
individual variables. However, multivariate methods of analysis allow multiple 
variables to be interpreted simultaneously and facilitate modelling of the 
relationships among these multiple variables. (Saccenti et al., 2014).  In addition, the 
multivariate statistical methods utilised are capable of dealing with data sets such as 
those presented within this research, where the number of variables greatly exceeds 
the number of samples/observations and where a significant amount of collinearity 
between variables is likely (Worley and Powers, 2013). 
This section describes the statistical analysis employed throughout this research. 
Data processing prior to multivariate statistical analysis is described in detail in each 
chapter. Analysis of both full scan and selected ion mode data was performed using 
hierarchical cluster analysis and principal component analysis using IBM SPSS 
Statistics versions 20 - 25 (IBM Corporation, Armonk, NY). 
 
2.10.1 Hierarchical Cluster Analysis 
Hierarchical cluster analysis is a data mining technique which aims to identify groups 
within the data set. An algorithm is used to score the dissimilarity between samples 
in the data set and construct a matrix; the matrix being made up of scores of pairwise 
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comparisons between each sample based on the entire data set of original variables. 
The dissimilarity matrix is visualised through the production of a dendrogram, in 
which the branching of the clusters groups the cases (samples) with the least 
dissimilarity. Ward’s method, as used within this research, is an agglomerative 
method of clustering, whereby each case is initially placed in an individual cluster, 
the two closest (least dissimilar) clusters are merged to form a larger cluster. This 
process continues until a single cluster containing all samples is formed (Wijetunge 
et al., 2013). In hierarchical cluster analysis there is no restriction on the number of 
clusters formed, hence the resulting dendrogram can indicate the data structure and 
relationships between each individual sample (Ren et al., 2015). The distance 
between the nodes indicates the relationship between the clusters. The distances 
between clusters within the dendrogram are expressed in squared Euclidean 
distance, a mathematical measure of the straight line distance between two points. 
 
2.10.2 Principal Component Analysis (PCA) 
Principal component analysis (PCA) is considered an important tool for the analysis 
of multivariate data and is widely used in metabolomics studies (Saccenti et al., 
2014). PCA aims to reduce the number of variables that make up a complex data set, 
to facilitate simpler visualisation of the data, while retaining as much information as 
possible. PCA generates new variables (principal components) from the data set that 
represent linear uncorrelated combinations of the original variables, with much of 
the variation from the original data set accounted for in the first few new variables 
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(principal components). The first component describes the largest variation within 
the data set, the second component the second largest variation etc.  This allows only 
the first two or three variables to be utilised for visualisation of the data set, reducing 
the dimensions while retaining the majority of the information contained within the 
original data set. Two sets of scores are generated by PCA; firstly the scores of the 
observations/samples against each principal component and secondly the loading of 
each original variable against the principal components (Grace and Hudson, 2016). 
These data sets can be visualised by generating scatter plots of these scores for the 
first two principal components. Plotting the scores of the samples for the first two 
principal components can provide a clear summary of the data set and reveal if there 
are differences between groups of samples as well as highlight any outliers. In 
addition, plotting the loading scores of the original variables against the first two 
principal components will indicate the influence of these variables within the model. 
The direction of the principal component scores of the samples and the variable 
loadings are equivalent, hence comparison of the two plots can indicate the variables 
that are most important for separating groups of samples (Grace and Hudson, 2016). 
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Chapter 3: In vitro discrimination of wound-
associated bacteria in planktonic culture 
3.1 INTRODUCTION 
Characteristic volatile metabolites of certain microorganisms have long been 
recognised by microbiologists, for example the distinctive odour of indole from E. coli 
(Li and Young, 2013). Previous work has shown that using selected ion flow tube mass 
spectrometry (SIFT-MS) analysis, it is possible to detect and quantify the different 
types and concentrations of volatile compounds produced by a range of bacterial 
species in vitro (Allardyce et al., 2006; Scotter et al., 2006; Storer et al., 2011; 
Shestivska et al., 2012; Chippendale et al., 2014) and that by employing appropriate 
statistical techniques the characteristic profiles can be used to discriminate between 
bacterial species (Thorn, Reynolds and Greenman, 2011). SIFT-MS analysis has been 
used to investigate bacterial volatiles emanating from a variety of sample types 
including; blood culture samples (Allardyce et al., 2006; Allardyce, Hill and Murdoch, 
2006; Scotter et al., 2006), serum (Spooner et al., 2009), urine (Storer et al., 2011) 
and breath (Dummer et al., 2013; Gilchrist et al., 2013), as well as microorganisms 
prepared in liquid culture medium (Thorn, Reynolds and Greenman, 2011; Shestivska 
et al., 2015).  
This chapter addresses the first main research aim;  
 To investigate if planktonic cultures of wound associated bacteria produce 
species specific volatile profiles in vitro, enabling significant discrimination. 
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Bacterial species were cultured in complex media; (Tryptone Soya Broth [TSB]) and 
in simulated wound fluid (SWF) to simulate wound similar conditions (Bowler et al., 
2004; Werthén et al., 2010; Said et al., 2014; Price et al., 2016), thus providing the 
bacterial cultures with substrates for metabolism similar to those available to 
organisms colonising the wound bed in vivo. This approach was developed to 
determine whether the main bacterial species associated with wound infection 
produce characteristic volatile profiles, which could be used for speciation and have 
the potential to be used in the development of diagnostics based on detection of 
volatile metabolites.  
A subset of the data presented in this chapter has been published in a peer reviewed 
journal (Slade et al., 2017), which is included in Appendix I. 
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3.2 METHODS SUMMARY 
Isolates of six bacterial species were used during this study; Escherichia coli NCTC 
10418, ATCC 10536 and NCTC 12900, Pseudomonas aeruginosa NCIMB 10548, ATCC 
15442, NCIMB 8295 and CC197, Proteus mirabilis NP1, NP4 and NP6, Staphylococcus 
aureus NCIMB 6571, NCTC 6538, MRSA Llewelyn and CC174, Staphylococcus 
epidermidis NCIMB 12721 and NCTC 11536, and Streptococcus pyogenes NCTC 10871 
and NCTC 10874 (see section 2.2). 
 
3.2.1 Preparation of Bacterial Cultures 
Headspace vials containing either TSB or SWF were inoculated with a suspension of 
the test organism as described in sections 2.5.1 and 2.5.2. Vials were incubated at 
37°C and 200 rev min-1 for 5 or 24 hours. A total of three independent samples were 
prepared for each bacterial strain in each of the liquid culture media used. Where 
bacterial strains were incubated for 5 hours and 24 hours, three independent 
samples were prepared for each incubation time. 
 
3.2.2 Selected Ion Flow Tube - Mass Spectrometry (SIFT-MS) 
Following incubation, the sample head space gases were analysed using the SIFT-MS 
Profile 3 instrument in Full Scan mode using the H3O+ reagent ion as described in 
Section 2.8.1.1. The headspace of each vial was analysed by three repeat scans over 
a spectrum range of 10 – 200 m/z. 
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3.2.3 Data Analysis 
Mean count rates were calculated as follows: Where a product ion was detected in 
both the headspace of a bacterial culture and the un-inoculated control, t-tests were 
performed to compare the count rate detected. Only product ions detected at 
significant levels (p<0.05) from the bacterial cultures compared to background 
control levels were included for further analysis. The mean product ion count rate of 
background volatiles from the un-inoculated culture media were then subtracted 
from those detected in bacterial culture head-space, to determine the total count 
rate attributed to production of volatile compounds in the bacterial culture. Any 
corrected negative values were disregarded (indicating a reduction significantly 
below the background levels), as were reagent ion peaks.  
A threshold detection signal of 10 counts per second (cps) was applied to negate 
instrument signal noise and identify discriminant volatile compound product ion 
data. Further selection was required to identify discriminate product ions for the SWF 
data: A minimum signal of 10 cps was required in at least two of the strains analysed 
for each species in order for each product ion to be included for further analysis.  
Hierarchical cluster analysis (see Section 2.10.1) was applied to the resultant data 
set, enabling construction of a dendrogram which indicates relationship between 
each of the samples based on the product ion peaks detected in the sample 
headspace. The data was subsequently transformed using Principal Component 
Analysis (PCA), described in Section 2.10.2, visualised by constructing plots of the 
principal components scores for each data set, and generating loading plots to 
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indicate the impact of each of the measured variables on the principal component 
scores.  All data was analysed using Microsoft Excel 2013 (Microsoft Corporation, 
Redmond, Washington, USA) and IBM SPSS Statistics version 20.0 (IBM Corporation, 
Armonk, NY, USA). 
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3.3 RESULTS 
3.3.1 Headspace Analysis of Wound Associated Bacteria Cultured in Complex 
Growth Media (TSB). 
Multivariate analysis of the headspace count rates (log10) of 51 selected mass 
spectral product ions using Ward’s method of hierarchical clustering analysis is 
visualised by the dendrogram in Figure 3.1. This shows successful discrimination 
between P. mirabilis, E. coli and the staphylococci based on the profile of selected 
 
Figure 3.1: Dendrogram generated by hierarchical cluster analysis using 51 selected 
headspace volatile compound product ion peaks, detected by SIFT-MS following 5 hours 
incubation (n = 3 per strain) in TSB. EC; Escherichia coli, PM; Proteus mirabilis, SE; 
Staphylococcus epidermidis, PA; Pseudomonas aeruginosa, SP; Streptococcus pyogenes, 
SA; Staphylococcus aureus. 
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volatile compound product ions detected. The data was transformed using principal 
component analysis to reduce the selected variables to principal components. The 
first two principal components account for 36.3% and 21.7% of the variability within 
the data respectively (Figure 3.2a). Plotting the scores generated by PCA enables the 
complex data set to be represented in 2-dimensional space and clearly visualises the 
association of each bacterial strain with the derived principal components. This 
shows that the strains of P. mirabilis and E. coli, occupy discrete regions of the 2-
dimensional plot. Figure 3.2b shows the loading of the 51 selected product ions 
constituting the original variables for the principal component analysis shown in 
Figure 3.2a. This plot shows the contribution of each of the original variables; product 
ion count rates, to the derived first two principal components and indicates the 
influence of these variables in determining the position of each test strain. It is 
important to note that both the absence and presence of product ions dictates the 
spatial location of the given bacterial strain within the principal component plot. For 
example, when considering P. aeruginosa and S. pyogenes within the principal 
component plot, the absence of the majority of detected product ions and the 
presence of product ions m/z 18 and 28 dictate the plotted location of these species. 
Figure 3.2a shows P. aeruginosa and S. pyogenes are located very close together on 
the two-dimensional plot, with some overlap between the two species, and are not 
well discriminated based on the profile of selected volatile compound product ions 
detected following 5 hour incubation in TSB. This was predominantly due to the 
absence of product ions detected in the culture headspace, as indicated by Figure 
3.2b, rather than the presence of numerous similar volatile product ions. S. aureus 
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and S. epidermidis appear to occupy overlapping regions on the plot shown in Figure 
3.2a. However, when the third principal component is employed (accounting for 
10.1% of the total variance) to construct a 3-dimensional plot, these two species 
separate along this theoretical z-axis. 
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Although it is not possible to display the 3-dimensional plot within this thesis, the 
data can be visualised by plotting the second and third principal components against 
each other in a 2-dimensional plot, as shown in Figure 3.3.  
To further investigate whether P. aeruginosa and S. pyogenes could be differentiated 
based on volatile analysis when cultured in TSB, independent samples were cultured 
 
Figure 3.3: Plot of the scores of the second and third principal components generated by 
principle component analysis of selected SIFT-MS product ion peaks from bacterial 
cultures incubated for 5 h in TSB (n = 3). Principal component 2 (horizontal axis) accounts 
for 21.7% and principal component 3 (vertical axis) accounts for 10.1% of the variation 
within the original data set. Showing separation of Staphylococcus aureus (Pink) and 
Staphylococcus epidermidis (Yellow). 
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for 24 hours and headspace gases analysed by SIFT-MS, with the resultant data 
processed as previously described. Following product ion selection, hierarchical 
cluster analysis resulted in the production of the dendrogram shown in Figure 3.4. 
This shows that through analysis of the headspace gases of P. aeruginosa and S. 
pyogenes cultured in TSB for 24 hours, the two species can be separated in to discreet 
clusters. Therefore indicating differences between headspace volatile compound 
product ions of P. aeruginosa and S. pyogenes detected following 24 hour incubation 
that were not present after 5 hours incubation.  
 
Figure 3.4: Dendrogram generated by hierarchical cluster analysis using selected 
headspace volatile product ion peaks, detected by SIFT-MS following 24 h of incubation 
in TSB (n = 3 per strain). PA; Pseudomonas aeruginosa, SP; Streptococcus pyogenes. 
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3.3.2 Headspace Analysis of Wound Associated Bacteria Cultured in a Simulated 
Wound Fluid (SWF). 
Analysis of the data generated through SIFT-MS analysis of bacterial cultures grown 
in SWF following the same processing procedure as that used for the samples 
cultured in TSB, indicated that the threshold detection level of 10 cps was not 
sufficient to identify discriminatory product ions within the data set. Applying this 
threshold to the SWF headspace m/z data resulted in the identification of 55 
potentially discriminatory product ion peaks.  
Analysis of these selected product ion peaks using hierarchical cluster analysis 
resulted in construction of the dendrogram shown in Figure 3.5. This dendrogram 
shows no species specific clustering based on the detection of the 55 selected SIFT-
MS product ions in the headspace of bacterial cultures in SWF following 5 hours 
incubation. However, the dendrogram shown in Figure 3.5 does indicate that the 
staphylococci can be discriminated from all other species based on analysis of these 
55 selected product ions.  
In order to identify discriminatory product ion peaks an additional level of 
thresholding was applied to the data set, product ions were only included in the 
analysis if the 10 cps threshold was met by at least two strains of any of the species 
included in the study. This resulted in the selection of 26 potentially discriminatory 
product ions. Hierarchical clustering analysis of these selected product ions, enabled 
discrimination of P. mirabilis, E. coli, S. pyogenes and P. aeruginosa at the species 
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level and staphylococci at the genus level as visualised by the dendrogram shown in 
Figure 3.6.  
 
 
Figure 3.5: Dendrogram generated by hierarchical cluster analysis using selected 
headspace volatile product ion peaks, detected by SIFT-MS following 5 h of incubation in 
SWF (n = 3 per strain). EC; Escherichia coli, PM; Proteus mirabilis, SE; Staphylococcus 
epidermidis, PA; Pseudomonas aeruginosa, SP; Streptococcus pyogenes, SA; 
Staphylococcus aureus. 
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Figure 3.6: Dendrogram generated by hierarchical cluster analysis using 26 selected 
headspace volatile product ion peaks, detected by SIFT-MS following 5 h of incubation 
in SWF (n = 3 per strain). EC; Escherichia coli, PM; Proteus mirabilis, SE; Staphylococcus 
epidermidis, PA; Pseudomonas aeruginosa, SP; Streptococcus pyogenes, SA; 
Staphylococcus aureus. 
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Principal component analysis was utilised to transform this data set; the first two 
principal components account for 34.3% and 19.7% of the total variance (Figure 
3.7a). Figure 3.7a shows that strains of E. coli and staphylococci each occupy specific 
discrete regions of the 2-dimensional plot, but that there is overlap between S. 
pyogenes, P. mirabilis and P. aeruginosa. Figure 3.7b shows the loading plot of the 
26 original variables (product ions) detected by SIFT-MS headspace analysis on the 
first two principal components, generated by the principal component analysis 
represented in figure 3.7a. In Figure 3.7a, strains of P. mirabilis, P. aeruginosa and S. 
pyogenes appear to occupy overlapping regions. An additional plot was constructed 
using the third principal component, which accounts for 9.5% of the total variation 
within the original data set (Figure 3.8). This shows that the P. aeruginosa and P. 
mirabilis are separated along the horizontal axis (third principal component). The 
strains of S. pyogenes do not occupy a discrete area of this plot, one strain is more 
closely associated with the P. mirabilis strains than with the other strain of S. 
pyogenes (Figure 3.8). 
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The strains of S. aureus and S. epidermidis did not form separate clusters in the 
dendrogram shown in figure 3.6 or occupy discrete regions of the PCA plot shown in 
Figure 3.7. Additional independent samples of S. aureus and S. epidermidis were 
inoculated and incubated for 24 hours, to investigate whether strains of these 
species could be differentiated based on the headspace volatiles produced during 
culture in SWF with an extended incubation period. Following background 
 
Figure 3.8: Plot of the scores of the second and third principal components generated by 
principle component analysis of selected SIFT-MS product ion peaks from bacterial 
cultures (n = 3) incubated for 5 h in SWF. Principal component 2 (vertical axis) accounts 
for 19.7% and principal component 3 (horizontal axis) accounts for 9.5% of the variation 
within the original data set. Showing separation of Proteus mirabilis (Grey), Pseudomonas 
aeruginosa (Green) and Streptococcus pyogenes (Orange). 
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subtraction and product ion selection as described previously, hierarchical cluster 
analysis was used to generate the dendrogram show in Figure 3.9. This dendrogram 
does not show any species specific clustering of S. aureus and S. epidermidis, 
indicating that these species cannot be discriminated using detection of headspace 
volatiles when cultured in simulated wound fluid for 24 hours.  
 
 
Figure 3.9: Dendrogram generated by hierarchical cluster analysis using selected 
headspace volatile product ion peaks, detected using SIFT-MS following 24 h incubation 
of Staphylococcus aureus and Staphylococcus epidermidis (n=3 per strain) in SWF. SA; S. 
aureus, SE; S. epidermidis. 
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The SIFT-MS Profile 3 instrument has an associated kinetics library, usually employed 
when operating the instrument in multi ion mode for the quantification of known 
compounds. Searching this library for the selected m/z product ion peaks detected 
in the bacterial culture headspace allows for a preliminary identification of the 
neutral analyte compounds that may have given rise to the detected product ion 
peaks. Table 3.1 shows presumptive identification for the 26 selected product ion 
peaks used for the analysis of the headspace of bacterial cultures in SWF following 5 
hours incubation. Some of these product ions peaks, such as 48, 64 and 106 m/z did 
not correspond with any entry in the kinetics library, while others match with 
multiple entries. Table 3.1 indicates each of the product ions detected, the library 
entries (compounds) associated with each product ion where applicable, the 
compound molecular formula and molecular weight (MW), and the reaction with the 
H3O+ reagent ion that that would give rise to the detected product ion from the 
suggested analyte compound. For example, a product ion at 81 m/z could be 
generated from acetaldehyde, which has a MW of 44, ionised by the addition of H3O+. 
H2O or dimethyl disulphide which has a MW of 62, ionised by the addition of H3O+.  
Table 3.2 shows the product ions detected from each bacterial strain and their 
intensity, when cultured in both TSB and SWF for 5 hours. Comparing these tables 
shows clear differences between the volatile compound product ions detected when 
these organisms are cultured in these two different liquid media. Table 3.2 shows 
that in general, the product ion peaks detected from the bacterial species included 
in this study, are greater in number and often at higher intensities in the TSB data set 
compared to the SWF data set. 
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3.4 DISCUSSION 
The main aim of this chapter was;  
 To investigate if planktonic cultures of wound associated bacteria produce 
species specific volatile profiles in vitro, enabling significant discrimination. 
The mass spectral profile of volatile compound product ions derived from the tested 
wound-associated bacterial species varies between species. This also extends, to 
some strains from a single species, as reported in previous studies (Thorn, Reynolds 
and Greenman, 2011; Shestivska et al., 2015). This work has demonstrated that the 
culture conditions; namely composition of culture media and duration of incubation, 
influence the range of product ions and count rates of the resultant volatile 
compound mass spectra. The variability in the range and relative concentrations of 
bacterial volatiles detected under different physicochemical conditions has been 
previously observed in other research studies (Dolch et al., 2012a, 2012b; O’Hara and 
Mayhew, 2009; Chippendale, Španěl and Smith, 2011). The range and count rates of 
product ions detected are greater in TSB, a complex nutrient rich commercially 
available culture media, compared to a simulated wound fluid containing Peptone, 
NaCl and Fetal Bovine Serum (Table 3.2). The differing nutrient sources in the culture 
media almost certainly results in the upregulation of altered bacterial metabolic 
pathways, resulting in the production of different volatile metabolites (Audrain et al., 
2015).   
The results from this work demonstrate that, it is possible to discriminate selected 
wound associated bacterial species based on the detected volatile compound 
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product ion profiles, whether cultures are grown within complex medium (TSB) or 
under wound similar conditions (in SWF). After 5 hours incubation it was possible to 
discriminate several species based on the volatile compound product ion profiles 
using hierarchical clustering analysis; however, it was not possible to discriminate 
between strains of P. aeruginosa and S. pyogenes. Similarly, when the transformed 
data set was plotted as principal components, P. aeruginosa and S. pyogenes occupy 
closely adjacent regions on the two-dimensional plot. This is the result of the absence 
of product ions detected in the headspace of either species under these conditions, 
visualised by comparing the two plots in Figure 3.2.  
Increasing the incubation period to 24 hours resulted in an increase in the number 
and count rates of SIFT-MS product ions detected from P. aeruginosa. This included 
high count rates for the 18 m/z product ion in all strains and the 28 m/z product ion 
in two of the four strains analysed. Hierarchical clustering analysis of the data 
obtained after 24 hours of incubation resulted in successful discrimination between 
the strains of these two species, based on the clustering shown in the resulting 
dendrogram (Figure 3.4).  
It is possible to make a preliminary identification of the volatile compounds which 
correspond with the detected SIFT-MS product ions, using predetermined reaction 
rate constants. When using the H3O+ reagent ion, 18 and 28 m/z product ions indicate 
the presence of protonated ammonia and hydrogen cyanide respectively (Turner, 
Španěl and Smith, 2006; Španěl, Wang and Smith, 2004). It has been previously 
demonstrated that both ammonia and hydrogen cyanide production are 
characteristic of P. aeruginosa (Nawaz et al., 1991; Gilchrist et al., 2011). A study 
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which investigated the production of these volatiles over time in a number of P. 
aeruginosa strains determined that both compounds began to rise above detectable 
levels only in older cultures, as they began to enter stationary phase (Neerincx et al., 
2015). This would explain the presumptive detection of these discriminant volatiles 
only after 24 hours of culture within this study. It is highly likely that these volatiles 
will be important for identification of P. aeruginosa in vivo, where growth conditions 
likely result in a slow growing biofilm state. Indeed, elevated hydrogen cyanide 
concentrations in nose-exhaled breath have been identified using SIFT-MS as a 
potential biomarker of P. aeruginosa infection in adult Cystic fibrosis patients 
(Gilchrist et al., 2013).  
The results of this study successfully demonstrated that it is possible to discriminate 
wound-associated bacterial species based on a profile of selected SIFT-MS product 
ions when cultured under wound similar conditions. Using hierarchical cluster 
analysis to determine strain relatedness, four of the six bacterial species were 
successfully discriminated, based on the clustering shown in the resulting 
dendrogram (Figure 3.6). Using PCA and constructing plots using the scores of the 
first 3 principal components resulted in incomplete discrimination of the bacterial 
species investigated, suggesting some essential information for discrimination may 
have been lost to the other smaller components not included in the plots. The two 
species of staphylococci could not be discriminated from each other based on the 
analysis of headspace volatile compound product ions following 5 hours of 
incubation. Further analysis of the headspace of both species of staphylococci 
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following 24 hours of incubation in SWF, also failed to successfully discriminate these 
species, in contrast to staphylococci cultured in complex culture media (TSB).  
The discrimination of these wound associated microorganisms based on the analysis 
of headspace gases using SIFT-MS resulted from careful selection of appropriate 
discriminatory product ions through the application of signal thresholds. As noted 
earlier, analysis of different discriminatory product ions was required for successful 
species specific clustering under the two different culture conditions testing during 
this work. The majority of studies of bacterial volatile metabolites to date rely on 
detection or quantification of specific compounds, which requires pre selection of 
appropriate compounds previously identified in the bacterial culture headspace. The 
approach used here facilitates discrimination of bacterial species based on all the 
volatile compound product ion peaks detected across a spectrum range. One 
advantage of this approach is that unknown compounds that have not been 
previously identified and may be important for species discrimination can contribute 
to the analysis, but conversely many non-discriminatory product ions peaks will be 
detected and so selection of discriminatory product ion peaks forms an important 
phase of the data analysis. Further investigation of alternative methods for selection 
of potentially discriminatory volatile compound product ion peaks would be an 
advantage for future work. 
Using the predetermined reaction rate constants, presumptive identification of the 
neutral analyte compounds which correspond to the detected SIFT-MS product ions 
is possible. However, it is important to be aware that the reaction of a single selected 
precursor ion with similar volatile compounds or compound fragments can result in 
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the production of the same product ions (Table 3.1). For example, utilising the H3O+ 
precursor ion as used within this study, the production of 89 m/z product ion can 
result from the protonation of a number of different analytes with a molecular 
weight of 88 Da, including pentanol (C5H12O), butyric acid (C3H7COOH) and putrescine 
(C4H12N2). Furthermore, if a mixture known to contain more than one of these 
compounds were analysed using only the H3O+ precursor ion in MIM mode, it would 
only be possible to determine the total partial pressure of all compounds resulting in 
the common product ion (Wang, Španěl and Smith, 2004). In some cases it may be 
possible to rule out the presence of certain compounds based on the nature of the 
sample being analysed. However, pentanol (C5H12O), butyric acid (C3H7COOH) and 
putrescine (C4H12N2) could all be produced as a result of bacterial metabolism, as 
products of fermentation and decarboxylation reactions (Schulz and Dickschat, 2007; 
Audrain et al., 2015; Thorn and Greenman, 2012). Ambiguity in the identification of 
neutral analyte compounds can potentially be overcome by the analysis of the 
sample using multiple precursor ions, usually H3O+ and NO+, as the reaction of 
compounds with different precursor ions can result in the production of different 
product ions. The compounds may then be identified and quantified using the 
appropriate precursor ion reaction (Wang, Španěl and Smith, 2004).  
This study has demonstrated that using SIFT-MS and multivariate statistical analysis, 
it is possible to discriminate wound-associated bacterial species based on the profile 
of selected SIFT-MS product ions when these species are grown in complex culture 
media (TSB) and under wound similar conditions in SWF. Discrimination of bacterial 
species associated with wound infection cultured in SWF to simulate the nutrients 
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supplied in wound like conditions begins to demonstrate the possibility of using 
detection of volatile metabolites for the identification of the causative organism of 
wound infection. This provides the first important step in this research, towards the 
application of volatile analysis for point of care identification of the cause of clinically 
relevant wound infection. 
Further work will assess whether it is possible to discriminate between bacterial 
species based on volatile headspace analysis when grown as biofilm rather than in 
liquid culture. A biofilm model will simulate more closely the real wound 
environment (James et al., 2008) and the altered growth conditions will likely affect 
the metabolic profile of the organisms and result in a change in the volatile 
metabolites produced, and hence the discriminatory product ions required for the 
resulting analysis. This approach required the development of a wound biofilm model 
based on a continuously perfused semi-solid matrix which is the focus of Chapter 5. 
Enabling volatile profiles of the wound associated organisms to be investigated under 
conditions that more closely simulate wound infection, will further facilitate the 
development of this approach to clinically useful wound diagnostics. 
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Chapter 4: Analysis of volatile compounds from 
discarded patient wound dressings 
4.1 INTRODUCTION 
The results presented in chapter three demonstrate that bacterial species associated 
with wound infection produce characteristic volatile profiles in vitro, and that 
differences between volatile profiles can be exploited to facilitate discrimination 
between bacterial species. Regular wound dressing changes are carried out during 
routine patient care and this material is usually discarded. Dressing material that has 
been in contact with an infected wound will absorb exudate (Spear, 2012) and may 
also capture volatile compounds emitted by the infecting bacteria. Hence, it may be 
possible to identify species specific volatile profiles derived from the organism 
causing an infection, using selected ion flow tube mass spectrometry (SIFT-MS) for  
analysis of discarded dressing material. In addition, wound dressing removal is 
associated with increased pain, which can cause considerable patient distress, and 
can contribute to delayed wound healing (Price et al. 2008; Upton et al. 2012). The 
ability to assess a wound for infection by direct assessment of discarded dressing 
material would be of significant clinical significance, since this would minimize 
additional interference with the wound.  
The main aim of this chapter was to address the second main research aim: 
 To investigate if the concept of species discrimination based on volatile 
compound detection could be applied to analysis of discarded wound 
dressings, as part of routine wound care.  
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4.2 METHODS SUMMARY 
4.2.1 Dressing Collection 
Burn wound dressings were collected from patients with scald, contact and flame 
burn injuries, presenting to the adult and children’s burn services at Bristol Royal 
Hospital for Children and Southmead Hospital, Bristol between April 2016 and 
September 2017. Dressings were collected from patients with suspected burn wound 
infection, once removed were stored refrigerated in a sealed container or bag for up 
to 72 hours. Dressings were then transported to UWE for analysis (UWE FREC 
number: HAS.15.08.005, NHS REC reference: 15/YH/0304, Human Tissue Register 
Reference: HTSC-31A) and analysed within 7 days. The clinical indicators of infection 
used as inclusion criteria for this study were high temperature, rash, vomiting, 
diarrhoea, decrease appetite, lethargy, wound odour, increased pain and wound 
appearance. In addition, a description of the wound presentation was recorded in 
line with the following criteria; Normal healing, red/inflammation, swelling, hot to 
touch, exudate, biofilm, pus, necrosis/tissue death, strong odour. 
 
4.2.2  SIFT-MS Analysis 
Dressing samples were transferred aseptically to a 1 L gas sampling bag (Tedlar®, 
Supelco, UK) which was sealed, filled with synthetic air (20% oxygen, 80% nitrogen) 
and incubated for 1 hour at 37°C to allow the equilibration of headspace gases.  
Following incubation, the gaseous headspace of the dressing samples were analysed 
by SIFT-MS (Profile 3, Instrument Science Limited, UK) in ‘Full Mass Scan’ mode using 
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the H3O+ precursor ion; each sample was analysed using 3 repeat scans of 100 
seconds, over a spectrum range of 10-200 m/z. Headspace samples were introduced 
to the instrument by piercing the silicone septum of the sample bag with a sterile 
needle attached to the SIFT-MS direct sampling inlet. After sampling was complete, 
the samples were destroyed by autoclaving (in line with the ethical approval 
requirements). 
In addition, sterile dressing sample controls (n=3) for each dressing type included in 
the study were analysed by SIFT-MS using the same experimental conditions and 
parameters as detailed above. 
 
4.2.3 Wound Swab Microbiology and Clinical Information 
The results of routine clinical wound swabbing microbiology, carried out at the time 
of dressing change, and anonymised patient clinical symptoms and wound 
presentation information, were provided by Bristol Royal Hospital for Children and 
Southmead Hospital (UWE FREC number: HAS.15.08.005, NHS REC reference: 
15/YH/0304, Human Tissue Register Reference: HTSC-31A). 
 
4.2.4 Data Analysis 
To allow comparison between samples, where different dressing types were used, 
corresponding sterile dressing samples were analysed and background subtraction 
performed. This allowed identification of the detected volatile compound product 
ion peaks that could be attributed to the patient sample, irrespective of dressing 
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type. Where a product ion peak was detected from both the patient dressing sample 
and the sterile control dressing, t-tests were performed to compare the count rate 
detected. Only product ions detected at significant levels (p<0.05) from the patient 
dressing sample when compared to sterile control dressings were included for 
further analysis. The mean product ion count rate of background volatiles from the 
sterile control dressings, were subtracted from those detected in patient dressing 
samples, to determine the total count rate attributed to volatile compounds 
detected from the patient dressing sample. Reagent ion peaks and corrected 
negative values (indicating a reduction below the background levels) were 
disregarded.  
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4.3 RESULTS 
Table 4.1 details the clinical signs and symptoms indicative of infection for each 
patient included in the study, Tables 4.2 details the clinical wound presentation 
recorded, and Table 4.3 details the results of routine clinical microbiological analysis 
of wound surface swabs. The patient ID indicates the origin of the patient dressing 
sample. The DRV2 samples were collected from paediatric patients at the Bristol 
Royal Hospital for Children, whilst NBT samples were collected from adult patients at 
Southmead Hospital. High temperature and vomiting were the most common clinical 
indicators of infection among children, recorded in 94% and 47% of these patients 
respectively. Wound appearance (100%), odour (76%) and increased pain (57%) were 
the most common clinical indicators of infection among the adult patients. 
Staphylococcus aureus was the most commonly isolated organism from all the wound 
surface swabs (54%).  
Patient dressing samples were analysed by SIFT-MS in full scan mode, using 3 repeat 
scans employing the H3O+ reagent ion, over a spectrum range of 10 – 200 m/z. 
Following analysis, t-tests and background subtraction of data obtained from scans 
of sterile controls of the same dressing type as the sample were carried out. Table 
4.4 shows the resulting data set, including only the product ion peaks with corrected 
values that were detected at levels significantly (p<0.05) in excess of the control 
dressing levels. Conditional formatting has been used on this table to ease 
interpretation, with colour increasing in intensity from white (not detected) to deep 
red with increased product ion intensity. Of the 55 dressing samples analysed by SIFT-
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MS there were 7 samples in which no volatile compounds product ion peaks were 
detected at an intensity significantly above that of the sterile control dressing. These 
were DRV2010, DRV2021, NBT009, NBT010, NBT012, NBT013 and NBT015. 
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 Table 4.1: Clinical indicators of infection corresponding to each of the discarded patient 
dressing samples included in this study.  
Sample Clinical indicators of Infection 
ID  
DRV2005 High temperature 
DRV2007 High temperature, rash, vomiting, wound appearance 
DRV2008 High temperature, rash, vomiting 
DRV2009 High temperature, rash, vomiting, lethargy 
DRV2010 Wound appearance, odour 
DRV2011 High temperature, vomiting 
DRV2012 High temperature 
DRV2013 High temperature 
DRV2014 High temperature, rash, wound appearance 
DRV2015 High temperature, rash, vomiting 
DRV2016 High temperature, vomiting, decreased appetite 
DRV2017 High temperature, decreased appetite, lethargy 
DRV2018 High temperature, vomiting, lethargy 
DRV2019 High temperature, rash, vomiting 
DRV2020 High temperature, decreased appetite, lethargy 
DRV2021 High temperature, vomiting, lethargy, tachycardia, low leukocytes 
DRV2022 High temperature, rash, decreased appetite, lethargy 
NBT002 High temperature, lethargy, wound appearance , odour, increased pain 
NBT003 Wound appearance 
NBT004 Wound appearance , odour, increased pain 
NBT005 Wound appearance , odour 
NBT006 High temperature, wound appearance, odour, raised CRP 
NBT007 Wound appearance , odour, increased pain 
NBT008 Wound appearance, odour, tracking cellulitis 
NBT009 Wound appearance , odour, increased pain 
NBT010 Wound appearance , odour, increased pain 
NBT011 Wound appearance , odour, increased pain 
NBT012 Rash, wound appearance , odour, increased pain 
NBT013 Rash, wound appearance 
NBT014 Wound appearance  
NBT015 Wound appearance 
NBT016 Wound appearance, odour 
NBT017 Wound appearance , odour, increased pain 
NBT018 Wound appearance , odour, increased pain 
NBT019 Wound appearance , odour 
NBT021 Wound appearance , odour, increased pain 
NBT022 Wound appearance , odour, increased pain 
NBT023 Wound appearance , odour, increased pain 
NBT024 High temperature, lethargy, wound appearance , odour, increased pain 
NBT025 High temperature, lethargy, wound appearance , odour, increased pain, shivers 
NBT026 Wound appearance 
NBT027 Lethargy, wound appearance , odour 
NBT028 Wound appearance , odour, increased pain 
NBT029 Wound appearance, increased pain, erythema around wound 
NBT030 Wound appearance , odour 
NBT031 Vomiting, decreased appetite, lethargy, wound appearance , increased pain 
NBT032 High temperature, wound appearance , odour, increased pain 
NBT033 Wound appearance , odour, increased pain 
NBT034 Rash, wound appearance, odour 
NBT036 Wound appearance , odour, increased pain 
NBT037 Wound appearance , odour, increased pain 
NBT038 Wound appearance , odour 
NBT039 Wound appearance 
NBT040 Wound appearance , increased pain 
 
 
Table 4.2: The clinical wound presentation corresponding to each of the discarded patient dressing samples 
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 Table 4.2: The clinical wound presentation corresponding to each of the discarded patient 
dressing samples included in this study.  
Sample Wound presentation 
ID  
DRV2005 Red inflamed, necrosis, strong odour 
DRV2007 Biofilm 
DRV2008 Normal healing, exudate, biofilm, rash 
DRV2009 Normal healing 
DRV2010 Red inflamed, swelling, pus, abscess 
DRV2011 Normal healing, exudate 
DRV2012 Exudate, deep burn 
DRV2013 Exudate  
DRV2014 Red inflamed, biofilm, rash with pustules 
DRV2015 Exudate, biofilm, rash 
DRV2016 Normal healing, exudate, deep burn 
DRV2017 Exudate 
DRV2018 Normal healing 
DRV2019 Red inflamed, exudate 
DRV2020 Exudate, deep burn 
DRV2021 Deep burn 
DRV2022 Normal healing, exudate, deep burn 
NBT002 Red inflamed, exudate 
NBT003 Red inflamed, hot to touch, exudate 
NBT004 Normal healing, Red inflamed, exudate, eschar 
NBT005 Red inflamed, exudate, biofilm 
NBT006 Red inflamed, exudate, biofilm, odour 
NBT007 Red inflamed, swelling, hot to touch, exudate, odour 
NBT008 Red inflamed, exudate 
NBT009 Normal healing, tattooing 
NBT010 Red inflamed, biofilm 
NBT011 Red inflamed, hot to touch, exudate 
NBT012 Red inflamed, hot to touch, exudate 
NBT013 Red inflamed, exudate, odour 
NBT014 Red inflamed, exudate, biofilm, odour 
NBT015 Red inflamed, hot to touch 
NBT016 Red inflamed, exudate, pus, odour 
NBT017 Red inflamed, hot to touch, exudate, odour 
NBT018 Red inflamed, hot to touch, exudate, biofilm, pus, odour 
NBT019 Red inflamed, exudate, biofilm, odour 
NBT021 Exudate, biofilm, odour 
NBT022 Red inflamed, biofilm, odour 
NBT023 Red inflamed, swelling, hot to touch, exudate 
NBT024 Red inflamed, swelling, hot to touch, exudate, odour 
NBT025 Red inflamed, biofilm 
NBT026 Red inflamed, exudate, odour 
NBT027 Red inflamed, hot to touch, exudate, odour 
NBT028 Red inflamed, hot to touch, biofilm, odour 
NBT029 Red inflamed, hot to touch, exudate, 
NBT030 Red inflamed, exudate, odour 
NBT031 Red inflamed, swelling, hot to touch, exudate 
NBT032 Red inflamed, hot to touch, exudate 
NBT033 Red inflamed, swelling, hot to touch, exudate, pus 
NBT034 Red inflamed, swelling, exudate 
NBT036 Red inflamed, hot to touch, exudate, odour 
NBT037 Red inflamed, swelling, hot to touch, exudate, odour 
NBT038 Red inflamed, hot to touch, exudate, odour 
NBT039 Red inflamed, hot to touch, exudate 
NBT040 Red inflamed, hot to touch, exudate 
 
 
Table 4.3: Microbiological results from analysis of wound surface swabs corresponding to each of the 
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 Table 4.3: Microbiological results from analysis of wound surface swabs corresponding to 
each of the discarded patient dressing samples included in this study.   
Sample Microbiological Swab Result 
ID  
DRV2005 Staphylococcus aureus 
DRV2007 - 
DRV2008 Staphylococcus aureus and scanty Acinetobacter ursingii. 
DRV2009 Mixed growth including Staphylococcus aureus 
DRV2010 MRSA and Staphylococcus aureus 
DRV2011 - 
DRV2012 Staphylococcus aureus 
DRV2013 Staphylococcus aureus, Moraxella catarrhalis, Streptococcus pneumoniae 
DRV2014 Pseudomonas species, Staphylococcus aureus 
DRV2015 Diptheroids, Staphylococcus aureus, CoN Staphylococcus, Acinetobacter lwoffii 
DRV2016 Staphylococcus aureus, Diptheroids 
DRV2017 Staphylococcus aureus 
DRV2018 Streptococcus (Alpha Haemolytic ) 
DRV2019 Staphylococcus aureus, CoN Staphylococcus 
DRV2020 Staphylococcus aureus 
DRV2021 No growth 
DRV2022 No growth 
NBT002 Group A Streptococcus, Staphylococcus sp., Coliforms 
NBT003 Staphylococcus aureus, Coliforms 
NBT004 Coliforms, Enterococcus sp 
NBT005 - 
NBT006 Staphylococcus aureus 
NBT007 Staphylococcus aureus, Group G Streptococcus, Diphtheroids  
NBT008 CoN Staphylococcus, Staphylococcus aureus, Group G Streptococcus 
NBT009 No growth 
NBT010 CoN Staphylococcus 
NBT011 Enterobacter cloacae, Alpha haemoltic Streptococcus, Diphtheroids 
NBT012 Staphylococcus aureus 
NBT013 - 
NBT014 CoN Staphylococcus, Coliforms 
NBT015 Staphylococcus aureus 
NBT016 Enterococcus sp, Pseudomonas sp, CoN Staphylococcus 
NBT017 Enterococcus sp, Staphylococcus aureus, Alpha haemolytic Streptococcus 
NBT018 - 
NBT019 Staphylococcus aureus 
NBT021 Staphylococcus aureus 
NBT022 Staphylococcus aureus 
NBT023 Staphylococcus aureus 
NBT024 Staphylococcus aureus 
NBT025 Group A Streptococcus  
NBT026 Group G & Group C Streptococcus, MRSA 
NBT027 Staphylococcus aureus, CoN Staphylococcus, Coliforms 
NBT028 Staphylococcus haemolyticus, Enterococcus faecalis, Diphtheroids 
NBT029 CoN Staphylococcus 
NBT030 Staphylococcus aureus, Klebsiella pneumoniae, Enterococcus sp, Diphtheroids 
NBT031 Staphylococcus aureus and Coliforms 
NBT032 Pseudomonas aeruginosa 
NBT033 Staphylococcus aureus 
NBT034 Staphylococcus aureus, CoN Staphylococcus 
NBT036 CoN Staphylococcus, Diphtheroids 
NBT037 CoN Staphylococcus, Alpha haemolytic Streptococcus 
NBT038 - 
NBT039 No growth 
NBT040 MRSA 
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Hierarchical cluster analysis of the data shown in Table 4.4 resulted in construction 
of the dendrogram shown in Figure 4.1. The dendrogram contains four main clusters, 
which are highlighted by the addition of the coloured boxes within the figure. The 
first cluster (green) contains 22 patient dressing samples, and includes those with 
few product ions that do not share common features with the other three clusters. 
The second cluster (blue) contains 19 patient dressing samples, common features 
among these samples are a product ion peak at 77 m/z, 59 m/z and/or 36 m/z. The 6 
patient dressing samples in the third cluster (yellow) are characterised by product 
ion peaks at 43 m/z, 44 m/z, 59 m/z, 61 m/z and 70 m/z. Finally, the bottom cluster 
(orange) contains 8 patient dressing samples which share common product ion peaks 
detected at 43 m/z, 45 m/z, 47 m/z, 65 m/z, 77 m/z and 83 m/z. 
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Figure 4.1: Dendrogram generated by hierarchical cluster analysis of SIFT-MS data from 
the analysis of discarded patient wound dressings (n=3 scans per dressing) following 
background subtraction of sterile control dressings. Coloured boxes highlight the four 
main cluster groupings. 
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Principal component analysis was used to transform the dressing sample data set to 
principal components. Figure 4.2 to 4.4 show scatter plots of the first two principal 
components, accounting for 22.0% and 14.0% of the variation within the original data 
set respectively. These scatter plots have been labelled to show the location of 
dressing samples within the two dimensional plot that had three of the key species 
that cause wound infections, isolated from the associated routine clinical wound 
swab. These plots show that there are no clear groupings of samples within the PCA 
plot, with the majority of samples grouping together, irrespective of microbiological 
swab result, and several scattered outside the main cluster of dressing samples.  
Figure 4.2, shows the dressing samples with corresponding routine clinical wound 
swabs that detected the presence of S. aureus. This shows that S. aureus was isolated 
from many of the routine wound surface swabs but that these samples did not all 
group together on the PCA plot based on the volatile compound product ion peaks 
detected from the dressing sample headspace.  
Figure 4.3 shows the same PCA plot, but labelled to show the location of samples 
that has Pseudomonas species detected from the microbiological analysis of wound 
surface swabs. Only three routine clinical wound swabs detected the presence of 
Pseudomonas species from the wound surface, two of these are located in the main 
cluster of samples on the PCA plot and one is located separately, scoring high against 
PC1 and negatively against PC2. The location of dressing samples with corresponding 
routine clinical wound swabs that detected Streptococci are show in Figure 4.4, all of 
these dressing samples are located in the main cluster of this plot, which also 
contains samples where Pseudomonas species and S. aureus were detected.   
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Figure 4.2: Plot of the scores of the first two principal components generated by principle 
component analysis of SIFT-MS full scan data of headspace volatiles product ion peaks of 
discarded patient dressing samples (n = 3 scans per sample). Principal component 1 
(horizontal axis) accounts for 22.0% of the total variation in the original data set and 
principal component 2 (vertical axis) accounts for 14.0% of the total variation. Labelling 
highlights the location of dressings with a corresponding wound surface swab that 
detected the presence of Staphylococcus aureus. 
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Figure 4.3: Plot of the scores of the first two principal components generated by principle 
component analysis of SIFT-MS full scan data of headspace volatiles product ion peaks of 
discarded patient dressing samples (n = 3 scans per sample). Principal component 1 
(horizontal axis) accounts for 22.0% of the total variation in the original data set and 
principal component 2 (vertical axis) accounts for 14.0% of the total variation. Labelling 
highlights the location of dressings with a corresponding wound surface swab that 
detected the presence of Pseudomonas species. 
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Figure 4.4: Plot of the scores of the first two principal components generated by principle 
component analysis of SIFT-MS full scan data of headspace volatiles product ion peaks of 
discarded patient dressing samples (n = 3 scans per sample). Principal component 1 
(horizontal axis) accounts for 22.0% of the total variation in the original data set and 
principal component 2 (vertical axis) accounts for 14.0% of the total variation. Labelling 
highlights the location of dressings with a corresponding wound surface swab that 
detected the presence of Streptococci. 
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4.4 DISCUSSION 
The main aim of this chapter was;  
 To investigate if the concept of species discrimination based on volatile 
compound detection could be applied to analysis of discarded wound 
dressings, as part of routine wound care. 
 A range of volatile compound product ions from across the full mass spectral range 
analysed were detected from 87% of the dressing samples analysed, after 
background subtraction of the volatile profile detected from the corresponding 
sterile dressing control sample. Volatile profiles detected from the samples analysed 
by SIFT-MS, differed between patient dressings irrespective of the dressing type.  
Hierarchical cluster analysis was used to group the dressing samples based on the 
profiles of volatile compound product ions detected from each sample. This analysis 
resulted in the generation of a dendrogram consisting of four main clusters (Figure 
4.1). Comparison of these cluster groupings with the microbiological data obtained 
from routine wound surface swabbing does not reveal the identification of specific 
bacterial species within each of these groupings. S. aureus was cultured from all of 
the wound surface swabs corresponding to the samples within the bottom cluster 
(highlighted in orange), but was also cultured from swabs corresponding to some of 
the samples in each of the other cluster groupings. Therefore, it is possible that S. 
aureus was the infecting organism in the orange group of samples, but was not 
responsible for infection when detected within the other groups. However, the data 
collected here is inconclusive.  
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These observations are reinforced by the PCA plots shown in Figures 4.2, 4.3 and 4.4 
where there is only one main cluster of dressing samples based on SIFT-MS analysis 
of volatile product ions from the discarded dressing headspace. These plots show 
that when comparing microbiological analysis of routine wound surface swabs with 
the distribution of samples based on this headspace analysis, the samples do not 
form discreet groupings associated with the bacterial species isolated from the 
corresponding wound surface swabs.  
The use of swabbing for the identification of the causative organism of wound 
infection has an important limitation; the technique only samples organisms that are 
present on the surface of the wound (Cooper and Lawrence, 1996; Halstead et al., 
2018). Quantitative biopsy of the wound bed is a superior method for the 
identification of bacteria in a wound, but this technique is not routinely used within 
clinical practice because specialist training is require and it is invasive and painful 
(Sjöberg et al., 2003; Uppal et al., 2007; Haalboom et al., 2019). In addition, the 
results obtained from the microbiological analysis of the wound surface swabs are 
qualitative only, and give no indication of the relative abundance of each of the 
organisms detected or the overall bioburden of the wound. It is likely that in addition 
to volatile compounds derived from bacteria present within the wound, the dressing 
material may have also captured volatile compounds emanating from the host and 
surrounding skin flora.  
A recent study used SPME-GC-MS to capture and analyse volatile compounds from 
the enclosed headspace of healthy skin on the forearm of seven participants (Duffy 
et al., 2017). The study identified 37 volatile compounds, 14 of which were common 
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to all seven participants, clearly demonstrating the diversity of volatiles detected 
from healthy human skin. Furthermore, the study found that damaging the integrity 
of the skin barrier, by repeated tape stripping of the stratum corneum, affected the 
volatile profiles detected (Duffy et al., 2017). Hence, it is possible that the differences 
seen in the volatile profiles detected from patients discarded wound dressings 
reported in this chapter, could be the result of natural patient variability coupled with 
differences in wound health. Due to the difficulties associated with the identification 
of infection, it is possible that some patients’ wounds were uninfected, despite 
infection being suspected at the time of recruitment to the study.  
In future, a comparison of volatile compounds detected from clinically infected 
versus clinically uninfected wounds, may facilitate identification of volatile 
compounds that indicate the infection status of the wound. In addition, parallel 
analysis of wounded and healthy skin on a larger cohort of patients may be valuable, 
to gain a clearer understanding of the effect of different wound types, as well as 
infection status on the profile of volatiles emitted from the skin.  
During this study, the sample dressing material was removed from the patient during 
routine care and would otherwise have been discarded. This approach facilitated 
relative ease of obtaining such samples and enabled an entirely non-invasive process 
of collecting samples for this proof-of-concept study. In future studies, it would be 
advantageous to identify and validate a reliable method for the collection and 
analysis of volatile compounds directly from wounded skin, as use of dressing 
material, which is not optimised for the capture of volatile compounds, is likely to 
have resulted in the loss of information within this study. A previous study has 
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identified volatile compounds from healthy human skin, using SIFT-MS connected to 
Nalophan tubing placed over the entire arm to collect skin volatiles directly from 
volunteers (Turner et al., 2008). Such an approach may also provide a suitable 
method for direct collection of volatiles from skin wounds. However, it may not be 
practical to transport and locate a SIFT-MS instrument within a clinical environment, 
so use of a purpose designed material to trap and transport wound volatile 
compounds for off-site analysis may provide a more suitable approach.  
The results of this proof-of-concept study demonstrate that it is possible to detect 
volatile compounds from discarded wound dressings. This suggests in future, it may 
be appropriate to implement volatile analysis in the clinic through the assessment of 
dressing material during routine wound care. It may also prove possible to routinely 
monitor wound infection with the dressing in situ.  
However, the data collected within this study, does not provide any specific insight 
in to the links between detected volatile profiles in the wound dressing and the 
bacteria present on the wound surface. This study does serve to highlight the 
potential challenges of validating a novel approach to wound diagnostics, due to the 
current difficulty in definitively diagnosing wound infection and identifying the 
causative organism(s). Before further patient studies are undertaken it will be 
essential to further characterise the volatile profiles of wound associated bacterial 
species cultured under controlled conditions more representative of the real wound 
environment, this is the focus of Chapters 5 and 6.
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Chapter 5: An in vitro collagen perfusion wound 
biofilm model 
5.1 INTRODUCTION 
In vitro studies of biofilms employ one of two approaches; a closed multi-well plate 
based model, or an open flow system with the continuous perfusion of nutrient into 
the model and waste products continuously exiting the system (Coenye and Nelis, 
2010). Both of these approaches often involve the development of biofilms on solid 
surfaces, usually plastic or glass. Microbial infection in vivo consists of biofilm growth 
on the surface of, or suspended within, the semi-solid matrix of the tissue, unless 
adhered to an implanted medical device or catheter (James et al., 2008). Collagen 
based gel matrices have been used as a substratum for culturing biofilms within 
closed systems in vitro, in an attempt to closely simulate the semi-solid nature of the 
wound (Werthén et al., 2010; Brackman et al., 2011; Hakonen et al., 2014; Price et 
al., 2016; Pompilio et al., 2017). However, a limitation of these closed systems, is that 
they do not simulate the replacement of nutrients and moisture that occur within 
the wound bed due to the production of exudate, which provides the continuous flux 
of nutrients available to the biofilm during formation and growth (Thorn and 
Greenman, 2009; Rhoads, Wolcott and Percival, 2008).  
To further assess the application of volatile analysis for the discrimination of wound 
associated bacteria, a wound biofilm model was required that combines the dynamic 
environment of a continuous flow biofilm model system with a semi-solid ‘wound-
like’ growth substrate, thereby simulating more closely the wound environment. This 
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chapter details the development of an in vitro method for culturing wound 
associated microorganisms within a collagen wound biofilm model, combining a drip 
flow reactor system (Biosurface technologies, MZ, USA) with a three-dimensional 
type I collagen gel growth matrix and continuous perfusion of a simulated would fluid 
(SWF) is described within this chapter. Staphylococcus aureus, Pseudomonas 
aeruginosa and beta-haemolytic streptococci are the main aerobic bacterial species 
thought to be responsible for delayed wound healing (Bowler, Duerden and 
Armstrong, 2001; Alrawi, Crowley and Pape, 2014; DiMuzio et al., 2014). As such, 
characterisation of the collagen wound biofilm model focuses on cultivation of P. 
aeruginosa, S. aureus and S. pyogenes biofilms. The main aim of this chapter is to 
elucidate the growth characteristics of these three pathogenic bacterial species in 
the collagen wound biofilm model.  
To demonstrate the application of this method, it has been utilized to study the 
antimicrobial kinetics of ceftazidime, when used to treat P. aeruginosa biofilms 
during early or late stage development. P. aeruginosa is among the most commonly 
isolated pathogens from both chronic and acute burn wound infections (Alrawi, 
Crowley and Pape, 2014; Branski et al, 2009) and biofilms have been shown to rapidly 
result in systemic infection in a mouse model of acute burn infection (Schaber et al., 
2007). Ceftazidime is considered a first choice antipseudomonal antibiotic (Alou et 
al., 2005; Aubert et al., 2010) for treatment when there is a high risk of systemic 
infection developing from an infected wound.  
To further demonstrate the potential of this novel model, a preliminary investigation 
of microbial metabolomics in relation to microbial biofilm development was 
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undertaken using selected ion flow tube mass spectrometry (SIFT-MS). Ammonia and 
hydrogen cyanide have previously been reported as important potential diagnostic 
metabolites detected in the headspace of P. aeruginosa liquid cultures in vitro 
(Neerincx et al., 2015), and in P. aeruginosa infections in vivo (Gilchrist et al., 2013; 
Smith et al., 2013), through analysis of the exhaled breath of cystic fibrosis patients. 
Hydrogen cyanide was also identified from the Profile 3 SIFT-MS library as a possible 
compound responsible for the product ion at 28 m/z from the data presented in 
Chapter 3.  Hydrogen cyanide is generated through decarboxylation of the amino acid 
glycine by the membrane bound hydrogen cyanide synthase enzyme (Blumer and 
Haas, 2000), ammonia is produced by the metabolism of nitrogen containing 
compounds including hydrogen cyanide (Neerincx et al., 2015).  
Real-time monitoring of bacterial volatile metabolites, has gained momentum in 
recent years as a potential rapid diagnostic tool (Spooner et al., 2009; Storer et al., 
2011; Dummer et al., 2013; Gilchrist et al., 2013; Slade et al., 2017; Lewis et al., 2017; 
Greenman et al., 2013; Ashrafi et al., 2018). The novel collagen wound biofilm model 
reported here, allows the development of this diagnostic approach in the context of 
wound infection. For example by the detection of volatile metabolite profiles emitted 
by biofilm cultures, produced under conditions which closely simulate the wound 
environment. This chapter therefore addresses the third main research aim;  
 To develop and characterise a suitable biofilm model for culture and 
headspace analysis of wound associated bacterial biofilms, that provides 
wound-like culture conditions. 
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A subset of the data presented in this chapter has been published in a peer reviewed 
journal (Slade et al, 2019), which is included in Appendix I. 
 
  
Chapter 5 – Collagen wound biofilm model 
 
 
131 
 
5.2 METHODS SUMMARY 
P. aeruginosa NCIMB 10548, S. aureus NCIMB 6571 and Streptococcus pyogenes 
NCTC 10881 were used for characterisation of the collagen wound biofilm model 
detailed in this chapter (see Section 2.2 for bacterial strain information).  
 
5.2.1 Biofilm Model 
Isolates of P. aeruginosa, S. aureus and S. pyogenes were used to prepare inoculum 
suspensions in SWF as described in Section 2.3. Bacterial suspensions (1mL) were 
used to inoculate collagen coated microscope slides, which were then incubated at 
33°C for 2 hours to allow adherence of bacterial cells to the collagen growth matrix. 
Following the initial incubation, the inoculated slides were transferred to the biofilm 
reactor connected to the media reservoir and waste containers. The reactor was 
incubated for up to 72 hours at 33°C. A detailed description of the collagen wound 
biofilm model set-up can be found in Section 2.6.  
 
5.2.2 Enumeration of Bacterial Biofilms 
Bacterial biofilms were sampled at 0, 3 and 6 hours, then every 6 hours until 48 hours 
and finally at 72 hours. At each time point a slide was aseptically removed from the 
reactor and the entire collagen layer containing the bacterial biofilm scraped in to a 
50 mL centrifuge tube. The collagen gel was digested using a collagenase solution. 
The resulting suspension was then disrupted by sonication in a water bath and 
washed two times in PBS to remove the collagenase solution as described in Section 
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2.6.3. The bacterial density of each biofilm was determined by spiral plating on to 
TSA plates as described in Section 2.4.2.  
 
5.2.3 Imaging of Bacterial Biofilms 
A coverslip was used to facilitate removal of a section of collagen gel for imaging 
experiments (see Section 2.7). 
 
5.2.3.1 Scanning Electron Microscopy (SEM) 
Biofilm samples were fixed, mounted and gold coated as described in Section 2.7.1 
before being examined and imaged using a FEI Quanta 650 FEG scanning electron 
microscope operating at 10 kV. 
 
5.2.3.2 Confocal Scanning Laser Microscopy 
Biofilm samples were stained with the FilmTracer LIVE/DEAD Biofilm Viability Kit as 
described in Section 2.7.2 and imaged using a Leica DMi8 Inverted microscope with 
confocal scanner. 
 
5.2.4 Volatile Analysis 
Custom made (Biosurface Technologies Corporation, Bozeman, MT, USA) reactor 
channel lids, containing an additional sampling port were used to facilitate sampling 
of the volatile headspace of biofilm samples. 
Chapter 5 – Collagen wound biofilm model 
 
 
133 
 
5.2.4.1 Selected Ion flow tube mass spectrometry 
Throughout the 72 hour incubation, the headspace of biofilms cultured in the 
collagen wound biofilm model were analysed using SIFT-MS. The heated direct 
sample inlet of the Syft Voice200 Ultra instrument was connected to a sampling port 
in the lid of the sealed reactor channel via a length of PEEK tubing (45 cm x 1.59 mm 
x 0.762 mm; L x OD x ID). Biofilm sample headspace was analysed in SIM scan mode 
as described in Section 2.8.2.2, to quantify the headspace concentration of hydrogen 
cyanide and ammonia over 72 hours, with mean hourly concentration reported. 
 
5.2.5 Antimicrobial Susceptibility 
5.2.5.1 Broth microdilution 
The antimicrobial susceptibility of P. aeruginosa NCIMB 10548 to ceftazidime was 
tested based on the broth microdilution method described by BS EN ISO 20776-
1:2006 58 and detailed in Section 2.9.1. 
 
5.2.5.2 Biofilms 
Biofilm cultures of P. aeruginosa NCIMB 10548 were grown on collagen coated slides 
in the drip flow reactor system as described in section 2.6 and treated with 
ceftazidime. Treatment was started after either 6 hours or 30 hours of continuous 
culture as detailed in section 2.9.2. 
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5.2.6 Data Analysis 
Biofilm enumeration data are presented as mean ± standard deviation, n=3 
independent biofilms per species per time point. Antibiotic susceptibility data was 
analysed by performing t-tests comparing specific time points of interest using 
Graphpad Prism 7 (GraphPad Software Inc., California, USA). 
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5.3 RESULTS 
5.3.1 Characterisation of Biofilm Growth in the Collagen Wound Biofilm Model 
The collagen wound biofilm model supports growth of reproducible P. aeruginosa, S. 
aureus and S. pyogenes biofilms. Figure 5.1 shows growth of biofilms over 72 hours 
at 33°C in the collagen wound biofilm model. A maximum biofilm density of 8 x 1010 
cfu slide-1 (dictated by the experimental conditions) was achieved by 30 hours of 
continuous culture for P. aeruginosa, and maintained at an approximately steady-
state of 6 – 8 x 1010 cfu slide-1, from 30 hours until the end of experimentation (72 
hours).  
S. aureus is the only one of the three species that showed a lag phase when cultured 
in the collagen wound biofilm model, the biofilm density remaining stable at 5 – 6 x 
108 cfu slide-1 for the first 12 hours of continuous culture. The biofilm density then 
increased between 12 and 36 hours to an approximately steady state between 9 x 
109 and 1 x 1010 cfu slide-1 for the remaining duration of the experiment.  
The density of S. pyogenes increased for the first 18 hours to reach a lower maximum 
density than the other two species at 3 x 109 cfu slide-1, although it should be noted 
that the mean density at the start of continuous culture was also lower in S. pyogenes 
at 4 x 107 cfu slide-1 compared to 3 x 108 and 4 x 108 cfu slide-1 respectively for P. 
aeruginosa and S. aureus. However, the observed differences between the three 
species at the start of continuous culture, following 2 hours incubation to allow 
adherence of bacterial cells to the collagen growth matrix, were not statistically 
significant (p>0.05). There are significant differences (p<0.01) between the final 
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mean maximum biofilm density (i.e. at 72 hours) achieved for each species grown 
under these specific culture conditions.  
Chapter 5 – Collagen wound biofilm model 
 
 
137 
 
  
 
Fig
u
re 5
.1
: P
seu
d
o
m
o
n
a
s a
eru
g
in
o
sa
 (green
), Sta
p
h
ylo
co
ccu
s a
u
reu
s (p
in
k) an
d
 Strep
to
co
ccu
s p
yo
g
en
es (o
ran
ge) b
io
film
 d
en
sity w
h
en
 
gro
w
n
 in
 th
e co
llagen
 w
o
u
n
d
 b
io
film
 m
o
d
el system
 o
ver 7
2
 h
o
u
rs at 3
3
°C
 (n
=3
 p
er tim
e p
o
in
t; m
ean
 ± SD
). 
Chapter 5 – Collagen wound biofilm model 
 
 
138 
 
5.3.1.1  Imaging of Collagen Gel Matrix and Bacterial Biofilms 
The un-inoculated collagen growth matrix, which polymerizes at 37°C to form a 
hydrated three-dimensional semi-solid gel layer on the surface of the microscope 
slide coupons, was imaged using scanning electron microscopy. The fixation and 
dehydration process required for preparation of samples for SEM results in collapse 
of the three-dimensional structure, although the mesh-like network of long collagen 
fibres remains clearly visible as shown in Figure 5.2a.  
Figure 5.2b shows SEM imaging of a P. aeruginosa biofilm cultured on the collagen 
gel growth matrix, which forms a dense layer of microbial cells masking the collagen 
fibres below. Multiple layers of P. aeruginosa are visible, as is the dehydrated biofilm 
extracellular polymeric substances (EPS) which can be seen connecting adjacent 
bacterial cells. Figure 5.2c shows that the S. aureus biofilm appears to form large 
three-dimensional aggregates of cells, with areas of un-colonised collagen fibres 
visible between the aggregates. Figure 5.2d show that S. pyogenes forms long chains 
of bacterial cells which have become tangled together and intertwined with the 
collagen fibres of the growth matrix.  
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5.3.2 Application of the Collagen Wound Biofilm Model for Studying Biofilm 
Volatile Metabolites  
Selected ion flow tube mass spectrometry (SIFT-MS) was used to quantify headspace 
concentration of hydrogen cyanide and ammonia in real-time, to demonstrate the 
capability of analysing volatile metabolites produced by developing biofilms in the 
collagen wound biofilm model. Biofilm headspace was repeatedly sampled and 
analysed using the SIFT-MS instrument throughout the 72 hour duration of biofilm 
growth and development.  
Figures 5.3 and 5.4 show the concentration of hydrogen cyanide and ammonia 
detected in the headspace of P. aeruginosa, S. aureus and S. pyogenes biofilm 
cultures. The concentration of hydrogen cyanide (ppb) detected in the headspace of 
P. aeruginosa biofilms increased from zero to an initial peak with a mean 
concentration of 138 ppb at 12 hours and then then dropped to a mean 
concentration of 81 ppb at 18 hours before again increasing gradually to a peak of 
191 ppb.  
The concentration of ammonia also peaked with a mean concentration of 2273 ppb 
at 12 hours in the headspace of P. aeruginosa biofilms. For both S. aureus and S. 
pyogenes biofilms, the concentration of hydrogen cyanide remained at less than 10 
ppb throughout the 72 hour duration of sampling. The concentration of ammonia 
remained at relatively low levels in the headspace of both S. aureus and S. pyogenes 
biofilms throughout the 72 hour sampling period, compared to P. aeruginosa, with 
maximum mean concentrations recorded of 458 ppb and 343 ppb respectively.  From 
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6 hours onwards the concentration of hydrogen cyanide detected in the headspace 
of P. aeruginosa biofilms was significantly higher (p<0.05) than in the headspace of 
both S. aureus and S. pyogenes biofilms. However, the concentration of ammonia in 
the headspace of P. aeruginosa biofilms was only significantly higher (p<0.05) than 
S. aureus and S. pyogenes biofilms between 9 and 34 hours, with the exception of 4 
time points (17, 20, 21 and 24 hours) where greater variability resulted in no 
significant difference between the headspace concentration of the three species. 
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5.3.3 Application of the Collagen Wound Biofilm Model for Studying Antimicrobial 
Kinetics 
To demonstrate the application of this model, the collagen wound biofilm model was 
used to investigate the antimicrobial activity of antibiotic therapy against biofilms at 
a clinically relevant dose. To confirm susceptibility of P. aeruginosa NCIMB 10548 to 
ceftazidime, planktonic minimum inhibitory concentration (MIC) values were 
determined (n=3) using a standard microdilution multi-well plate assay; the MIC was 
determined to be 2.0 mg L-1. The clinical breakpoint for ceftazidime against P. 
aeruginosa according to the European Committee on Antimicrobial Susceptibility 
testing is 8 mg L-1 (The European Committee on Antimicrobial Susceptibility Testing, 
2018). Hence, the MIC of 2.0 mg L-1, indicates that this strain is considered sensitive 
to ceftazidime. 
Once susceptibility of the strain was confirmed the efficacy of ceftazidime against P. 
aeruginosa biofilms was investigated using the collagen wound biofilm model. A 
target serum concentration of 40 mg L-1 for continuous infusion of ceftazidime is 
recommended for effective treatment of P. aeruginosa infections in vivo (Alou et al, 
2005; Aubert et al, 2010; Buijk et al, 2002), hence this drug concentration was 
selected to challenge the P. aeruginosa biofilms in the collagen wound biofilm model. 
Figure 5.5 shows the change in biofilm density resulting from ceftazidime treatment 
at 40 mg L-1, compared to normal growth conditions. Treatment was started after 
either 6 hours or 30 hours of continuous culture, to enable comparison of treatment 
efficacy on the early stage of biofilm formation and on established steady state 
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maturing P. aeruginosa biofilms. 
When treatment was initiated at the early stage of biofilm formation, the total 
biofilm density decreased for the first 12 hours of treatment to approximately 5 x 108 
cfu slide-1 (1.63 log reduction compared to untreated controls; p <0.01). The biofilm 
density remained stable at the subsequent sampling time, but increased over the 
following 24 hours to reach a density of 2 x 109 cfu slide-1. This density was 
maintained until the final sampling time (72 hours of continuous culture) resulting in 
a significant 1.6 log reduction compared to untreated controls (p <0.05) at the end 
of experimentation. 
 During treatment of established maturing biofilms, the biofilm density gradually 
decreased ultimately resulting in a mean biofilm density of 5.5 x 109 cfu slide-1 at 72 
hours (a significant 1.2 log reduction compared to the untreated control; p <0.05). 
When comparing the antimicrobial efficacy of treatment initiated at the early stage 
of biofilm development or on established maturing biofilms, there was no significant 
difference in biofilm density between these treatment groups after 72 hours of 
continuous culture. In order to determine the effect of ceftazidime treatment on 
biofilm structure, both untreated and treated biofilms were sampled for confocal 
microscopy.  
Figure 5.6 shows untreated P. aeruginosa biofilms sampled after 6, 12, 24 and 48 
hours of continuous culture. The biofilm sampled at 6 hours consisted of sparsely 
arranged P. aeruginosa cells with some small aggregates (Figure 5.6a), whereas at 12 
hours the cell density had increased and some larger aggregates were visible (Figure 
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5.6b). At 24 hours the density of the bacterial cells had again increased, in line with 
the enumeration data (Figure 5.1), whereby more complex structural formations and 
the development of surface protrusions and channels can be seen (Figure 5.6c). At 
48 hours, the biofilm architecture within the maturing biofilm shows evidence of 
increased variability in surface topography, as described within other biofilm studies 
(Luján et al., 2011; Klausen et al., 2003; Ghafoor, Hay and Rehm, 2011).  
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Figure 5.6: Confocal scanning laser micrographs of Pseudomonas aeruginosa biofilms 
grown in the collagen wound biofilm model. Sampled after (a) 6 hours, (b) 12 hours, (c) 
24 hours and (d) 48 hours of continuous culture. Main panels show XY plane, right panels 
show YZ slice and bottom panels show XZ slice. Green Syto 9 staining indicates live 
bacterial cells and red propidium iodide staining indicates dead bacterial cells. 
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Figure 5.7 shows confocal scanning laser micrographs of P. aeruginosa biofilms 
treated with 40mg L-1 ceftazidime. Samples for both treatment regimens were 
imaged after both 18 hours and 42 hours of exposure to the ceftazidime; this 
corresponds to a total culture time of 24 hours and 48 hours for the samples where 
antibiotic treatment was started at the early stage of biofilm formation, and 48 hours 
and 72 hours total culture time for the samples where treatment was started on 
established biofilms.  
Samples imaged following 18 hour of exposure to ceftazidime at 40 mg L-1 (Figure 5.7; 
a1 & b1) both show some elongation of P. aeruginosa cells. Within the confocal z-
stack, it was observed that this was most pronounced in the bacterial cells nearest to 
the surface of the biofilms, whereas cells deeper within the biofilm were 
morphologically more similar to the untreated samples (Figure 5.6).  After 42 hours 
of antibiotic exposure, it was observed that there was a high proportion of elongated 
bacterial cells (Figure 5.7; a2 & b2). The biofilm appears less densely packed with 
clear spaces between the tangles of filamentous cells, compared to untreated 
biofilms shown in Figure 5.6.  
By comparing untreated (Figure 5.6c) and treatment of early stage biofilms (Figure 
5.7; a1 and a2) it is clear that the ceftazidime treatment prevents the development 
of complex biofilm architecture. In addition, when comparing untreated (Figure 5.6d) 
and the treatment of established biofilms (Figure 5.7; b1), it is evident that 
ceftazidime treatment has resulted in the collapse of the characteristic three-
dimensional biofilm structure. This demonstrates the effect of ceftazidime on the 
complex biofilm structure, as well as the morphology of individual bacterial cells.  
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Figure 5.7: Confocal scanning laser micrographs of Pseudomonas aeruginosa biofilms 
treated with ceftazidime at 40 mg L-1. Top panels, treatment initiated at 6 hours (early 
stage of biofilm formation); (a1) sample imaged following 18 hours exposure to treatment 
and (a2) 42 hours exposure to treatment. Bottom panels, treatment initiated at 30 hours 
(maturing biofilm); (b1) biofilm sampled following 18 hours exposure to treatment (48 
hours) and (b2) 42 hours exposure to treatment. Main panels show XY plane, right panels 
show YZ slice and bottom panels show XZ slice. Green Syto 9 staining indicates live 
bacterial cells and red propidium iodide staining indicates dead bacterial cells. 
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5.4 DISCUSSION 
The main aim of this chapter was; 
 To develop and characterise a suitable biofilm model for culture and 
headspace analysis of wound associated bacterial biofilms, that provides 
wound-like culture conditions.  
The dermis of human skin is primarily composed of the protein collagen (Church et 
al, 2006). Type I collagen is the most abundant type found in human skin and is 
distributed throughout all layers of the dermis (Meigel, Gay and Weber, 1977). This 
chapter demonstrated the successful development of a dynamic collagen wound 
biofilm model utilising a three-dimensional collagen gel growth matrix comprised of 
a mesh of polymerized type I collagen fibres (Figure 5.2a), to simulate the semi-solid 
wound environment found in vivo.  
Continuous perfusion with SWF provides replacement of moisture and nutrients, and 
removal of waste products, that would be provided by the flow of exudate within 
infected wounds (Vuolo, 2004). The simulated wound fluid provides a similar range 
of nutrients as exudate, a high protein fluid that leaks from the blood vessels in 
response to inflammation associated with wound healing processes (Cutting and 
White, 2002). Biochemical analysis of wound fluid has shown that a similar range of 
constituents are present when compared to serum, with concentrations in wound 
fluid at lower levels than in serum for the majority of components  (Trengove, 
Langton and Stacey, 1996). This suggests use of a simulated wound fluid comprised 
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of 50 % serum will provide a suitable range of nutrients, many of which will be at 
biologically relevant concentrations. 
The growth of P. aeruginosa, S. aureus and Streptococcus pyogenes biofilms has been 
validated within this biofilm model system producing reproducible steady state 
biofilms at a density greater than that considered to be the critical threshold of 
clinically relevant wound infection. A density of 105 cfu g-1 tissue is considered the 
critical threshold indicative of clinically relevant wound infection (Bowler, Duerden 
and Armstrong, 2001; Sjöberg et al, 2003; Uppal et al., 2007), with a bioburden of 
between 109 and 1011 cfu g-1 tissue identified from infected wounds with the heaviest 
bacterial loads (Levine et al., 1976; Sjöberg et al., 2003). Hence, the density achieved 
within the collagen wound biofilm model represents an appropriate bacterial load, 
reflective of a challenging clinical situation for assessing antimicrobial efficacy. The 
final biofilm density varied between the species utilised for characterisation of this 
model. However, differences in biofilm forming ability, not only between bacterial 
species but also between strains of the same species have been reported previously 
(Hou et al., 2012; Lajhar, Brownlie and Barlow, 2018).  
Within the collagen wound biofilm model, the biofilm density after 72 hours of 
continuous culture was greatest in P. aeruginosa biofilms (8 x 1010 cfu slide-1). S. 
aureus biofilms achieved a final density (1 x 1010 cfu slide-1) less than that of P. 
aeruginosa but greater that S. pyogenes, which had the lowest final biofilm density 
(3 x 109 cfu slide-1) of these three species cultured within the collagen wound biofilm 
model.  
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The collagen wound biofilm model enabled investigation of microbial volatile 
metabolites produced by bacterial species associated with causing clinically relevant 
wound infection. SIFT-MS was used for real-time detection of hydrogen cyanide and 
ammonia in the collagen wound biofilm model. Monitoring of volatile compounds 
during biofilm growth and development from a perfusion biofilm model has not been 
reported previously. In the collagen wound biofilm model, the concentration of 
hydrogen cyanide increased for approximately the first 12 hours in the headspace of 
P. aeruginosa biofilms, corresponding to the most rapid increase in biofilm density. 
The concentration then decreased over the subsequent 6 to 12 hours. Investigations 
of real-time production of hydrogen cyanide from reference strains and clinical 
isolates of P. aeruginosa in liquid culture indicated a peak in hydrogen cyanide 
concentration at the transition to stationary phase only (Neerincx et al., 2015). 
Interestingly the drop in concentration of this volatile compound between 12 and 24 
hours corresponds with distinct changes in the arrangement of bacterial cells and 
development of biofilm structures observed by confocal microscopy (Figure 5.5), as 
well as a decrease in the rate at which the biofilm density was increasing.  When the 
P. aeruginosa biofilm density had stabilized within the collagen wound biofilm model 
(≥30 hours) the concentration of hydrogen cyanide continued to increase gradually 
throughout the remaining analysis time. Again, this is in contrast to that reportedly 
seen in planktonic culture (Neerincx et al., 2015), whereby production of HCN was 
maintained for only 1 to 4 hours after the initial peak. These differences may result 
from changes in the metabolic activity associated with the biofilm mode of growth, 
coupled with the continuous supply of substrates for metabolism and removal of 
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waste products within the model, which is more representative of the in vivo 
environment.  
In contrast to the headspace of P. aeruginosa biofilms, the headspace concentration 
of hydrogen cyanide from S. aureus and S. pyogenes cultures remained below 10 ppb 
for the entire 72 hour sampling period. Monitoring hydrogen cyanide production 
within this model system demonstrates the feasibility of sampling the headspace of 
developing biofilms and shows that differences between species can be detected 
from an early stage of biofilm development (6 hours) and throughout growth and 
maturation. However, the concentration of ammonia was only significantly higher in 
the headspace of P. aeruginosa biofilms than that of S. aureus and P. aeruginosa for 
a portion of the 72 hour analysis, indicating that this compound may be less useful 
than hydrogen cyanide for discrimination between these species.  
MIC assays are routinely used clinically to determine the susceptibility of bacterial 
isolates to the antibiotic treatments available. However, as demonstrated within this 
study, this is unlikely to predict the effectiveness of antimicrobials against biofilms 
and hence their therapeutic effectiveness against biofilm infections. To demonstrate 
the application of this model system for evaluating the efficacy and kill kinetics of 
antimicrobial agents, both developing and established P. aeruginosa biofilms were 
challenged with the cephalosporin antibiotic ceftazidime.  
There was no significant difference (p >0.05) in the final biofilm density after 72 hours 
of continuous culture, when comparing the two treatment start times. Both 
treatment strategies resulted in a significant reduction of total biofilm density at 72 
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hours compared to the untreated biofilm. Although a statistically significant 
reduction in viable P. aeruginosa biofilm density was demonstrated, the remaining 
mean biofilm density of 2.2 x 109 and 5.5 x 109 cfu slide-1 for the two treatment 
regimens equates to 1.5 x 109 and 3.6 x 109 cfu g-1 of collagen ‘tissue’ respectively. 
This density remains vastly in excess of the 105 cfu g-1 of ‘tissue’, used as the critical 
threshold indicative of invasive infection and risk of sepsis in studies of quantitative 
microbiological analysis of wound biopsy samples (Sjöberg et al, 2003; Uppal et al, 
2007).  
It has previously been reported that there are differences between the planktonic 
MIC and the concentration of ceftazidime (and a range of other antimicrobials) 
required to eradicate biofilms, with concentrations 1000-fold greater than the MIC 
unable to eradicate P. aeruginosa biofilms within a static model (Ceri et al., 1999). 
Using the collagen wound biofilm model, the time course of the development of such 
tolerance has been demonstrated for the first time under wound like conditions in 
vitro, and the effect of drug treatment on the biofilm structure visualized.  
Ceftazidime treatment resulted in distinct morphological changes in the general 
biofilm architecture as well as the discrete bacterial cells. This elongation response 
by P. aeruginosa to β-lactam antibiotics, including ceftazidime, has been described 
previously and was observed to result in cell lysis and a reduction in viable cells in 
planktonic culture (Elliott and Greenwood, 1984). It has been determined that 
inhibition of penicillin binding protein 3 (PBP3) by β-lactam antibiotics is responsible 
for causing filamentation in P. aeruginosa. This has been demonstrated by deletion 
of the gene required for PBP3 expression and comparison of the resulting 
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morphological changes to those seen when P. aeruginosa was exposed to sub-lethal 
concentrations of β-lactam antibiotics (Chen, Zhang and Davies, 2017). This 
phenomena has also been observed in response to β-lactam exposure in Escherichia 
coli (Yao, Kahne and Kishony, 2012), where cell elongation is reported to be the first 
of a four step process leading to eventual cell lysis.  
In conclusion, the collagen wound biofilm model has been successfully developed 
and evaluated for the growth of steady-state biofilms under wound like conditions. 
The potential of the collagen wound biofilm model for use in studies of volatile 
metabolites has been demonstrated, by characterising hydrogen cyanide and 
ammonia production from P. aeruginosa, a clinically relevant pathogen associated 
with wound infection, while demonstrating absence of production of these 
metabolites from other pathogenic species. Furthermore, the collagen wound 
biofilm model demonstrates the failure of biofilm eradication using a clinically 
relevant ceftazidime concentration, and also allows the evaluation of antimicrobial 
kinetics, clearly demonstrating the development of tolerance in the P. aeruginosa 
biofilm cultures during treatment of biofilms at both early and late stage 
development.  
Application of the collagen wound biofilm model for the study of volatile metabolites 
produced by these wound associated bacterial species facilitated further progression 
of the work described in Chapter 3, by allowing investigation of volatile profiles from 
these species when cultured under wound like biofilm growth conditions, which is 
the focus of Chapter 6. 
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Chapter 6: In vitro discrimination of wound 
associated bacterial biofilms 
6.1 INTRODUCTION 
The use of volatile metabolite detection employing a range of analytical techniques 
to discriminate between species of planktonic bacteria in vitro, has been 
demonstrated in the literature (Scotter et al., 2006; Storer et al., 2011; Thorn, 
Reynolds and Greenman, 2011; Dolch et al., 2012a; Nizio et al., 2016). The data 
presented in Chapter 3 clearly demonstrates that discrimination of pathogenic 
species associated with wound infection is achievable through the detection of 
volatile metabolites produced when these organisms are cultured in liquid media. 
However, wound infection in vivo consists of biofilm growth on the surface of, or 
suspended within the wound tissue rather than as free swimming planktonic cells 
(James et al., 2008).  
The work described in this Chapter focuses on applying SIFT-MS coupled with 
multivariate data analysis for the detection and discrimination of bacterial biofilms 
cultured in the collagen wound biofilm model developed and described in chapter 5. 
This study uses both SIFT-MS modes, full scans (FS) to generate a full spectrum of 
volatile compound product ion peaks, as well as selected ion mode (SIM) to quantify 
specific bacterial volatile compounds following identification using GC-MS. Multiple 
approaches to statistical analysis of the resultant data sets are explored to determine 
an effective process for identification of discriminant product ions or compounds.  
This chapter addresses the final two main research aims; 
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 To investigate the volatile profiles of biofilm cultures of wound associated 
bacteria in vitro that can be used for the discrimination between species. 
 To investigate the effect of multispecies biofilms on bacterial volatile 
profiles in vitro. 
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6.2 METHODS SUMMARY 
The following bacterial strains were used during this study; Pseudomonas aeruginosa 
NCIMB 10548, NCIMB 8295 and ATCC 15442, Staphylococcus aureus NCIMB 6571, 
ATCC 6538 and a clinical strain of methicillin resistant S. aureus obtained from the 
UWE culture collection, and Streptococcus pyogenes NCTC 10881, NCTC 10874 and 
NCTC 10871 (see Section 2.2 for bacterial strain information). 
 
6.2.1 Biofilm Model 
Isolates of P. aeruginosa, S. aureus and S. pyogenes were used to prepare inoculum 
suspensions in SWF as described in Section 2.3. These suspensions were used to 
inoculate collagen coated microscope slides, which were then incubated at 33°C for 
2 hours to allow adherence of bacterial cells to the collagen growth matrix. Following 
the initial incubation, the inoculated slides were transferred to the biofilm reactor. 
Tubing to the media reservoir and waste containers was connected to the reactor, 
and the reactor incubated for 48 hours at 33°C. A detailed description of the collagen 
wound biofilm model can be found in Section 2.6.  
 
6.2.1.1 Multispecies biofilms 
When inoculating the collagen wound biofilm model for the culture of multispecies 
biofilms, initial inoculum suspensions containing S. aureus NCIMB 6571, S. pyogenes 
NCTC 10881 or a mixture of both organisms was prepared as described in Section 2.3. 
One mL of the inoculum suspension was used to inoculate collagen coated 
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microscope slides, which were then incubated at 33°C for 2 hours. Following 
incubation, the slides were transferred to the reactor channels and the reactor set 
up with continuous perfusion of simulated wound fluid, as previously described in 
Section 2.6.  
For the culture of multispecies biofilms containing P. aeruginosa; after 18 hours of 
incubation at 33°C, the flow of nutrient media was halted and the reactor moved 
from a 10° angle to a flat surface. Inoculum suspensions of P. aeruginosa NCIMB 
10548 were prepared in SWF as described in Section 2.3. The developing biofilms 
were then inoculated with one millilitre of P. aeruginosa inoculum suspension. The 
reactor was incubated in a flat position at 33°C for 1 hour, before perfusion of SWF 
at a 10° angle was resumed. As the flow of media was resumed, the reactor channels 
were briefly purged with SWF at the maximum pump speed (8.5 mL min-1) to remove 
any planktonic cells, before normal perfusion rates were resumed for a further 29 
hours, incubated at 33°C (48 hours in total).  
 
6.2.2 Volatile Analysis 
To facilitate sampling of the volatile headspace of the cultured biofilms, modified lids 
custom made (Biosurface Technologies Corporation, Bozeman, MT, USA) to contain 
an additional sampling port were used during the experiments described in this 
chapter.  
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6.2.2.1 Selected Ion Flow Tube – Mass Spectrometry (SIFT-MS) 
Following incubation for a total of 48 hours, the headspace of biofilms cultured in the 
collagen wound biofilm model were analysed using SIFT-MS. The heated direct 
sample inlet of the Syft Voice200 Ultra instrument was connected to a sampling port 
in the lid of the sealed reactor channel via a length of PEEK tubing (45 cm x 1.59 mm 
x 0.762 mm; L x OD x ID).  
Biofilm sample headspace was analysed in FS mode as described in section 2.8.2.1, 
to generate a profile of volatile compound product ion peaks. The headspace of each 
independent biofilm was analysed with three replicate scans across a spectrum range 
of 10 – 200 m/z. In addition, following gas chromatography mass spectrometry (GC-
MS) to identify volatile compounds within the biofilm headspace (described in 
6.2.2.2), biofilm sample headspace was analysed using the Syft Voice200 Ultra SIFT-
MS instrument SIM scans to quantify the headspace concentration of 19 volatile 
compounds. The headspace of each independent biofilm was analysed for 60 
seconds in SIM mode, resulting in 12 replicate measurements for each volatile 
compound (see Section 2.8.2.2). 
 
6.2.2.2 Gas Chromatography – Mass Spectrometry 
Following 48 hours of culture in the collagen wound biofilm model, the headspace of 
single species biofilm cultures were sampled on to solid phase micro extraction 
(SPME) fibres and analysed using an Agilent technologies GC-MS instrument (see 
Section 2.8.3). The biofilm headspace was sampled for 30 minutes, by inserting the 
Chapter 6 – Differentiation of bacterial biofilms 
 
162 
 
SPME fibre assembly through the sampling port in the lid of the sealed biofilm reactor 
channel. A detailed description of the procedure and instrument parameters can be 
found in Section 2.8.3. 
 
6.2.3 Enumeration of Multispecies Biofilms 
Following volatile analysis by SIFT-MS multispecies biofilms were aseptically removed 
from the biofilm reactor, the entire collagen layer scraped in to a falcon tube and 
then collagen gel digested using a collagenase solution. The resulting suspension was 
disrupted by sonication in a water bath and washed two times in PBS to remove the 
collagenase solution as described in Section 2.6.3.  The bacterial density of each 
species within the resulting suspension was determined by spiral plating on to agar 
plates for selective enumeration as described in Section 2.4.2. The selective culture 
media used are detailed in Section 2.1.  
 
6.2.4 Data Analysis 
6.2.4.1 Comparing Mean Values 
In the first instance, data processing was based on the procedure used for the 
analysis of planktonic culture headspace data (section 3.2.1). The mean count rates 
(n=3) of the full scan data were calculated for each mass-to-charge (m/z) product ion 
across the spectrum range (10-200 m/z) for each bacterial strain. T-tests were 
performed to compare the count rate detected from the biofilm headspace with 
uninoculated controls. Only product ions detected at a significant level (p>0.05) in 
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the biofilm headspace compared to the background level detected from 
uninoculated controls (n=9) were selected for further analysis. The mean count rate 
from the uninoculated controls was then subtracted from the count rate from the 
bacterial biofilm headspace samples for each corresponding product ion, to 
determine the volatile compound product ion count rate attributed to production of 
volatile compounds by the biofilm culture alone. Reagent ion peaks and any negative 
values, indicating a reduction in count rate below that of the uninoculated controls, 
were disregarded.  
A threshold was applied to facilitate the identification of discriminant volatile 
compound product ions, as discussed in Section 3.2.3, whereby a minimum signal of 
10 cps was required in at least two of the three strains analysed for each species in 
order for each product ion to be included for further analysis.  
A similar process was followed for the analysis of selected ion mode (SIM) data 
whereby the mean concentration (ppb) for each bacterial strain (n=3) was calculated 
for each volatile compound quantified by SIFT-MS. The mean concentration detected 
in the headspace of uninoculated controls (n=9) was then subtracted, to calculate 
the mean compound concentration produced by each bacterial strain analysed. 
 
6.2.4.2 Multivariate Analysis of Variance (MANOVA) 
As an alternative to processing the data sets as described above, the mean product 
ion intensity or compound concentration was calculated for each independent 
biofilm from multiple replicate scans; for FS the mean was calculated from 3 replicate 
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scans across the spectrum range of 10-200 m/z and for SIM scans from 12 replicate 
measurements for each volatile compound.  
Multivariate analysis of variance (MANOVA) was utilised to compare product ion 
intensity (cps) or compound concentration (ppb) between species. Product ions or 
volatile compounds that were identified by MANOVA as having a high level of 
statistically significant difference in intensity or concentration between bacterial 
species (p<0.01) were selected as potentially discriminant variables. These variables 
were then carried forward for further analysis by hierarchical cluster analysis and 
principal component analysis as described below in Section 6.2.4.3. 
 
6.2.4.3 Multivariate Statistical Analysis 
Following selection of potential discriminatory product ions or compounds, 
hierarchical cluster analysis was applied to the selected data set, whereby a statistical 
algorithm creates a matrix of measures (squared Euclidean distance) of dissimilarity 
between each of the cases (bacterial strains). The dissimilarity matrix is then used to 
produce a dendrogram, the branching of which indicates the distance and therefore 
the dissimilarity between the clusters.  
Both the FS and SIM scan data sets were also transformed using Principal 
Components Analysis (PCA), visualised by plotting the resulting scores in a scatter 
plot. The PCA loading scores for each of the original variables (m/z or volatile 
compound) were plotted on an additional scatter plot to indicate their influence over 
the positioning of each of the cases against the generated principal components. 
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6.3 RESULTS 
6.3.1 Single Species Biofilms 
6.3.1.1 Full Scan SIFT-MS Analysis of Bacterial Biofilms; Comparing Mean Values 
The data presented in this section was analysed as described in section 6.2.3.1. 
Analysis of mean (log10) headspace count rates of selected mass spectral product ions 
from biofilm cultures of P. aeruginosa, S. aureus and S. pyogenes, using hierarchical 
cluster analysis, resulted in the production of the dendrogram in Figure 6.1. This 
shows successful discrimination of the three species analysed based on the profile of 
46 selected volatile compound product ions detected. 
The FS data set was also transformed using principal component analysis to reduce 
the selected variables to principal components. Figure 6.2a shows the scatter plot 
resulting from plotting the scores of the first two principal components. Principal 
components 1 and 2 account for 40.4% and 21.2% of the variability within the original 
data set respectively. Plotting the PCA scores in this way allows the complex data set 
to be represented in 2-dimensions and visualises the association of each bacterial 
strain with the derived principal components. Figure 6.2a shows that the strains of S. 
aureus, P. aeruginosa and S. pyogenes each occupy a discrete region of the 2-
dimensional plot. Figure 6.2b shows the loading plot for the 46 selected product ions 
constituting the original variables for the principal component analysis shown in 
Figure 6.2a. This plot shows the contribution of each of the original variables; i.e. 
product ion count rates, to the derived first two principal components and indicates 
the influence of these variables in determining the position of each bacterial strain. 
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There are 7 product ions in the sector of the loading plot (Figure 6.2b) associated 
with the position occupied by S. pyogenes in the PCA plot (Figure 6.2a), 59, 60, 61, 
77, 80, 114 and 117 m/z. Four product ions are associated with the positioning of P. 
aeruginosa, 29, 68, 76 and 155 m/z, whereas there are up to 35 product ions that are 
associated with the position of S. aureus on the PCA plot.  
   
 
Figure 6.1: Dendrogram generated by hierarchical cluster analysis using 46 selected 
headspace volatile product ion peaks, detected by SIFT-MS following 48h of continuous 
culture in the collagen wound biofilm model. PA; Pseudomonas aeruginosa, SP; 
Streptococcus pyogenes, SA; Staphylococcus aureus (n=3 biofilms per strain). Coloured 
boxes indicate species specific clustering. 
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6.3.1.2 Headspace Solid Phase Micro Extraction Gas Chromatography Mass 
Spectrometry (SPME-GC-MS) Analysis of Bacterial Biofilms 
Volatile compounds were sampled from the headspace of bacterial biofilms cultured 
for 48 hours in the collagen wound biofilm model, by solid phase micro extraction 
(SPME) for 30 minutes at 33°C. Compounds adsorbed to the fibre were then 
desorbed on to and analysed using GC-MS over a spectrum range of 15-400 m/z, as 
described in section 2.8.3. Chromatogram deconvolution and comparison with the 
NIST2.0 library was carried out using the Agilent Mass hunter software to identify 
compounds present (see Section 2.8.3).  
Table 6.1 lists the compounds identified in the headspace of bacterial biofilm 
samples. Three biofilm samples each of S. aureus NCIMB 6571, P. aeruginosa NCIMB 
10548 and S. pyogenes NCTC 10881 were analysed by HS-SPME-GC-MS. In addition 
uninoculated controls (n=4) were also analysed to identify compounds from the 
environment and emitted by culture media. Alongside the general compound 
information, the SIFT-MS product ions used for subsequent quantification of each of 
the compounds by SIFT-MS are listed, as well as the species of bacterial biofilm 
headspace the compound was detected from. 
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6.3.1.3 Selected Ion Mode (SIM) SIFT-MS Analysis of Bacterial Biofilms; Comparing 
Means. 
All 17 compounds listed in Table 6.1 were used in the analysis, following background 
subtraction of volatile compound concentrations obtained from uninoculated 
controls as described in Section 6.2.4.1. In addition to the compounds identified using 
GC-MS, hydrogen cyanide and ammonia have been included due to consistent 
reporting in the literature of their importance as potential biomarkers of P. 
aeruginosa (Gilchrist et al., 2013; Smith et al., 2013; Neerincx et al., 2016). The 28 
m/z product ion, which could arise from the presence of hydrogen cyanide was also 
selected as a discriminatory product ion within SWF planktonic culture data in 
Chapter 3.   
Analysis of mean headspace volatile compound concentrations (ppb) from biofilm 
cultures of P. aeruginosa, S. aureus and S. pyogenes, using hierarchical cluster 
analysis, resulted in the production of the dendrogram in Figure 6.3. Figure 6.3 shows 
successful discrimination of the three species analysed, with the exception of S. 
aureus NCIMB 6571, which shows a high level of dissimilarity from the other strains 
of S. aureus and the other two species analysed based on this statistical approach.  
Principal component analysis was then utilised to transform this data set, the first 
two principal components accounting for 51.1% and 20.0% of the variation within 
the original data set respectively. Plotting the principal component scores, as shown 
in Figure 6.4a, results in each of the three species analysed occupying a separate area 
of the 2-dimensional plot. Figure 6.4b shows the loading plot of the 19 original 
volatile compounds quantified by SIFT-MS on the first two principal components, 
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indicating how these compounds influence the positioning of each of the bacterial 
strains in Figure 6.4a. Dimethyl sulphide, dimethyl disulphide, ethanol, hydrogen 
cyanide and ammonia appear to most strongly influence the position of P. aeruginosa 
on the PCA plot. Acetone is the only compound that is associated with the position 
of S. pyogenes on the PCA plot and the remaining 13 compounds all appear to be 
involved in the positioning of S. aureus. 
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Figure 6.3: Dendrogram generated by hierarchical cluster analysis using 19 headspace 
volatile compound concentration (ppb), quantified by SIFT-MS following 48h of 
continuous culture in the collagen wound biofilm model. PA; Pseudomonas aeruginosa, 
SP; Streptococcus pyogenes, SA; Staphylococcus aureus (n=3 biofilms per strain). 
Coloured boxes indicate species specific clustering. 
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6.3.1.4 Full scan SIFT-MS analysis of bacterial biofilms; comparing independent 
biofilms with MANOVA 
This section presents the same data set as Section 6.3.1.1 using an alternative process 
of statistical analysis. Background subtraction of uninoculated controls was not 
undertaken, to allow direct comparison between bacterial biofilm headspace and 
controls consisting of sterile collagen gel matrices perfused with SWF.  
Multivariate analysis of variance (MANOVA), as described in Section 6.2.3.4, was 
used to select potentially discriminant product ion peaks. A total of 59 product ion 
peaks were identified by MANOVA and utilised for further analysis. Figure 6.5 shows 
the dendrogram generated to visualise the result of subsequent hierarchical cluster 
analysis, where each case shown represents headspace analysis of a single 
independent biofilm (3 biofilms per strain and 3 strains of each species). The 
dendrogram shows clear discrimination between S. aureus, S. pyogenes and P. 
aeruginosa biofilms based on the profile of selected headspace volatile compound 
product ion peaks detected in the sample headspace after 48 hours of continuous 
culture in the collagen wound biofilm model.  
Principal component analysis was used to transform the data set (59 selected 
product ions), which included control data for the 59 selected product ions from 
uninoculated controls to enable direct comparison. Figure 6.6a shows a scatter plot 
of the scores for each of the independent biofilms against the first two principal 
components, while Figure 6.6b shows the loading of each of the original variables 
(m/z product ion peaks) on these components.  
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Figure 6.5: Dendrogram generated by hierarchical cluster analysis using 59 selected 
headspace volatile product ion peaks (√cps), detected by SIFT-MS following 48h of 
continuous culture in the collagen wound biofilm model (n=3 biofilms per strain, with 3 
replicate scans per biofilm). Coloured boxes indicate species specific clustering. PA; 
Pseudomonas aeruginosa, SP; Streptococcus pyogenes, SA; Staphylococcus aureus. 
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The first two principal components account for 57.7% and 22.6% of the total variation 
in the original data. Clear discrimination between the three bacterial species S. 
aureus, S. pyogenes and P. aeruginosa biofilms is demonstrated in Figure 6.6a, with 
each bacterial species occupying a discrete region of the plot. However, the inclusion 
of data from uninoculated controls indicates substantial overlap between S. 
pyogenes biofilms and the uninoculated collagen coated slides continuously perfused 
with simulated wound fluid within the collagen wound biofilm model. This is likely as 
a result of a lack of detection of product ions from either sample type. This is 
indicated on Figure 6.6b, which shows the loading of each of the selected product 
ion peaks on the first two principal components and indicates the influence these 
original variables have on the positioning of each biofilm sample in Figure 6.6a. Only 
3 product ions are located within the region of the plot associated with the position 
of S. pyogenes and the uninoculated controls (60, 67 and 196 m/z). Eight product ions 
(28, 29, 50, 95, 96, 97, 98 and 115 m/z) appear to influence the position of P. 
aeruginosa on the PCA plot, while up to 41 product ions are involved in determining 
the position of the S. aureus biofilms. 
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order to further assess the relationship between S. pyogenes and the control samples 
an additional scatter plot including the third principal component was constructed 
(Figure 6.7a), component 3 accounted for 3.67% of the variation within the original 
data set. This showed clear separation of S. pyogenes and the control samples on the 
third principal component. Figure 6.7b shows the loading plot of the 59 selected 
product ions on the second and third principal components and indicates 12 main 
product ions potentially responsible for the separation of the S. pyogenes samples 
and the uninoculated controls on the third principal component. Of these 12, seven 
are primarily involved in the positioning of S. pyogenes (26, 30, 60, 144, 161, 175 and 
196 m/z) and a further 5 (43, 65, 66, 67 and 93 m/z) drive the positioning of the 
uninoculated control samples. 
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6.3.1.5 SIM Scan SIFT-MS Analysis of Bacterial Biofilms; Comparing Independent 
Biofilms with MANOVA. 
This section presents the same data set as Section 6.3.1.3 but with individual biofilms 
analysed separately, using MANOVA to identify potentially discriminant volatile 
compounds and includes comparison of bacterial biofilm headspace volatiles to the 
background levels detected from uninoculated controls. Multivariate analysis of 
variance (MANOVA), as described in Section 6.2.4.2, was used to select potentially 
discriminant volatile compounds. Of the 19 compounds quantified using SIFT-MS in 
selected ion mode, 8 were found to be statistically highly significantly different 
(p<0.01) between bacterial species. These potentially discriminant volatile 
compounds were hydrogen cyanide, dimethyl sulphide, acetaldehyde, 3-methyl-1-
butanol, 2,3-buanedione, 2-methyl-2-propanol, 2-methylbutanal and 3-
methylbutanal.  
Hierarchical cluster analysis was applied to the data set, resulting in production of 
the dendrogram shown in Figure 6.8. The dendrogram shows clear discrimination 
between S. aureus, S. pyogenes and P. aeruginosa biofilms based on SIFT-MS 
quantification of selected headspace volatile compounds detected in the sample 
headspace after 48 hours of continuous culture in the collagen wound biofilm model.  
Again, principal component analysis was used to transform the data set (8 selected 
volatile compound concentrations) to principal components, with the inclusion of 
data from SIFT-MS headspace analysis of uninoculated controls. Figure 6.9a shows 
the scatter plot of the scores of each bacterial biofilm and the uninoculated controls 
against the first two principal components. Principal components 1 and 2 account for 
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63.6% and 26.1% of the variability within the original data set of 8 selected volatile 
compounds. Figure 6.9a shows that all P. aeruginosa biofilms occupy a discrete 
region of the 2-dimensional plot, but that there is an overlap of one S. pyogenes 
biofilm sample in to the area of the plot otherwise occupied by S. aureus. As with the 
analysis of the FS data set presented in 6.3.1.4 there is also substantial overlap 
between S. pyogenes biofilms and the ‘background’ volatile compounds detected 
from uninoculated collagen coated slides continuously perfused with simulated 
wound fluid within the collagen wound biofilm model. Figure 6.9b shows the loading 
of the 8 quantified volatile compounds on the first two principal component and 
indicates the influence the production of these compounds has on the position of the 
biofilm samples on the scatter plot shown in Figure 6.9a. Dimethyl sulphide and 
hydrogen cyanide appear to influence the position of the P. aeruginosa samples on 
the PCA plot, while 3-methyl -1-butanol, 2,3-butanedione, 2-methyl-2-propanol, 2-
methylbutanal, 3-methylbutanal and acetaldehyde appear to influence the 
positioning of S. aureus biofilm samples. The absence of these compounds from the 
headspace of the S. pyogenes samples as well as the uninoculated controls is likely 
driving the positioning of the samples on the PCA plot in Figure 6.9a.  
Figure 6.10 shows an additional scatter plot which visualises the scores of the S. 
pyogenes biofilms and uninoculated controls against the second and third principal 
components, with principal component 3 accounting for 5.45% of the variation 
within the data set. Figure 6.10 show that there is substantial overlap between S. 
pyogenes and the controls on the third principal component and confirms that 
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discrimination between these two groups is not possible within this analysis, using 
only 8 selected volatile compounds.  
 
 
Figure 6.8: Dendrogram generated by hierarchical cluster using 8 selected headspace 
volatile compound concentrations (ppb), detected by SIFT-MS following 48h of 
continuous culture in the collagen wound biofilm model (n=3 biofilms per strain, with 12 
replicate scans per biofilm). Coloured boxes indicate species specific clustering. PA; 
Pseudomonas aeruginosa, SP; Streptococcus pyogenes, SA; Staphylococcus aureus. 
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Figure 6.10: Plot of the scores of the second and third principal components generated 
by principle component analysis of SIFT-MS SIM data of selected headspace volatile 
compound concentrations (ppb) of bacterial biofilms and uninoculated controls, showing 
S. pyogenes (Orange) and control (Blue) only. Principal component 2 accounts for 26.1 % 
of the variation within the original data set, while the third components accounts for 5.45 
% of the variation. 
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6.3.2 Multispecies Biofilms 
6.3.2.1 Enumeration of Multispecies Biofilms 
Previous studies have reported that when culturing multispecies biofilms containing 
P. aeruginosa, this organism readily dominates the bacterial population, allowing 
little or no recovery of other organisms present in the starting inoculum (Dalton et 
al., 2011; Woods et al., 2012). In order to allow growth of S. aureus and S. pyogenes 
in the multispecies biofilms containing P. aeruginosa, they were inoculated first and 
allowed to establish for 18 hours prior to inoculation with P. aeruginosa. As a result, 
the culture time of P. aeruginosa was limited to only 29 hours within the multispecies 
biofilms. However, comparison of P. aeruginosa biofilms at 30 and 48 hours (t-test), 
from the data presented in Chapter 5, which shows the development of single species 
biofilms over 72 hours, reveals that there is no statistically significant difference 
(p>0.05) in P. aeruginosa biofilm density at 30 and 48 hours.  
Figure 6.11 shows the density (cfu slide-1) of each bacterial species when cultured as 
a single species biofilm, for 48 hours, and in multispecies biofilms with one or both 
of the other two species included in this study. Analysis of variance (ANOVA) was 
used to compare density of each species cultured as a single species biofilm, to the 
density achieved when that species was included in each multispecies biofilm 
combination. The density of S. aureus is significantly less (p<0.05) in multispecies 
biofilms containing P. aeruginosa compared to single species biofilms. Similarly, the 
density of P. aeruginosa was significantly less (p<0.05) in all multispecies biofilms 
compared to single species biofilms. Although there is some variability, there is no 
statistically significant differences in the density of S. pyogenes when cultured as a 
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single species biofilm or in any of the multispecies biofilms (p>0.05) with one or both 
of the other species.  
Figure 6.12 also show the enumeration of each bacterial species within multispecies 
biofilms, but indicates the total density (cfu slide -1) of each multispecies biofilm 
combination (one per panel) and the density of each individual species included in 
the multi species community. In addition the percentage contribution to the 
multispecies biofilm of each species is indicated above the bars. Where P. aeruginosa 
is present within the multispecies biofilm this species makes up the majority of the 
multispecies community, this is consistent with the higher achievable density of this 
species seen in single species biofilms, under the specific culture conditions 
employed within the collagen wound biofilm model.   
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6.3.2.2 SIFT-MS Analysis of Multispecies Biofilms 
The headspace of multispecies biofilms cultured in the collagen wound biofilm model 
were analysed using SIFT-MS following a total of 48 hours continuous culture. SIM 
scans were performed to quantify the concentration of 19 volatile compounds in the 
biofilm headspace (see Section 6.3.1.3). This data was corrected by background 
subtraction of the concentrations quantified in the headspace of uninoculated 
controls, to determine the volatile compound production attributed to the bacterial 
biofilms only. Table 6.3 shows the compound concentration (ppb) detected in the 
headspace of multi species biofilms (n=3 per multi species combination) compared 
to the concentration of the same compounds detected in the headspace of single 
species biofilms of each of the three species included in this research.  
Many of the compounds detected in the headspace of S. aureus biofilms are not 
present in the headspace of the S. aureus and P. aeruginosa biofilms, instead the 
compounds and concentrations detected are more similar to those detected in the 
headspace of P. aeruginosa biofilms. Eighteen of the 19 compounds quantified were 
detected in the headspace of S. aureus and S. pyogenes multispecies biofilms, the 
exception is ammonia. Ammonia is detected in the headspace of both species alone, 
but is absent from the headspace of the multispecies biofilms following background 
subtraction of controls. In general the composition of the headspace of the S. aureus 
and S. pyogenes multispecies biofilms appears more similar to that of S. aureus as a 
single species biofilm than that of S. pyogenes.  
The headspace of multispecies biofilms containing S. pyogenes and P. aeruginosa, 
compared to single species biofilms of both these species indicates that the 
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multispecies biofilms produce all compounds found in the headspace of P. 
aeruginosa biofilms, but lack several produced by S. pyogenes biofilms. These include 
acetoin and 2-methyl-2-propanol. Similarly, the headspace of multispecies biofilms 
containing S. aureus, S. pyogenes and P. aeruginosa, appear to be dominated by 
compounds detected in the headspace of P. aeruginosa single species, with many of 
the compounds detected in the headspace of S. aureus absent from the headspace 
of the multispecies biofilm. The compounds absent from the multispecies biofilm 
containing P. aeruginosa and S. pyogenes, that are produced by S. pyogenes single 
species biofilms, are also absent from the biofilm containing all three bacterial 
species.  
In order to further compare multispecies and single species biofilms, the SIM scan 
data sets (without background subtraction) were combined (i.e. data from section 
6.3.1.5 and 6.3.2.2). Hierarchical cluster analysis was applied to the combined data 
set, resulting in the dendrogram shown in Figure 6.13. The largest cluster grouping is 
formed by the single species P. aeruginosa biofilms with all the multi species biofilms 
containing P. aeruginosa, suggesting this species is dominant in determining the 
composition of headspace volatiles when cultured with either S. aureus or S. 
pyogenes. A second cluster contains the single species S. aureus biofilms and the 
multispecies biofilms containing S. aureus and S. pyogenes, and the final smallest 
cluster contains only the S. pyogenes single species biofilms. 
The data sets, including all strains of single species biofilms as well as the multispecies 
biofilms, were then transformed using principal component analysis to reduce the 
complex data sets to a smaller number of principal components. Figure 6.14 shows 
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the scatter plots of the scores of all single and multispecies biofilms against the first 
two principal components from the analysis of SIM scan data, including the same 8 
volatile compounds identified using MANOVA in Section 6.3.1.5. Component 1 
accounts for 68.1 % and component 2 23.0 % of the variation within this data set. 
Figure 6.14 indicates that all three combinations of multispecies biofilm containing 
P. aeruginosa cluster with the P. aeruginosa single species biofilms in the 2-
dimensional plot. This again suggests the headspace volatile compounds produced 
by multispecies biofilms containing P. aeruginosa are dominated by the production 
of volatiles associated with this species. The multispecies biofilms containing S. 
aureus and S. pyogenes locate with the S. aureus single species biofilms on the 2-
dimensional PCA plot, showing that in this multi species biofilm volatile compounds 
produced by S. aureus dominate.  
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Figure 6.13: Dendrogram generated by hierarchical cluster using 8 selected headspace 
volatile compound concentrations (ppb), detected by SIFT-MS following 48h of 
continuous culture in the collagen wound biofilm model (n=3 biofilms per 
strain/multispecies combination, with 12 replicate scans per biofilm). PA; Pseudomonas 
aeruginosa, SP; Streptococcus pyogenes, SA; Staphylococcus aureus. 
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6.4 DISCUSSION 
The mains aim of this chapter was to determine if three important bacterial 
pathogens associated with clinically relevant wound infection, S. aureus, P. 
aeruginosa and S. pyogenes, could be successfully discriminated based on their 
production of volatile metabolites when grown in a collagen wound biofilm model. 
The results of this chapter demonstrate that by using both SIFT-MS FS and SIM scans 
(following compound identification using GC-MS), to detect characteristic volatile 
profiles combined with the use of multivariate statistical analysis all three species 
could be successfully differentiated. Therefore, this work has shown that S. aureus, 
P. aeruginosa and S. pyogenes biofilms produce headspace gases that vary between 
species. These differences can be detected as volatile compound product ion profiles 
when employing SIFT-MS in full scan mode and through the quantification of specific 
volatile compounds when the SIFT-MS instrument is operated in selected ion mode.  
Two different methods for the selection of potentially discriminatory product ions 
were used for the analysis of the full scan data set. Initially the same process that was 
previously employed for the selection of discriminatory product ions for the analysis 
of volatile compound product ion peaks from the headspace of planktonic cultures 
(Chapter 3) was utilised. This process required comparison of bacterial sample 
headspace analysis to that of the uninoculated controls using t-tests, followed by 
background subtraction of the mean control product ion intensity from the mean test 
value for each bacterial strain.  A threshold was then applied to this data set as 
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detailed in section 6.4.2.1. This method resulted in the identification of 46 product 
ions that were produced by at least one of the bacterial species, for further analysis. 
A second method of analysis was carried out to test the application of a statistical 
test (MANOVA) for the selection of potentially discriminant product ions. This 
omitted the background subtraction to allow direct comparison of individual 
independent biofilms, rather than generating a corrected mean value for each strain 
analysed. This method of analysis resulted in selection of 59 product ions peaks 
(p<0.01).  
Comparison of these two methods highlights 22 product ion peaks common to both 
processes of selection. For both methods of analysis, the location of the product ion 
peaks on the PCA loading plots can be used to determine their likely influence on the 
discrimination of the three bacterial species on the corresponding plots of their PCA 
scores. Of these 22 product ion peaks 16 are located, in the direction that indicates 
involvement in positively determining the position of S. aureus on both loading plots 
(62, 63, 64, 69, 70, 71, 72, 87, 88, 90, 99, 101, 104, 105, 106 and 145 m/z), 1 product 
ion peak appears in the direction associated with S. pyogenes positioning (60 m/z) 
and a further 4 associated with P. aeruginosa (28, 29, 68 and 155 m/z). The product 
ion peak at 50 m/z is not positioned consistently within the two different analysis 
method PCA plots. Plotting PCA scores generated from transformation of the data 
sets including only these 22 ‘core’ product ion peaks (appendix II, Figure S1) results 
in similar discrimination of the bacterial species as seen in Figures 6.2a and 6.6a, 
suggesting identification of the product ions most essential for species discrimination 
can be achieved by employing and comparing multiple methods of analysis.  
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The approach using background subtraction and a 10 cps threshold focuses on 
selection of product ion that are produced at high intensities by at least one of the 
bacterial species analysed but does eliminate product ions produced by several or all 
species. However, use of MANOVA selects only product ions produced at significantly 
different intensities between species. It is likely that product ions selected by the first 
method but not by MANOVA will be those produced at high levels in all species, 
which are therefore not useful for discrimination between species. Conversely, 
product ions selected by MANOVA, without thresholding, are likely to have 
significantly different intensities between species but may only be produced at 
relatively low intensities. Overall, if only one method of selection is to be used, 
MANOVA is likely to be most effective at identifying discriminatory product ions or 
volatile compounds. 
HS-SPME-GC-MS was used to identify compounds in the bacterial biofilm headspace 
that may be responsible for the product ion peaks detected using SIFT-MS in full scan 
mode. Seventeen compounds were identified from the headspace of the three 
species included in this work. The 17 compounds identified by GC-MS included 5 
alcohols; ethanol, 1-butanol, isobutyl alcohol, 2-methyl-2-propanol and 3-methyl-1-
butanol. Ethanol and 1-butanol are produced by fermentation of carbohydrates 
(Thorn and Greenman, 2012) and the  branched alcohols are thought to arise from 
the catabolism of branched amino acids (Audrain et al., 2015). Four aldehydes; 
acetaldehyde, 2-methylpropanal, 2-methylbutanal and 3-methylbutanal, and 4 
ketones; acetone, acetoin, butanone and 2,3-butanedione were identified by GC-MS.  
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3-methylbutanal arises from the catabolism of the amino acid leucine, as does the 
alcohol 3-methyl-1-butanol (Filipiak et al., 2012). Catabolism of pyruvate produces 
acetaldehyde, acetone and acetoin (Filipiak et al., 2012), and oxidation of acetoin 
results in 2,3-butanedione production (Audrain et al., 2015). 3-methylbutanoic acid, 
the carboxylic acid identified by GC-MS, is also produced during catabolism of 
pyruvate, either from oxidation of 3-methylbutanal or using an alternative pathway 
via the intermediate isovaleryl-CoA (Filipiak et al., 2012). It is suggested that bacterial 
production of butane may involve cysteine, but the role of this and other amino acids 
in volatile hydrocarbon synthesis remains unknown (Ladygina, Dedyukhina and 
Vainshtein, 2006). The sulphur compounds detected, dimethyl sulphide and dimethyl 
disulphide result from oxidation of methanethiol, which is itself produced from 
bacterial catabolism of methionine (Filipiak et al., 2012; Audrain et al., 2015).  
In addition to the compounds identified by GC-MS, ammonia and hydrogen cyanide 
were included for further analysis of bacterial biofilm headspace using SIFT-MS SIM 
scans. These compounds have both previously been detected from the headspace of 
P. aeruginosa, both in liquid cultures and in vivo (Neerincx et al., 2015; Gilchrist et 
al., 2013; Smith et al., 2013b), with the suggestion that they may be important 
markers of P. aeruginosa infection.  
Hydrogen cyanide is generated through decarboxylation of glycine by the membrane 
bound HCN synthase enzyme in P. aeruginosa (Blumer and Haas, 2000), and 
ammonia is produced by the metabolism of nitrogen containing compounds, 
including hydrogen cyanide and amino acids (Neerincx et al., 2015). It has been 
previously reported that interaction and competition between compounds in 
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complex mixtures can result in inconsistent results using SPME and that displacement 
of low molecular weight compounds by those of higher molecular weights can result 
in under detection of low molecular weight compounds (Murray, 2001). This may 
explain why ammonia (17 Da) and hydrogen cyanide (28 Da) were not detected 
during GC-MS analysis of P. aeruginosa biofilms, but were detected using SIFT-MS. 
Of the 17 compounds detected by GC-MS in this research acetaldehyde has the 
lowest molecular weight at 44 Da, giving rise to a SIFT-MS product ion peak of 45 m/z 
when using the H3O+ reagent ion. However, the 59 FS SIFT-MS product ions selected 
using MANOVA included 7 product ion peaks between 26 m/z and 44 m/z suggesting 
additional discriminant compounds of lower molecular weight may be present within 
the biofilm headspace. One of these product ions, 28 m/z may result from the 
production of hydrogen cyanide and is seen at high intensities (cps) in the headspace 
analysis of all 3 strains of P. aeruginosa when observing the raw data (not shown).  
SIM mode was used to quantify the headspace concentration of 17 compounds 
previously detected using GC-MS and ammonia and hydrogen cyanide, for a scan 
duration of 60 seconds, resulting in the acquisition of 12 replicate measurements of 
each compound. Initial analysis of the SIM scan data set using the same background 
subtraction method as described for the FS data utilised all 19 compounds quantified 
by SIFT-MS and resulted in insufficient grouping of the three species by hierarchical 
cluster analysis. S. pyogenes and P. aeruginosa strains formed species specific 
clusters, but for S. aureus, only two of the strains analysed clustered together with 
the third strain forming its own distant cluster.  
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Scrutiny of the SIM scan data shows that strain NCIMB 6571 of S. aureus produced 
several compounds at much greater concentrations than the other strains of this 
species. For example, 2-methylbutanal, which has been previously reported in the 
headspace of S. aureus cultures (Thorn, Reynolds and Greenman, 2011; Filipiak et al, 
2012b), was measured at >1000 ppb for this strain, compared to between 40 and 110 
ppb for the other two strains of S. aureus. Although the specific compounds produced 
by the three stains of S. aureus are similar, there appear to be differences in the levels 
of production between strains, which may be causing S. aureus NCIMB 6571 to be 
grouped separately to the other strains of S. aureus in the cluster analysis. This 
suggests strain to strain variation in the activity or production of the metabolic 
enzymes responsible for the production of these metabolites.  
Of the 19 compounds quantified using SIFT-MS SIM scans, five are located in the 
region of the PCA loading plot (figure 6.4) associated with the positioning of P. 
aeruginosa on the associated plot of PCA score; ethanol, dimethyl sulphide, dimethyl 
disulphide, hydrogen cyanide and ammonia. One compound; acetone, appears to 
influence the position of S. pyogenes and the remaining 13 compounds; 1-butanol, 
Isobutyl alcohol, 2-methyl-2-propanol, 3-methyl-1-butanol, acetaldehyde, 2-
methylpropanal, 2-methylbutanal, 3-methylbutanal, acetoin, butanone, 2,3-
butanedione, 3-methylbutanoic acid and butane are most strongly associated with 
the position of S. aureus on the PCA plot.  
MANOVA was used to identify which of the 19 compounds quantified occurred at 
significantly (p<0.01) different concentrations between the three bacterial species 
analysed. This identified 8 compounds; 3-methyl-1-butanol, 2-methyl-2-propanol, 
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acetaldehyde, 2-methylbutanal, 3-methylbutanal, 2,3-butanedione, dimethyl 
sulphide and hydrogen cyanide, which were then selected for further analysis as 
potentially discriminant compounds. Hierarchical cluster analysis carried out using 
these 8 compounds gave rise to species specific clustering of all biofilm samples. 
However, it can still be seen in Figure 6.8 that the dissimilarity between strains of S. 
aureus NCIMB 6571 and the other S. aureus strains is larger than those within the 
other two species specific clusters. Analysis of the SIM scan data results in PCA plots 
that show less reliable species specific grouping than those produced from analysis 
of the full scan data. Figure 6.9 shows that P. aeruginosa biofilms occupy a discreet 
region on the two dimensional plot, but that one S. pyogenes biofilm appears to 
group closer to S. aureus than the other S. pyogenes biofilms. However, S. aureus and 
S. pyogenes do separate when plotted against the third principal component 
(Appendix II, Figure S2).  
Figure 6.9 show that of the 8 compounds selected using MANOVA, hydrogen cyanide 
and dimethyl sulphide are driving the position of P. aeruginosa on the associated PCA 
plot. Both of these compounds have been identified and quantified in the headspace 
of P. aeruginosa culture in a previous study (Shestivska et al., 2012) which used a 
similar approach, combining GC-MS and SIFT-MS for the analysis of P. aeruginosa 
cultured using liquid and solid media. In addition, hydrogen cyanide production by P. 
aeruginosa has been widely reported in the literature (Castric, Ebert and Castric, 
1979; Askeland and Morrison, 1983; Gilchrist et al., 2011, 2013; Smith et al., 2013; 
Neerincx et al., 2015), hence the inclusion of this compound in this study.  
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Six compounds; 2-methyl-2-propanol, 3-methyl-1-butanol, acetaldehyde, 2-
methylbutanal, 3-methylbutanal, 2,3-butanedione, are driving the position of S. 
aureus on the PCA plot (Figure 6.9) suggesting high levels of production of these 
compounds from this species. Acetaldehyde and 2-methylbutanal were detected in 
the headspace of S. aureus liquid cultures in previous studies using SIFT-MS (Thorn, 
Reynolds and Greenman, 2011; Chippendale, Španěl and Smith, 2011), and 2-methyl-
1-propanol, 3-methyl-1-butanol, acetaldehyde, 3-methylbutanal and 2,3-
butanedione have been detected from S. aureus cultures by GC-MS (Filipiak et al., 
2012). Conversely, no compounds are strongly associated with the position of S. 
pyogenes, demonstrating that this species does not produce any of these compounds 
at high levels.  Catabolism of pyruvate and leucine give rise to a number of the 
compounds responsible for the discrimination of S. aureus from the other two 
species; 3-methylbutanal and 3-methyl-1-butanol from leucine, and acetaldehyde 
and 2,3-butanedione from pyruvate. Suggesting that the enzymes required for these 
metabolic processes are produced by this species and not by the others.  
There is considerable overlap between S. pyogenes and uninoculated controls in 
Figure 6.9, but unlike the FS data set, plotting the second and third principal 
components does not aid discrimination of S. pyogenes from uninoculated control 
samples. This suggests that using the specific volatile compounds identified within 
this work may not be suitable for successful discrimination of S. pyogenes from 
uninoculated controls. However, this may be possible if additional compounds that 
drive the discrimination of S. pyogenes can identified. For example, in Figure 6.7, 
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there are seven product ions strongly associated with the positioning of S. pyogenes 
biofilms on the PCA plot (26, 30, 60, 144, 161, 175 and 196 m/z).  
Cross referencing with the LabSyft library reveals possible compound identifications 
for three of these product ions, 60; trimethylamine, 161; 2-nonanone/decane and 
175; decanal. However, a previous study of microbial volatiles that included 
trimethylamine did not detect this compound in the headspace of the strain of S. 
pyogenes analysed (Thorn, Reynolds and Greenman, 2011). Further investigation of 
volatile metabolites produced by S. pyogenes is warranted, as few studies have 
included this organism to date and only a limited number of volatile metabolites have 
been identified (Julák et al., 2003; Thorn, Reynolds and Greenman, 2011). 
In order to fully develop the use of quantification of volatile headspace compound 
concentrations for discrimination between these bacterial species and discrimination 
from control samples, it will be essential to identify the additional compounds that 
give rise to the product ions that drive the discrimination between S. pyogenes 
biofilms and uninoculated controls.  
Comparison of the 22 ‘core’ product ion peaks within the FS data set, with the SIFT-
MS product ions used for quantification in the SIM scan analysis, shows that just 4 of 
the FS product ions are accounted for within the compounds quantified. These are 
28; hydrogen cyanide, 63; dimethyl sulphide, 71; 3-methyl-1-butanol and 87; 2-
methylbutanal/3-methylbutanal/2,3-Butanedione, suggesting the presence of 
further, as yet unidentified, discriminant compounds.  
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Analysis of multispecies biofilms complicates possible species discrimination. The 
data presented in Table 6.3 indicates that rather than a mixture of volatile 
compounds or product ion peaks associated with all species being detected, the 
volatile headspace is dominated by one of the species present within the biofilm. This 
is particularly evident with biofilms containing P. aeruginosa and S. aureus where the 
presence of P. aeruginosa appears to suppress the majority of the volatile 
compounds produced by S. aureus as a single species biofilm, resulting in a 
headspace analysis that closely mirrors that of P. aeruginosa alone.  
However, a study using GC-MS to investigate volatile compound release and uptake 
by S. aureus and P. aeruginosa mono-cultures in liquid media found that a number 
of aldehydes were taken up from the media by P. aeruginosa (Filipiak et al, 2012a). 
The authors also found that a variety of these aldehydes were released by S. aureus 
cultures, several of which are included in this chapter; 2-methylpropanal, 3-
methylbutanal, acetaldehyde, 2,3-butanedione. This suggests that the absence of 
these compounds from the headspace of S. aureus and P. aeruginosa multispecies 
biofilms may instead be a result of uptake by P. aeruginosa rather than suppression 
of release from S. aureus. This may explain the absence of S. aureus associated 
compounds from the biofilm headspace despite the enumeration data indicating that 
S. aureus is able to grow to 109 cfu slide-1 in the presence of P. aeruginosa.  
This finding requires further investigation if volatile analysis is to be used for the 
diagnosis of polymicrobial chronic wound infection. However, this would be less of 
an issue for diagnosis of infection of acute wounds, which generally results from 
invasion of a single pathogenic species and where early management of such 
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infections is essential to minimise the risk of sepsis (Edwards-Jones and Flanagan, 
2013; Ma, Tian and Liang, 2016; Patil et al., 2017). The findings reported in this 
chapter suggest that development of a diagnostic test, for identification of 3 
important pathogens associated with causing clinically relevant wound infection, is 
feasible using volatile analysis.   
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Chapter 7: Discussion & Future Work 
7.1 GENERAL DISCUSSION 
For the first time, this research investigated volatile profiles of planktonic pathogenic 
bacteria cultured in a simulated wound fluid. This approach was then further 
progressed through the development and application of a collagen wound biofilm 
model continuously perfused with a simulated wound fluid to more closely simulate 
wound-like growth conditions. Comparison of detected volatile product ions 
(following background subtraction and a 10 cps threshold) highlights the presence of 
30 product ions that are common to both the planktonic and biofilm models that 
were studied. The application of further thresholding of the detected product ions (a 
minimum of 10 cps in at least two strains of any species), resulted in a more selective 
profile of 26 product ions that were then used to discriminate species cultured within 
SWF. When these 26 volatile compounds are compared with product ions data 
derived from FS analysis of bacterial biofilms (discussed in Chapter 6), then 17 volatile 
compound product ions can be identified as being common to both the planktonic 
and biofilm volatiles data set. From this discrete set of 17 common product ion peaks 
(table 7.1), one product ion peak (28 m/z) influences the positioning of P. aeruginosa 
on both PCA plots that are shown in Figures 3.7 and 5.2 respectively. The product ion 
peak at 28 m/z may be indicative of hydrogen cyanide, a compound which has 
previously been reported as a potential biomarker of P. aeruginosa infection 
(Gilchrist et al., 2011; Smith et al., 2013a). Due to this, hydrogen cyanide was also 
included in the SIM scan analysis of biofilm headspace and was detected for all strains 
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of P. aeruginosa and subsequently selected by MANOVA as a potential discriminatory 
volatile compound. Hydrogen cyanide was not detected in the headspace of S. aureus 
or S. pyogenes bacterial biofilms. In total, 12 volatile compound product ion peaks 
influence the positioning of S. aureus on the PCA plots associated with planktonic and 
biofilm data sets (selected using t-tests and thresholding) have been identified. These 
are listed in Table 7.1 with suggested volatile compounds which these product ions 
may be derived from, based on cross referencing with the Syft Voice200 volatile 
compound library. Of the 17 compounds listed in Table 7.1, four do not show a clear 
association with the positioning of S. aureus, S. pyogenes or P. aeruginosa on the PCA 
plots from the planktonic culture data (Figure 3.2). The product ions 31 and 35 m/z 
drive the positioning of E. coli, whilst 49 and 50 m/z are closely associated with the 
positioning of P. mirabilis within this data set. Within the biofilm culture data (Figure 
6.2) 35, 49 and 50 m/z, do not show a definitive association with the any of the three 
species analysed, instead locating within the bottom right sector of the loading plot 
(Figure 6.2). Nine of the 17 product ions (listed in Table 7.1) common to planktonic 
and biofilm data sets (selected using t-tests and thresholding), were also included 
when the MANOVA statistical test was used to select discriminatory product ions 
within the biofilm data set. These product ion are 28, 50, 63, 64, 69, 87, 101, 105 and 
106 m/z. Several of the compounds, which may be responsible for the product ions 
detected by SIFT-MS in full scan mode, were also detected by GC-MS and included in 
the subsequent SIM mode analysis, as detailed in chapter 6. The confirmation of the 
identity of these product ions from different analytical techniques gives increased 
confidence to the importance of these compounds for the discrimination of these 
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wound associated bacterial species. For example, 2,3-butanedione, 2-methylbutanal 
and 3-methylbutanal were detected from S. aureus biofilm headspace by GC-MS and 
also by SIFT-MS in SIM scan mode, and also correspond to product ion peaks 
associated with the identification of S. aureus within the FS headspace analysis. 
Furthermore, 2,3-butanedione, 2-methylbutanal and 3-methylbutanal have all 
previously been detected in the headspace of S. aureus cultures in other studies using 
SIFT-MS or GC-MS (Thorn, Reynolds and Greenman, 2011; Filipiak et al., 2012). 
Acetoin was also identified from the headspace of S. aureus biofilms using GC-MS 
and detected using SIFT-MS in SIM scan mode in this study as well as in the headspace 
of S. aureus cultures in a previous study using GC-MS for quantification (Filipiak et al., 
2012b).  However, in this present study, acetoin was detected at low levels in the 
headspace of S. aureus biofilms and was not selected as a potential discriminatory 
compound using MANOVA. 
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Acetaldehyde was detected using GC-MS, in the headspace of S. pyogenes biofilms 
cultured in the collagen wound biofilm model and from all three species, S. pyogenes, 
S. aureus and P. aeruginosa, using SIFT-MS in SIM scan mode. The 45 m/z product ion 
peak included in the FS analysis of biofilm headspace was detected at the greatest 
intensity from S. aureus biofilms, whereas acetaldehyde was detected at the lowest 
concentration from this species by SIFT-MS. This indicates that there may be other 
compounds, in addition to acetaldehyde, present in the headspace that result in the 
production of a product ion with a mass-to-charge ratio of 45 m/z. For example, lactic 
acid can give rise to a product ion peak at 45 m/z, which is known to be produced by 
S. aureus as an end point of glucose fermentation (Smith, 1991).  
Conversely, there are 9 discriminatory product ions, obtained from the headspace 
analysis of planktonic cultures in SWF that were not included as discriminant product 
ions in the analysis of the FS data set of product ions derived from the headspace of 
biofilm cultures. Furthermore 29 product ions that were included for the analysis of 
biofilm data were not present in the planktonic data set. Of the 9 product ions in the 
planktonic culture data set, 4 were detected predominantly in the headspace of E. 
coli cultures and therefore the absence of these product ions is expected, since E. coli 
was not cultured in the collagen wound biofilm model. Of the remaining five product 
ions, three were detected predominantly from S. aureus planktonic cultures, 
whereby the product ion 81 m/z could potentially be a secondary product ion derived 
for acetaldehyde, 109 m/z from 4-methylphenol, or perhaps as a secondary product 
ion from 2-methylpropanal. The product ion at 123 m/z may be derived from 
ethylphenol, or could arise as a secondary product ion of 3-methylbutanal or 2,3-
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butanedione, while the LabSyft library does not provide any likely compounds 
responsible for the 92 m/z product ion. The analysis of the headspace of biofilms of 
P. aeruginosa, S. pyogenes and S. aureus identified 29 potentially discriminant 
product ions using 10 cps as a threshold that were not selected in the planktonic 
culture data set.  These include several product ions identified which could arise from 
compounds subsequently identified by GC-MS; ammonia (18 and 36 m/z), acetone 
(59 and 77 m/z), butanone (91 m/z) and butane (77 m/z). This also highlights the 
potential identification of additional compounds with further GC-MS analysis.  The 
selection of a large number of discriminatory product ions using MANOVA for the 
analysis of the FS biofilm data, many of which are in addition to those derived from 
the 19 compounds included in the SIM mode analysis, provides further evidence of 
this. Identification of additional volatile compounds from which these product ions 
are derived, may facilitate improved groupings for identified bacterial species using 
SIM scan data, resulting in improved discrimination between bacterial species. In 
particular, it will be necessary to identify the compounds that give rise to the product 
ions that drive separation of S. pyogenes from uninoculated controls in Figure 6.7. 
This would facilitate the discrimination of S. pyogenes from uninoculated controls 
based on the quantification of known volatile compounds. This was not possible 
using SIM scan analysis with the compounds (19 in total) utilised within this study.  
This study determined that analysis of the headspace of multispecies biofilms 
containing two or more species of S. aureus, S. pyogenes and P. aeruginosa, resulted 
in a headspace profile dominated by the volatile compounds associated with one of 
the species present. When P. aeruginosa was present in the multispecies biofilm, the 
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profile of the biofilm headspace was most similar to that of P. aeruginosa single 
species biofilms. In the absence of P. aeruginosa (i.e. S. aureus and S. pyogenes 
multispecies biofilms), the volatile headspace profile was similar to that of single 
species S. aureus biofilms. 
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7.2 SUMMARY AND CONCLUSIONS 
This research was carried out to investigate if volatile profiles derived from bacterial 
species associated with causing wound infection could be detected and utilised to 
enable discrimination. The rationale for this study was to inform the future 
development of rapid diagnostics that will aid diagnosis of would infection and 
facilitate timely and appropriate treatment. Current clinical practice relies on clinical 
experience complimented by surface swab microbiology and blood tests for markers 
of inflammation. This approach often leads to empirical prescribing of broad 
spectrum antibiotics. 
Point of care diagnostics have the potential to revolutionise treatment of wound 
infection. The ability to rule out infection would prevent over-use of antimicrobials 
when there is no clinical need. In addition, early identification of the causative 
organism of infection, combined with knowledge of local epidemiology, would 
expedite selection of the most appropriate drug, improving patient outcomes. 
 
7.2.1 Chapter 3 
This chapter addressed the first aim, “to investigate if planktonic cultures of wound 
associated bacteria produce species specific volatile profiles in vitro, enabling 
discrimination”. 
This study demonstrates that using SIFT-MS and multivariate statistical analysis it is 
possible to discriminate wound-associated bacterial species based on the profile of 
selected SIFT-MS product ions and demonstrates that bacterial species associated 
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with causing wound infection produce species specific volatile profiles in vitro, when 
grown in planktonic culture in TSB and SWF. Volatile profiles vary between species 
and to a lesser extent, between stains of the same species under specific culture 
conditions. Culture conditions, including the composition of culture media and 
duration of incubation, influence the range of product ions and count rates of the 
resultant volatile compound mass spectra. It is evident from these results, as well as 
from other published studies, that culture conditions impact the production of 
microbial volatile metabolites. The ability to discriminate wound associated species 
when cultured in SWF, which provides a similar range of nutrients to wound exudate, 
lays the foundations for the development of this research in the subsequent chapters 
of this thesis. 
 
7.2.2 Chapter 4 
Chapter 4 addresses the second aim, “to investigate if the concept of species 
discrimination based on volatile compound detection could be applied to analysis of 
discarded wound dressings, as part of routine wound care”. 
Following the successful discrimination of six species of bacteria in planktonic 
culture, a research study was carried out in collaboration with the Children’s burns 
research centre at Bristol Royal Hospital for Children and Southmead Hospital adult 
burns centre. The aim of this study was to investigate if the concept of species 
discrimination based on detected volatile profiles could easily be translated to a 
clinical setting, through the detection of volatile profiles emanating from discarded 
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dressings. The rationale for this approach was to try and establish a feasible 
methodology for the detection of bacterial volatiles directly associated with patients’ 
wounds. This study demonstrated that it is possible to detect volatile profiles from 
discarded clinical wound dressings, and that the profile of volatiles differs between 
samples irrespective of dressing type. This suggests that the detected volatile profiles 
are derived from the patient and/or any bacteria present within the wound.  
However, these observed differences in the product ion profiles did not form 
groupings that correspond to the bacterial species detected on the wound surface by 
routine wound swabbing, when subjected to multivariate analysis (hierarchical 
cluster analysis). This study highlighted the potential difficulty of validating any new 
approach to the diagnosis of wound infection. As outlined above, diagnosis relies 
heavily on experienced clinicians recognising subtle signs and symptoms, and 
inevitably, the identification of infection will differ between clinicians. The routine 
use of wound surface swabbing does not represent an effective means of detecting 
the infecting organisms, particularly if these organisms lie deeper within the wound 
tissue. These factors will make testing the effectiveness of any new diagnostic 
methodologies very challenging. The findings of this chapter indicated that additional 
in vitro investigations of the volatile profiles of wound associated organisms grown 
under wound-like conditions was required before further development of the 
concept towards clinical applications. This lead to the development of the biofilm 
model and subsequent study reported in Chapters 5 and 6.  
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7.2.3 Chapter 5 
This Chapter addressed the third aim of the thesis “to develop and characterise a 
suitable biofilm model for culture and headspace analysis of wound associated 
bacterial biofilms, which provides wound-like culture conditions”. 
Development of this model was necessary to better assess the feasibility of volatile 
analysis for the discrimination of bacterial species growing within a wound, where 
bacteria will either grow as aggregates on the surface or will be embedded within the 
semi-solid matrix of the wound bed. The specific culture conditions employed will 
likely affect the metabolic profile of the organisms under investigation, resulting in a 
change in the volatile metabolites produced, compared to those detected from the 
same bacteria grown as planktonic cultures in a simulated wound fluid. A collagen 
wound biofilm model that combines a continuous flow system with a collagen gel 
growth matrix has been successfully developed to enable the culture of wound 
associated microorganisms under controlled conditions that more closely simulate a 
real wound environment. Reproducible culture of steady-state biofilms of S. aureus, 
P. aeruginosa and S. pyogenes within the developed collagen wound biofilm model 
have been successfully characterised. The model can be utilised for real-time analysis 
of volatile metabolites throughout biofilm formation and growth, and for discrete 
sampling to allow comparison of headspace volatile profiles between species of 
bacterial biofilms at specific time points. The collagen wound biofilm model is also 
suitable for assessing antimicrobial efficacy against biofilms cultured under ‘wound-
like’ conditions in vitro. Using the collagen wound biofilm model for the evaluation 
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of antimicrobial efficacy, a clinically relevant ceftazidime concentration was shown 
to fail in eradicating P. aeruginosa.  
 
7.2.4 Chapter 6 
Chapter 6 addressed the final two thesis aims, “to investigate if biofilm cultures of 
wound associated bacteria produce species specific volatile profile in vitro that can 
be used to discriminate between species” and “to investigate the effect of 
multispecies biofilms on bacterial volatile profiles in vitro”. The collagen wound 
biofilm model was applied to the study of volatile metabolites produced by wound 
associated bacterial species, allowing investigation of the volatile profiles detected 
from S. aureus, P. aeruginosa and S. pyogenes when these species are cultured as 
biofilms under wound-like growth conditions.  
This study demonstrates that S. aureus, P. aeruginosa and S. pyogenes biofilms 
produce headspace gases that vary between species. These differences can be 
detected as volatile compound product ion profiles when employing SIFT-MS in full 
scan mode and through the quantification of specific volatile compounds in selected 
ion mode. Combined with the use of multivariate statistical analysis, these 
differences in volatile headspace profiles can be used to successfully discriminate 
between species. However, the discrimination between S. pyogenes and 
uninoculated controls was only possible using full scan product ion profiles and not 
by the data obtained from the quantification of 19 specific volatile compounds.  The 
collagen wound biofilm model was also utilised to culture multispecies biofilms 
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containing S. aureus, P. aeruginosa and S. pyogenes either as dual species cultures or 
as biofilms containing all three bacterial species. Enumeration after 48 hours of total 
culture time demonstrated successful co-culture of these organisms in the collagen 
wound biofilm model. SIFT-MS was used to analyse and compare volatiles detected 
in the headspace of multispecies and single species biofilms. Identification of 
bacterial species using the detection of volatile metabolites is more complex when 
multiple species are present within the biofilm. In general, the multispecies biofilm 
headspace was dominated by volatiles strongly associated with one of the species 
present rather than exhibiting a range of volatiles characteristic of all species within 
the biofilm. The results of this study indicate that in a polymicrobial wound biofilm, 
the species investigated may be identified by the volatiles produced, but that this is 
also dependent upon the extent to which other bacterial species are present. 
Interestingly, the PCA plot comparing volatile profiles of single and multispecies 
biofilms suggests that P. aeruginosa may be identified regardless of the other species 
present, and that S. aureus may be identified if P. aeruginosa is absent. This study 
suggests that the application of volatile analysis to the diagnosis of clinically relevant 
wound infection may prove useful for identifying the causative organism where only 
a single organism is present, and for identifying P. aeruginosa and possibly S. aureus 
within an infection of polymicrobial aetiology. 
 
Overall, this research has successfully demonstrated the use of volatile analysis for 
discrimination between three important pathogens associated with causing wound 
infections. The results presented within this thesis indicate that this approach to 
Chapter 7 – Discussion & Future Work 
 
220 
 
wound diagnostics may be of particular use for the identification of the cause of 
infection within acute wounds, which are often caused by a single species. 
Application to the diagnosis of chronic wounds, which are more likely to be 
polymicrobial in aetiology, will be more complicated and will require further study.   
The results of this research indicate that use of volatile analysis has excellent 
potential as a novel approach to the diagnosis of wound infection. 
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7.3 FUTURE WORK 
7.3.1 Volatile Analysis 
This research has successfully demonstrated the application of volatile analysis for 
the discrimination of wound associated bacterial species, primarily P. aeruginosa, S. 
aureus and S. pyogenes. Although these species are commonly isolated from wounds, 
a diverse range of other organisms are also capable of causing wound infection 
(Bessa et al., 2015; Norbury et al., 2016). Analysis of volatile profiles of a broad range 
of organisms that are implicated in wound infection, cultured in the collagen wound 
biofilm model must also be undertaken to further this research. This should include 
clinical isolates of all species of interest in addition to reference strains, and 
additional isolates of species already analysed. Analysis of additional strains and 
species under wound like conditions, in the collagen wound biofilm model, will help 
elucidate the potential of volatile profiling as a novel approach to the diagnosis of 
wound infection.  
The GC-MS undertaken during this study identified 17 volatile compounds from the 
head space of three bacterial species, P. aeruginosa, S. aureus and S. pyogenes. To 
maximise the potential discrimination between a broad range of wound associated 
bacterial species, additional and extensive GC-MS analysis of all species of interest 
should be performed. As well as covering a broad range of wound associated 
bacterial species, this analysis should focus on optimising the GC-MS method, to 
maximise compound identification, and this may require the use of a variety of 
methods/materials to capture the volatile compounds. A number of pre-
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concentration methods have been utilised for the identification of microbial volatiles 
from human breath samples, including thermal desorption tubes, SPME fibres and 
headspace sorptive extraction, all of which use a range of sorbent materials that 
exhibit affinities for a variety of compound types (Thalavitiya Acharige, Koshy and 
Koo, 2018). Application of multiple extraction methods could also be applied to the 
identification of volatile metabolites released from biofilm cultured bacteria, to 
maximise the range of compounds captured and ultimately identified by GC-MS 
analysis.  
In addition, the collagen wound biofilm model combined with SIFT-MS could be used 
to monitor biofilm headspace volatile profiles during antimicrobial treatment. Not 
only to identify changes in volatile profiles which may occur during treatment, but 
also to determine if these profiles vary between susceptible and resistant isolates. A 
recent study using thermal desorption-gas chromatography-mass spectrometry (TD-
GC-MS) found that the volatile profiles of bacterial species associated with causing 
urinary tract infections varied depending on antibiotic sensitivity (Smart et al., 2019). 
The authors found that there were differences between sensitive and resistant 
isolates under normal culture conditions, but a greater number of compounds 
differed when the cephalosporin antibiotic cephalexin was added to the culture 
media. Further work is required in this area to explore this further. 
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7.3.2 Collagen Wound Biofilm Model 
Within this research, the developed collagen wound biofilm model was utilised for 
the analysis of volatile headspace of wound associated biofilms and for the 
assessment of the efficacy of ceftazidime against P. aeruginosa biofilms (chapter 5). 
However, the use of this model could be applied to any number of in vitro studies 
focused on bacterial species associated with would infection. Such studies could 
include assessing the efficacy of antimicrobial treatments on a range of pathogens 
associated with wound infection at various stages of biofilm development.  
In addition, this model system could be utilised to investigate treatment strategies 
against multispecies biofilms, to investigate the effect of treatment on polymicrobial 
infections such as those commonly found in chronic wounds. In direct relation to the 
work described in this thesis, it would be of interest to utilise this model to further 
investigate the interactions between species when culturing multispecies biofilms. 
For example, confocal microscopy was used within this research to compare the 
structure of treated and untreated P. aeruginosa biofilms. This technique combined 
with species specific staining, such as fluorescent in situ hybridisation (FISH) could be 
utilised to visualise physical interactions between bacterial species within 
multispecies biofilms. Furthermore, it may also be possible to determine if the spatial 
arrangement of the included species changes as the biofilm matures. The use of FISH 
combined with confocal microscopy to visualise the orientation of five bacterial 
species and Candida albicans within multispecies biofilms has been previously 
demonstrated (Thurnheer, Gmür and Guggenheim, 2004).  
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In addition, further developments could be made to the collagen wound biofilm 
model to improve the provision of a ‘wound like’ environment by this model system. 
In vivo, organisms infecting the wound bed will be ‘fed’ from below by exudate 
seeping from the host tissue. Would biofilm models incorporating the supply of 
nutrients from below have been developed (Anderl, Franklin and Stewart, 2000; 
Duckworth et al, 2018). However, these model systems involve the development of 
biofilms on the surface of a permeable membrane (polycarbonate or cellulose).  
Modification of the collagen wound biofilm model to supply SWF to the growing 
biofilm from below, while maintaining the continuous flow of fluid, would facilitate 
delivery of nutrients via a mechanism more akin to the real wound environment. 
Adaptation of the collagen wound biofilm model to facilitate delivery of simulated 
wound fluid in this manner is likely to be challenging due to the fragile nature of the 
collagen gel matrix, but casting the gels on to a permeable membrane instead of 
directly on to glass slides may facilitate this approach. Furthermore, delivery of SWF 
in this manner would allow the collagen wound biofilm model to be used for a wider 
range of antimicrobial studies, including assessment of topical treatments and 
antimicrobial dressing. 
 
7.3.3 Statistical Analysis 
The multivariate techniques used within this research, hierarchical cluster analysis 
and principal component analysis, are both unsupervised methods of analysis. Only 
the matrix of data is taken in to account during analysis and as such, these models 
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provide an unbiased summary of the data set without introducing bias from assigning 
groupings to the samples (Grace and Hudson, 2016). Of these two analyses, 
hierarchical cluster analysis gives a more precise description of the relationship 
between each individual sample within the data set. Although plotting only the first 
two or three principal components generated by PCA results in the loss of some of 
the information contained within the original data set, the majority of the variability 
will be accounted for. This method has the advantage that the plots of sample PCA 
scores and loading plots can be interpreted in combination. Thus allowing the 
influence of the original variables within the model and therefore on the separation 
of sample grouping to be determined.  
The statistical approach used within this research could be developed further to 
employ the use of supervised statistical techniques such as partial least squared 
discriminant analysis (PLS-DA) where known group classification is included within 
the analysis. PLS-DA is often used to compliment PCA and aims to identify the 
differences between the known sample  groupings and to identify the biologically 
relevant features within the model which account for such differences (Saccenti et 
al., 2014; Grace and Hudson, 2016). A significant advantage of PLS-DA is that the 
model defines the relationship between the data set and the sample categories, so 
that the sample category can then be predicted based on the structure of an 
unknown data set (Szymańska et al., 2012). Use of this statistical method to further 
analyse the data obtained during this research would allow testing of the model 
following the analysis of additional strains of each species by SIFT-MS as suggested 
in the previous section. The ability to predict sample groupings i.e. bacterial species, 
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based on the matrix of SIFT-MS data will be an essential step in the development of 
this research towards a diagnostic tool that can be implemented in a clinical setting. 
Interest in the use of machine learning for the analysis and implementation of 
multivariate data sets, including metabolomics data, has been increasing in recent 
years. Supervised machine learning is an application of artificial intelligence, where 
an algorithm is taught to map input data to specific outputs. Once trained, the 
algorithm can then classify unknown data based on what it has learned (Palma et al, 
2018). Combining real-time detection of bacterial metabolites emanating from 
infected wounds with rapid analysis is a key requirement for useful implementation 
of this research for the development of point of care diagnostics.  
 
7.3.4 Diagnostic Applications 
The underlying motivation for the research described in this thesis was the need to 
transform the diagnosis of wound infection. Not only to improve patient outcomes, 
but also to facilitate appropriate prescribing of antibiotics only when an infection is 
genuinely present, an important strategy in the response to the AMR crisis. 
Development of the use of volatile analysis for clinical application could utilise SIFT-
MS for direct or indirect assessment of patient wounds. Due to the size and high cost 
of a SIFT-MS instrument, this approach may only be feasible in a centralised hospital 
setting. A SIFT-MS study of volatile compounds from healthy human volunteers 
(Turner et al, 2008) successfully demonstrates the feasibility of collecting volatiles 
from human skin for direct analysis by SIFT-MS.  
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Secondly, development of a portable sensor device for point of care testing would 
enable widespread use. So called ‘electronic-nose’ technologies have been 
developed for application to disease diagnosis through detection of volatile 
compounds (Pavlou, Turner and Magan, 2002; Turner and Magan, 2004; Sethi, Nanda 
and Chakraborty, 2013). These systems consist of sensor arrays (e.g. conducting 
polymer sensors, metal oxide sensors, electrochemical sensors) for volatile 
characterisation generally based on pattern recognition, rather that detection of 
specific volatile compounds, and could be applied to the detection of volatile profiles 
of wound associated bacteria.  Any new approach to wound diagnostics would 
require validation. However, the lack of a current gold standard for the diagnosis of 
wound infection may make this challenging; a large scale trial in parallel with current 
diagnostic protocols would be required.
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Figure S2: Plot of the scores of the second and third principal components generated by principle component 
analysis of SIFT-MS SIM data of selected headspace volatile compound concentrations (ppb) of bacterial biofilms 
and uninoculated controls, showing Streptococcus pyogenes (Orange) and Staphylococcus aureus (Pink) only. 
Principal component 2 accounts for 26.1 % of the variation within the original data set, while the third 
components accounts for 5.45 % of the variation. 
  
